ࡱ> GJ@ABCDEF_ bjbj kbbN+&&&&&$8&8&8&P&$'8& *)XP*f*f*f*+++rtttttt5tQ&+++++t&&f*f*H+P&f*&f*+r޹Xf*Q1փ4|86(0 ^mlmPLm&6`+++++++tt+++ ++++m+++++++++ $: Appendix I: Therapeutic Modalities: Definitions and Examples Intervention CategoryDistinct ModalityDefinitionExamples of Modality ComponentsAcupunctureAny body needling, moxibustion, electric acupuncture, laser acupuncture, microsystem acupuncture, and acupressureTraditional needling Dry needling Burning of specific herbs Electro-acupuncture Photo-acupunctureEducationAny structured, standardized and condition-specific intervention learning experience intended to influence a patients health knowledge and behaviourPamphlets Books Videos Neck schools Discussion with healthcare providersExerciseA series of specific movements with the aim of training or developing the body by routine practice or as physical training to promote good physical healthStrengthening Flexibility Stretching/range of motion  Intervention CategoryDistinct ModalityDefinitionExamples of Modality ComponentsManual TherapyManipulationTechniques incorporating a high velocity, low amplitude impulse or thrust applied at or near the end of a joints passive range of motionCervical manipulation Thoracic manipulationMobilisationTechniques incorporating a low velocity and small or large amplitude oscillatory movement, within a joints passive range of motionCervical mobilization Thoracic mobilizationTractionManual or mechanically assisted application of an intermittent or continuous distractive forceCervical traction Prescribed MedicationA substance used in treating disease or relieving painAcetaminophen Non-steroidal anti-inflammatory drugs Muscle relaxants Intervention CategoryDistinct ModalityDefinitionExamples of Modality ComponentsPassive Physical Modalities A form of cold, heat or light application affecting the body at the skin level, or ultrasonic or electromagnetic radiation affecting structures beneath the skin surfaceHeat application: heat pack, hydrotherapy Cryotherapy: cold pack, vapocoolant spray Low level laser Electrical muscle stimulation Pulsed electromagnetic therapyPassive assistive devicesDevice to encourage immobilization in anatomic positions or actively inhibit or prevent movementPillows Seat cushions Collars Corsets Rest splintsFunctional assistive devicesDevice to align, support or otherwise facilitate function in the affected regionShoe orthotics Taping BracesPsychological InterventionsMethods used to treat emotional disturbances or mental illness primarily by verbal or non-verbal communicationCognitive behavioral therapy Interpersonal therapy Relaxation therapy BiofeedbackSoft Tissue TherapiesA mechanical form of therapy where soft tissue structures are pressed and kneaded, using physical contact with the hand or mechanical deviceMassage Muscle energy technique Strain-counterstrain therapy Appendix IIA. MEDLINE Literature Search Dates and Results Searches for all interventions for WAD/NAD were conducted in MEDLINE, EMBASE, PsycINFO and the Cochrane Central Register of Trials (through Ovid Technologies Inc.), and CINAHL Plus with Full Text through EBSCOhost. Listed below are the MEDLINE search dates and results for all interventions. Search strategies are available on request from the corresponding author. Acupuncture Search run April 10, 2013 in Ovid MEDLINE(R) 1946 to March Week 4 2013 and Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations April 5, 2013; 259 results; RCT update run May 28, 2015 in Ovid MEDLINE(R) 1946 to May Week 4 2015 and Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations May 27, 2015; 24 results Cost Effectiveness Search run March 12, 2013 in Ovid MEDLINE(R) 1946 to February Week 4 2013 and Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations March 12, 2013; run 354 results; Update run May 22, 2015 in Ovid MEDLINE(R) 1946 to May Week 3 2015; 178 results Education Search run October 31, 2012 in Ovid MEDLINE(R) 1946 to October Week 4 2012 and Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations October 29, 2012; 3482 results; RCT update run May 28, 2015 in Ovid MEDLINE(R) 1946 to May Week 4 2015 and Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations May 27, 2015; 81 results Exercise Search run April 10, 2013 in Ovid MEDLINE(R) 1946 to March Week 4 2013 and Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations March 30, 2013; 1350 results; RCT update run May 29, 2015 in Ovid MEDLINE(R) 1946 to May Week 4 2015 and Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations May 28, 2015; 204 results Manual Therapy Search run March 21, 2013 in Ovid MEDLINE(R) 1946 to March Week 2 2013 and Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations March 18, 2013; 335 results; RCT update run May 28, 2015 in Ovid MEDLINE(R) 1946 to May Week 4 2015 and Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations May 27, 2015; 86 results Medication Note: The original searches included WAD/NAD, back pain and systematic reviews only. The updates included only WAD/NAD. Medication: Analgesics Search run May 21, 2014 in Ovid MEDLINE(R) 1946 to May Week 1 2014 and Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations May 20, 2014; 359 results; Update run May 29, 2015 in Ovid MEDLINE(R) 1946 to May Week 4 2015 and Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations May 28, 2015; 14 results Medication: NSAIDs Search run April 8, 2014 in Ovid MEDLINE(R) 1946 to March Week 4 2014 and Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations April 08, 2014; 104 results Update run May 29, 2015 in Ovid MEDLINE(R) 1946 to May Week 4 2015 and Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations May 28, 2015; 2 results Medication: Muscle Relaxants Search run June 8, 2014 in Ovid MEDLINE(R) 1946 to May Week 4 2014 and Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations June 06, 2014; 65 results; Update run May 29, 2015 in Ovid MEDLINE(R) 1946 to May Week 4 2015 and Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations May 28, 2015; 4 results Multimodal Therapies Search run May 16, 2013 in Ovid MEDLINE(R) 1946 to May Week 2 2013 and Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations May 12, 2013; 777 results RCT update run May 28, 2015 in Ovid MEDLINE(R) 1946 to May Week 4 2015 and Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations May 27, 2015; 24 results Psychological Interventions Search run June 27, 2013 in Ovid MEDLINE(R) 1946 to June Week 3 2013; 945 results; Update run January 9, 2015 in Ovid MEDLINE(R) 1946 to November Week 3 2014 and Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations January 08, 2015; 133 results Passive Modalities Search run April 9, 2013 in Ovid MEDLINE(R) 1946 to March Week 4 2013 and Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations March 21, 2013; 502 results; RCT update run May 29, 2015 in Ovid MEDLINE(R) 1946 to May Week 4 2015 and Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations May 28, 2015; 60 results Soft Tissue Therapies Note: The original searches included back pain and WAD/NAD. The updates included only WAD/NAD. Search run May 30, 2013; Ovid MEDLINE(R) 1946 to May Week 4 2013 and Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations May 28, 2013; 1378 results; update run Feb. 26, 2014 in Ovid MEDLINE(R) 1946 to February Week 2 2014; 113 results; RCT update run May 29, 2015 in Ovid MEDLINE(R) 1946 to May Week 4 2015 and Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations May 28, 2015; 68 results Appendix IIB. MEDLINE Literature Search Strategies Acupuncture Search run April 10, 2013 in Ovid MEDLINE(R) 1946 to March Week 4 2013; 259 results; RCT update run May 28, 2015 in Ovid MEDLINE(R) 1946 to May Week 4 2015; 24 results [other study designs removed] 1. exp Whiplash Injuries/ 2. exp Neck Injuries/ 3. exp Neck Pain/ 4. Neck Muscles/in [Injuries] 5. exp Cervical Vertebrae/in [Injuries] 6. exp Radiculopathy/ 7. exp Brachial Plexus Neuropathies/ 8. exp Torticollis/ 9. Headache/ 10. whiplash.ab,ti. 11. "neck injur*".ab,ti. 12. "neck pain*".ab,ti. 13. "cervical pain*".ab,ti. 14. "neck ache*".ab,ti. 15. "neckache*".ab,ti. 16. "cervicalgia*".ab,ti. 17. "cervicodynia*".ab,ti. 18. "radiculopath*".ab,ti. 19. "brachial plexus neuropath*".ab,ti. 20. torticollis.ab,ti. 21. "headache*".ab,ti. 22. or/1-21 23. guideline.pt. 24. Practice Guidelines as Topic/ 25. Guideline Adherence/ 26. Randomized Controlled Trials as Topic/ 27. exp Controlled Clinical Trials as Topic/ 28. exp consensus development conferences as topic/ 29. "Review Literature as Topic"/ 30. meta-analysis.pt. 31. exp case-control studies/ 32. exp Cohort Studies/ 33. Double-Blind Method/ 34. single-blind method/ 35. Placebos/ 36. randomized controlled trial.pt. 37. controlled clinical trial.pt. 38. guideline.pt. 39. practice guideline.pt. 40. consensus development conference.pt. 41. "systematic review*".ab,ti. 42. (meta analys* or meta-analys* or metaanalys*).ab,ti. 43. (cohort adj4 (study or studies or analys*)).ab,ti. 44. (random* adj4 (control* or clinical or allocat*)).ab,ti. 45. "guideline*".ab,ti. 46. (case adj control*).ab,ti. 47. ((double or single) adj3 blind*).ab,ti. 48. "placebo*".ab,ti. 49. or/23-48 50. exp Acupuncture Therapy/ 51. Acupuncture Points/ 52. Acupuncture/ 53. Electric Stimulation Therapy/ 54. Electroacupuncture/ 55. Acupressure/ 56. exp Auriculotherapy/ 57. "acupuncture*".ab,ti. 58. (needling and (dry or body or "trigger point*")).ab,ti. 59. acupressure.ab,ti. 60. auriculotherapy.ab,ti. 61. (Shiatsu or Shiatzu or Zhi Ya or Chih Ya).ab,ti. 62. moxibustion.ab,ti. 63. electrical stimulation.ab,ti. 64. (Ching Lo or Jing Luo or Jingluo).ab,ti. 65. artemisia vulgaris.ab,ti. 66. Japanese Meridian Therapy.ab,ti. 67. French Energetic.ab,ti. 68. Korean Constitutional.ab,ti. 69. Lemington Five Elements.ab,ti. 70. intramuscular stimulation.ab,ti. 71. or/50-70 72. 22 and 49 and 71 73. limit 72 to (english language and humans and yr="1990-2015") Cost Effectiveness Search run March 12, 2013 in Ovid MEDLINE(R) 1946 to February Week 4 2013; run 354 results; Update run May 22, 2015 in Ovid MEDLINE(R) 1946 to May Week 3 2015; 178 results [run in all databases] 1. "Costs and Cost Analysis"/ 2. exp Cost-Benefit Analysis/ 3. Quality-Adjusted Life Years/ 4. Economics, Medical/ 5. Economics, Pharmaceutical/ 6. (economic* adj4 (evaluat* or stud*)).ab,ti. 7. (health economic* adj4 (evaluat* or stud*)).ab,ti. 8. ((cost-utility or cost utility) adj4 (stud* or analys*)).ab,ti. 9. ((cost-benefit or cost benefit) adj4 (stud* or analys*)).ab,ti. 10. (CEA or CUA or CBA).ab,ti. 11. ((cost-effective* or cost effective*) adj4 (analys* or stud*)).ab,ti. 12. (economic* adj4 (impact or value or factor* or analys*)).ab,ti. 13. "pharmacoeconomic*".ab,ti. 14. (cost* adj4 (health care or analys* or savings or hospital or medical or utilit* or effective* or efficac* or benefit* or consequence* or unit or drug*)).ab,ti. 15. (decision adj1 (tree* or analy* or model*)).ab,ti. 16. (qol or qoly or qolys or hrqol or qaly or qalys or qale or qales).ab,ti. 17. (sensitivity analys* or "willingness to pay" or quality-adjusted life year* or quality adjusted life year* or quality-adjusted life expectanc* or quality adjusted life expectanc*).ab,ti. 18. (markov* or monte carlo*).ab,ti. 19. or/1-18 20. exp Neck Injuries/ 21. exp Neck Pain/ 22. Neck Muscles/ 23. Cervical Vertebrae/ 24. exp Radiculopathy/ 25. exp Brachial Plexus Neuropathies/ 26. exp Torticollis/ 27. exp Whiplash Injuries/ 28. whiplash.ab,ti. 29. (headache* adj4 (whiplash or WAD or "neck pain")).ab,ti. 30. "neck injur*".ab,ti. 31. neck pain.ab,ti. 32. "neck ache*".ab,ti. 33. "neckache*".ab,ti. 34. "cervicalgia*".ab,ti. 35. "cervicodynia*".ab,ti. 36. "radiculopath*".ab,ti. 37. "brachial plexus neuropath*".ab,ti. 38. torticollis.ab,ti. 39. or/20-37 40. 19 and 39 41. limit 40 to (english language and yr="1990-2015") Education Search run October 31, 2012 in Ovid MEDLINE(R) 1946 to October Week 4 2012; 3482 results; RCT update run May 28, 2015 in Ovid MEDLINE(R) 1946 to May Week 4 2015; 81 results [other study designs removed] 1. exp Whiplash Injuries/ 2. exp Neck Injuries/ 3. exp Neck Pain/ 4. Neck Muscles/ 5. Cervical Vertebrae/ 6. exp Radiculopathy/ 7. exp Brachial Plexus Neuropathies/ 8. exp Torticollis/ 9. Headache/ 10. whiplash.ab,ti. 11. "neck injur*".ab,ti. 12. "neck pain*".ab,ti. 13. "cervical pain*".ab,ti. 14. "neck ache*".ab,ti. 15. "neckache*".ab,ti. 16. "cervicalgia*".ab,ti. 17. "cervicodynia*".ab,ti. 18. "radiculopath*".ab,ti. 19. "brachial plexus neuropath*".ab,ti. 20. torticollis.ab,ti. 21. "headache*".ab,ti. 22. or/1-21 23. exp Professional-Patient Relations/ 24. exp Patient Education as Topic/ 25. exp Patient Compliance/ 26. exp Patient Participation/ 27. exp Self Care/ 28. Program Evaluation/ 29. exp Health Knowledge, Attitudes, Practice/ 30. Learning/ 31. exp Videotape Recording/ 32. Communication/ 33. exp Internet/ 34. exp Cognitive Therapy/ 35. (patient* adj4 (educat* or inform* or learn* or teach* or knowledge or advice or advise*)).ab,ti. 36. (doctor* patient* adj4 (communicat* or educat* or relations* or interact*)).ab,ti. 37. (physician* patient* adj4 (communicat* or educat* or relations* or interact*)).ab,ti. 38. (nurse* patient* adj4 (communicat* or educat* or relations* or interact*)).ab,ti. 39. (educat* adj4 (consumer* or health)).ab,ti. 40. (pamphlet* or book* or neck book* or neck school* or internet or facebook or twitter or youtube or social media or advice or advise*).ab,ti. 41. ((cognitive or behavi*) adj3 (therap* or treatment*)).ab,ti. 42. "small group*".ab,ti. 43. (group* adj3 (learn* or teach*)).ab,ti. 44. self management.ab,ti. 45. or/23-44 46. exp guideline/ 47. Practice Guidelines as Topic/ 48. Guideline Adherence/ 49. Randomized Controlled Trials as Topic/ 50. exp Controlled Clinical Trials as Topic/ 51. exp consensus development conferences as topic/ 52. "Review Literature as Topic"/ 53. meta-analysis/ 54. exp case-control studies/ 55. exp Cohort Studies/ 56. Double-Blind Method/ 57. single-blind method/ 58. Placebos/ 59. randomized controlled trial.pt. 60. controlled clinical trial.pt. 61. guideline.pt. 62. practice guideline.pt. 63. consensus development conference.pt. 64. "systematic review*".ab,ti. 65. (meta analys* or meta-analys* or metaanalys*).ab,ti. 66. (cohort adj4 (study or studies or analys*)).ab,ti. 67. (random* adj4 (control* or clinical or allocat*)).ab,ti. 68. "guideline*".ab,ti. 69. (case adj control*).ab,ti. 70. ((double or single) adj3 blind*).ab,ti. 71. "placebo*".ab,ti. 72. or/46-71 73. 22 and 45 and 72 74. limit 73 to (english language and humans and yr="2000 -Current") Exercise Search run April 10, 2013 in Ovid MEDLINE(R) 1946 to March Week 4 2013; 1350 results; RCT update run May 29, 2015 in Ovid MEDLINE(R) 1946 to May Week 4 2015; 204 results [other study designs removed] 1. exp Whiplash Injuries/ 2. exp Neck Injuries/ 3. exp Neck Pain/ 4. Neck Muscles/in [Injuries] 5. exp Cervical Vertebrae/in [Injuries] 6. exp Radiculopathy/ 7. exp Brachial Plexus Neuropathies/ 8. exp Torticollis/ 9. whiplash.ab,ti. 10. "neck injur*".ab,ti. 11. "neck pain*".ab,ti. 12. "cervical pain*".ab,ti. 13. "neck ache*".ab,ti. 14. "neckache*".ab,ti. 15. "cervicalgia*".ab,ti. 16. "cervicodynia*".ab,ti. 17. "radiculopath*".ab,ti. 18. "brachial plexus neuropath*".ab,ti. 19. torticollis.ab,ti. 20. ("headache*" adj4 (whiplash or WAD or neck pain)).ab,ti. 21. or/1-20 22. Randomized Controlled Trials as Topic/ 23. exp Controlled Clinical Trials as Topic/ 24. meta-analysis.pt. 25. exp case-control studies/ 26. exp Cohort Studies/ 27. Double-Blind Method/ 28. single-blind method/ 29. Placebos/ 30. randomized controlled trial.pt. 31. controlled clinical trial.pt. 32. (meta analys* or meta-analys* or metaanalys*).ab,ti. 33. (cohort adj4 (study or studies or analys*)).ab,ti. 34. (random* adj4 (control* or clinical or allocat*)).ab,ti. 35. (case adj control*).ab,ti. 36. ((double or single) adj3 blind*).ab,ti. 37. "placebo*".ab,ti. 38. or/22-37 39. exp Exercise Therapy/ 40. exp Exercise/ 41. exp Exercise Movement Techniques/ 42. Physical Fitness/ 43. exp Physical Therapy Modalities/ 44. Neck Pain/rh, th [Rehabilitation, Therapy] 45. Shoulder Pain/rh, th [Rehabilitation, Therapy] 46. Whiplash Injuries/rh, th [Rehabilitation, Therapy] 47. exp Biofeedback, Psychology/ 48. exp Combined Modality Therapy/ 49. Motor Activity/ 50. Muscle Strength/ 51. Physical Endurance/ 52. Physical Exertion/ 53. Relaxation Therapy/ 54. Behavior Therapy/ 55. (alexander and (technique or method)).ab,ti. 56. dynamic muscle training.ab,ti. 57. "dynamic multimodal treatment protocol*".ab,ti. 58. "dynamic resisted strengthening exercise*".ab,ti. 59. (exercis* adj4 (strengthening or home or fitness or neck or mobilization or mobilisation or mobility or supervis* or MedX)).ab,ti. 60. (exercis* adj4 (eye-neck coordination or low load or low-load or low-tech or Mackenzie or proprioceptive or strength* or aerobic or therapy)).ab,ti. 61. (exercis* adj4 (stretch-shortening or stretch shortening)).ab,ti. 62. (training and (fitness or endurance or physical or postural or program* or strength* or supervis* or plyometric)).ab,ti. 63. (rehabilitat* and (eye-head coupling or program* or training)).ab,ti. 64. Feldenkrais.ab,ti. 65. "behavio* graded activity program*".ab,ti. 66. (stretch* and (active or ballistic or dynamic or isometric or static)).ab,ti. 67. "early active mobili*".ab,ti. 68. physical conditioning.ab,ti. 69. (shoulder and (isometric or endurance or strength* or training)).ab,ti. 70. (physiotherap* and (program* or regimen*)).ab,ti. 71. (physical therap* and (program* or regimen*)).ab,ti. 72. pilates.ab,ti. 73. kinesthesia.ab,ti. 74. Proprioceptive Neuromuscular Facilitation.ab,ti. 75. (Qigong or Qi Gong or Ch'i Kung).ab,ti. 76. (Tai-ji or Tai Chi or Tai Ji Quan or Tai Ji or Taiji or Taijiquan or T'ai Chi or Tai Chi Chuan).ab,ti. 77. or/39-76 78. 21 and 38 and 77 79. limit 78 to (english language and humans and yr="1990 -2015") Manual Therapy Search run March 21, 2013 in Ovid MEDLINE(R) 1946 to March Week 2 2013; 335 results; RCT update run May 28, 2015 in Ovid MEDLINE(R) 1946 to May Week 4 2015; 86 results [other study designs removed] 1. exp Whiplash Injuries/ 2. exp Neck Injuries/ 3. exp Neck Pain/ 4. Neck Muscles/in [Injuries] 5. exp Cervical Vertebrae/in [Injuries] 6. exp Radiculopathy/ 7. exp Brachial Plexus Neuropathies/ 8. exp Torticollis/ 9. whiplash.ab,ti. 10. "neck injur*".ab,ti. 11. "neck pain*".ab,ti. 12. "cervical pain*".ab,ti. 13. "neck ache*".ab,ti. 14. "neckache*".ab,ti. 15. "cervicalgia*".ab,ti. 16. "cervicodynia*".ab,ti. 17. "radiculopath*".ab,ti. 18. "brachial plexus neuropath*".ab,ti. 19. torticollis.ab,ti. 20. ("headache*" adj4 (whiplash or WAD or neck pain)).ab,ti. 21. Randomized Controlled Trials as Topic/ 22. exp Controlled Clinical Trials as Topic/ 23. exp consensus development conferences as topic/ 24. meta-analysis.pt. 25. exp case-control studies/ 26. exp Cohort Studies/ 27. Double-Blind Method/ 28. single-blind method/ 29. Placebos/ 30. randomized controlled trial.pt. 31. controlled clinical trial.pt. 32. (meta analys* or meta-analys* or metaanalys*).ab,ti. 33. (cohort adj4 (study or studies or analys*)).ab,ti. 34. (random* adj4 (control* or clinical or allocat* or trial*)).ab,ti. 35. (case adj control*).ab,ti. 36. ((double or single) adj3 blind*).ab,ti. 37. "placebo*".ab,ti. 38. or/1-20 39. or/21-37 40. Musculoskeletal Manipulations/ 41. Manipulation, Spinal/ 42. Manipulation, Chiropractic/ 43. Manipulation, Orthopedic/ 44. Manipulation, Osteopathic/ 45. Motion Therapy, Continuous Passive/ 46. Muscle Stretching Exercises/ 47. (manipulat* adj4 (spinal or lumbar or thoracic or cervical)).ab,ti. 48. (mobili?ation adj4 (spinal or lumbar or thoracic or cervical)).ab,ti. 49. (manipulat* adj4 (chiropract* or osteopath* or orthopedic* or orthopaedic*)).ab,ti. 50. (mobili?ation adj4 (chiropract* or osteopath* or orthopedic* or orthopaedic*)).ab,ti. 51. (adjustment* adj4 (chiropract* or spinal or lumbar or cervical or thoracic)).ab,ti. 52. (therap* adj4 (manual or manipulat* or mobili?at*)).ab,ti. 53. (traction and (manual or passive or mechanical or non-surgical or nonsurgical)).ab,ti. 54. (flexion-distraction or flexion distraction).ab,ti. 55. (HVLA or high velocity low amplitude).ab,ti. 56. (manipulat* and (instrument assisted or instrument-assisted)).ab,ti. 57. (manipulat* and (physiotherap* or physical therap*)).ab,ti. 58. (mobili?ation and (physiotherap* or physical therap*)).ab,ti. 59. (musculoskeletal and (physiotherap* or physical therap*)).ab,ti. 60. or/40-59 61. 38 and 39 and 60 62. limit 61 to (english language and yr="1990-2015") Medication Note: The original searches included back pain and systematic reviews only. The updates included only WAD/NAD. Medication: Analgesics Search run May 21, 2014 in Ovid MEDLINE(R) 1946 to May Week 1 2014; 359 results; Update run May 29, 2015 in Ovid MEDLINE(R) 1946 to May Week 4 2015; 14 results 1. Whiplash Injuries/ 2. Neck Injuries/ 3. Neck Pain/ 4. Neck Muscles/in [Injuries] 5. exp Cervical Vertebrae/in [Injuries] 6. Radiculopathy/ 7. exp Brachial Plexus Neuropathies/ 8. Torticollis/ 9. whiplash.ab,ti. 10. "neck injur*".ab,ti. 11. "neck pain*".ab,ti. 12. "cervical pain*".ab,ti. 13. "neck ache*".ab,ti. 14. "neckache*".ab,ti. 15. "cervicalgia*".ab,ti. 16. "cervicodynia*".ab,ti. 17. "radiculopath*".ab,ti. 18. "brachial plexus neuropath*".ab,ti. 19. torticollis.ab,ti. 20. or/1-19 21. exp Back/ 22. exp Back Injuries/ 23. exp Back Pain/ 24. Coccyx/in [Injuries] 25. Intervertebral Disc Degeneration/ 26. Intervertebral Disc Displacement/ 27. Lumbar Vertebrae/in [Injuries] 28. exp Lumbosacral Plexus/ 29. Lumbosacral Region/in [Injuries] 30. Osteoarthritis, Spine/ 31. Piriformis Muscle Syndrome/ 32. Polyradiculopathy/ 33. Sacrococcygeal Region/ 34. Sacroiliac Joint/ 35. Sacrum/ 36. Sciatica/ 37. Spinal Diseases/ 38. Spinal Stenosis/ 39. (avulsed lumbar adj3 (disc* or disk*)).ab,ti. 40. (back adj3 (ache* or injur* or pain*)).ab,ti. 41. (backache* adj3 (injur* or pain*)).ab,ti. 42. (back pain or back-pain).ab,ti. 43. coccydynia.ab,ti. 44. coccyx.ab,ti. 45. dorsalgia.ab,ti. 46. (lumbar disc* adj3 (extruded or degenerat* or herniat* or prolapse* or sequestered or slipped)).ab,ti. 47. (lumbar disk* adj3 (extruded or degenerat* or herniat* or prolapse* or sequestered or slipped)).ab,ti. 48. "low* back pain".ab,ti. 49. "low*-back-pain*".ab,ti. 50. (lumbar adj3 (pain or facet or nerve root* or osteoarthritis or radicul* or spinal stenosis or spondylo* or zygapophys*)).ab,ti. 51. "lumbarsacr*".ab,ti. 52. lumboischialgia.ab,ti. 53. "lumbosacr*".ab,ti. 54. "Piriformis syndrome*".ab,ti. 55. radiculalgia.ab,ti. 56. (sacral adj2 pain*).ab,ti. 57. (sacrococcygeal adj2 pain*).ab,ti. 58. (sacroiliac or sacro-iliac).ab,ti. 59. "sciatic*".ab,ti. 60. (SI adj2 joint).ab,ti. 61. (spinal adj2 stenos?s).ab,ti. 62. spondylosis.ab,ti. 63. "tailbone adj3 pain*".ab,ti. 64. "vertebrogenic adj3 pain*".ab,ti. 65. or/21-64 66. 20 or 65 67. Analgesics/ 68. Analgesics, Short-Acting/ 69. Analgesics, Non-Narcotic/ 70. Acetaminophen/ 71. Colchicine/ 72. Bupivacaine/ 73. Lidocaine/ 74. choline magnesium trisalicylate/ 75. Analgesic*.ab,hw,ti,nm. 76. Acetaminophen.ab,hw,ti,nm. 77. Colchicine.ab,hw,ti,nm. 78. Bupivacaine.ab,hw,ti,nm. 79. Lidocaine.ab,hw,ti,nm. 80. choline magnesium trisalicylate.ab,hw,ti,nm. 81. or/67-80 82. Acamol.ab,ti. 83. Ace+.ab,ti. 84. Adol.ab,ti. 85. Adolinta.ab,ti. 86. Aldolor.ab,ti. 87. Aloprim.ab,ti. 88. Alvedon.ab,ti. 89. Anestacaine.ab,ti. 90. APAP.ab,ti. 91. Apiretal.ab,ti. 92. Atamel.ab,ti. 93. Atasol.ab,ti. 94. Benuron.ab,ti. 95. Biogesic.ab,ti. 96. Biogesic-Kiddielets.ab,ti. 97. Buscapina.ab,ti. 98. Calpol.ab,ti. 99. Captin.ab,ti. 100. Colcrys.ab,ti. 101. Coldex.ab,ti. 102. Conzip.ab,ti. 103. Cotibin.ab,ti. 104. Dafalgan.ab,ti. 105. Daleron.ab,ti. 106. Dawa ya magi.ab,ti. 107. Depon.ab,ti. 108. Dexamol.ab,ti. 109. Dolex.ab,ti. 110. Dolgesic.ab,ti. 111. Doliprane.ab,ti. 112. Dolprone.ab,ti. 113. Duiyixian anjifen pian.ab,ti. 114. Efferalgan.ab,ti. 115. Enelfa.ab,ti. 116. Europain.ab,ti. 117. Febrectal.ab,ti. 118. Febricet.ab,ti. 119. Febridol.ab,ti. 120. Fensum.ab,ti. 121. Gelocatil.ab,ti. 122. Gesic.ab,ti. 123. Gripin.ab,ti. 124. Hedanol.ab,ti. 125. Hedex.ab,ti. 126. Herron.ab,ti. 127. Influbene.ab,ti. 128. Kafa.ab,ti. 129. Kitadil.ab,ti. 130. Lekadol.ab,ti. 131. Lopurin.ab,ti. 132. Lupocet.ab,ti. 133. Marcain*.ab,ti. 134. Metacin.ab,ti. 135. Mexalen.ab,ti. 136. Milidon.ab,ti. 137. Minoset.ab,ti. 138. Momentum.ab,ti. 139. Napa.ab,ti. 140. Neo-Kiddielets.ab,ti. 141. Pacimol.ab,ti. 142. Pacol.ab,ti. 143. (Pain adj Relief).ab,ti. 144. Pamol.ab,ti. 145. Panadeine.ab,ti. 146. Panado*.ab,ti. 147. Panamax.ab,ti. 148. Panda.ab,ti. 149. Panodil.ab,ti. 150. Para.ab,ti. 151. Para,ol.ab,ti. 152. Paracet.ab,ti. 153. Paracitol.ab,ti. 154. Paracod.ab,ti. 155. Paralen.ab,ti. 156. Paramed.ab,ti. 157. Parol.ab,ti. 158. Perdolan.ab,ti. 159. Perfalgan.ab,ti. 160. Pinex.ab,ti. 161. Plicet.ab,ti. 162. PyongSu Cetamol.ab,ti. 163. Pyrenol.ab,ti. 164. Pyrigesic.ab,ti. 165. Ralivia.ab,ti. 166. Reliv.ab,ti. 167. Revanin.ab,ti. 168. Rokamol.ab,ti. 169. Rubophen.ab,ti. 170. Ryzolt.ab,ti. 171. Sara.ab,ti. 172. Scanol.ab,ti. 173. Sensorcaine.ab,ti. 174. Sinpro N.ab,ti. 175. Tachipirin Tachipirina.ab,ti. 176. Tafirol.ab,ti. 177. Tapsin.ab,ti. 178. Tempra.ab,ti. 179. Termalgin.ab,ti. 180. Thomapyrin.ab,t. 181. Tipol.ab,ti. 182. Togal Classic Duo.ab,ti. 183. Treuphadol.ab,ti. 184. Triaminic.ab,ti. 185. Tylenol.ab,ti. 186. Ultracet.ab,ti. 187. Ultram.ab,ti. 188. Uphamol.ab,ti. 189. Vermidon.ab,ti. 190. Vitamol.ab,ti. 191. Vivacaine.ab,ti. 192. Xumadol.ab,ti. 193. Xylocaine.ab,ti. 194. ZolbenZytram.ab,ti. 195. Zyloprim.ab,ti. 196. Zytram XL Durella.ab,ti. 197. or/82-196 198. 81 or 197 199. Meta-Analysis as Topic/ 200. Meta-Analysis.pt. 201. (meta adj analy*).ti,ab. 202. metaanaly*.ti,ab. 203. (systematic adj3 (review* or overview*)).ti,ab. 204. (methodologic* adj3 (review* or overview*)).ti,ab. 205. (integrative adj3 (review* or overview*)).ti,ab. 206. (collaborative adj3 (review* or overview*)).ti,ab. 207. exp Review Literature as Topic/ 208. medline.ab. 209. pubmed.ab. 210. cochrane.ab. 211. embase.ab. 212. (psychlit or psyclit).ab. 213. (psychinfo or psycinfo).ab. 214. (cinahl or cinhal).ab. 215. science citation index.ab. 216. (reference adj3 list*).ab. 217. bibliograph*.ab. 218. (hand-search* or handsearch).ab. 219. manual search*.ab. 220. or/199-219 221. Review/ 222. (selection adj3 criteria).ab. 223. (data adj3 (extraction or synthes*)).ab. 224. 221 and (222 or 223) 225. 220 or 224 226. 66 and 198 and 225 227. limit 226 to (english language and yr="2000 -2015") Medication: NSAIDs Search run April 8, 2014 in Ovid MEDLINE(R) 1946 to March Week 4 2014; 104 results Update run May 29, 2015 in Ovid MEDLINE(R) 1946 to May Week 4 2015; 2 results 1. Whiplash Injuries/ 2. Neck Injuries/ 3. Neck Pain/ 4. Neck Muscles/in [Injuries] 5. exp Cervical Vertebrae/in [Injuries] 6. Radiculopathy/ 7. exp Brachial Plexus Neuropathies/ 8. Torticollis/ 9. whiplash.ab,ti. 10. "neck injur*".ab,ti. 11. "neck pain*".ab,ti. 12. "cervical pain*".ab,ti. 13. "neck ache*".ab,ti. 14. "neckache*".ab,ti. 15. "cervicalgia*".ab,ti. 16. "cervicodynia*".ab,ti. 17. "radiculopath*".ab,ti. 18. "brachial plexus neuropath*".ab,ti. 19. torticollis.ab,ti. 20. or/1-19 21. exp Back/ 22. exp Back Injuries/ 23. exp Back Pain/ 24. Coccyx/in [Injuries] 25. Intervertebral Disc Degeneration/ 26. Intervertebral Disc Displacement/ 27. Lumbar Vertebrae/in [Injuries] 28. exp Lumbosacral Plexus/ 29. Lumbosacral Region/in [Injuries] 30. Osteoarthritis, Spine/ 31. Piriformis Muscle Syndrome/ 32. Polyradiculopathy/ 33. Sacrococcygeal Region/ 34. Sacroiliac Joint/ 35. Sacrum/ 36. Sciatica/ 37. Spinal Diseases/ 38. Spinal Stenosis/ 39. (avulsed lumbar adj3 (disc* or disk*)).ab,ti. 40. (back adj3 (ache* or injur* or pain*)).ab,ti. 41. (backache* adj3 (injur* or pain*)).ab,ti. 42. (back pain or back-pain).ab,ti. 43. coccydynia.ab,ti. 44. coccyx.ab,ti. 45. dorsalgia.ab,ti. 46. (lumbar disc* adj3 (extruded or degenerat* or herniat* or prolapse* or sequestered or slipped)).ab,ti. 47. (lumbar disk* adj3 (extruded or degenerat* or herniat* or prolapse* or sequestered or slipped)).ab,ti. 48. "low* back pain".ab,ti. 49. "low*-back-pain*".ab,ti. 50. (lumbar adj3 (pain or facet or nerve root* or osteoarthritis or radicul* or spinal stenosis or spondylo* or zygapophys*)).ab,ti. 51. "lumbarsacr*".ab,ti. 52. lumboischialgia.ab,ti. 53. "lumbosacr*".ab,ti. 54. "Piriformis syndrome*".ab,ti. 55. radiculalgia.ab,ti. 56. (sacral adj2 pain*).ab,ti. 57. (sacrococcygeal adj2 pain*).ab,ti. 58. (sacroiliac or sacro-iliac).ab,ti. 59. "sciatic*".ab,ti. 60. (SI adj2 joint).ab,ti. 61. (spinal adj2 stenos?s).ab,ti. 62. spondylosis.ab,ti. 63. "tailbone adj3 pain*".ab,ti. 64. "vertebrogenic adj3 pain*".ab,ti. 65. or/21-64 66. 20 or 65 67. exp Anti-Inflammatory Agents, Non-Steroidal/ 68. alclofenac.ab,hw,ti,nm. 69. Aspirin.ab,hw,ti,nm. 70. Cyclooxygenase 2.ab,hw,ti,nm. 71. benoxaprofen.ab,hw,ti,nm. 72. Benzydamine.ab,hw,ti,nm. 73. Bufexamac.ab,hw,ti,nm. 74. celecoxib.ab,hw,ti,nm. 75. dexibuprofen.ab,hw,ti,nm. 76. dexketoprofen trometamol.ab,hw,ti,nm. 77. Diclofenac.ab,hw,ti,nm. 78. Dipyrone.ab,hw,ti,nm. 79. Diflunisal.ab,hw,ti,nm. 80. droxicam.ab,hw,ti,nm. 81. Etodolac.ab,hw,ti,nm. 82. etofenamate.ab,hw,ti,nm. 83. etoricoxib.ab,hw,ti,nm. 84. Fenoprofen.ab,hw,ti,nm. 85. firocoxib.ab,hw,ti,nm. 86. Flufenamic Acid.ab,hw,ti,nm. 87. Flurbiprofen.ab,hw,ti,nm. 88. Ibuprofen.ab,hw,ti,nm. 89. Indomethacin.ab,hw,ti,nm. 90. isoxicam.ab,hw,ti,nm. 91. Ketoprofen.ab,hw,ti,nm. 92. Ketorola.ab,hw,ti,nm. 93. loxoprofen.ab,hw,ti,nm. 94. lumiracoxib.ab,hw,ti,nm. 95. lysine clonixinate.ab,hw,ti,nm. 96. Magnesium Salicylate.ab,hw,ti,nm. 97. Meclofenamic Acid.ab,hw,ti,nm. 98. Mefenamic Acid.ab,hw,ti,nm. 99. meloxicam.ab,hw,ti,nm. 100. morniflumate.ab,hw,ti,nm. 101. Naproxen.ab,hw,ti,nm. 102. Niflumic Acid.ab,hw,ti,nm. 103. Oxyphenbutazone.ab,hw,ti,nm. 104. piketoprofen.ab,hw,ti,nm. 105. Piroxicam.ab,hw,ti,nm. 106. salicylsalicylic acid.ab,hw,ti,nm. 107. Sulindac.ab,hw,ti,nm. 108. tenoxicam.ab,hw,ti,nm. 109. Tolmetin.ab,hw,ti,nm. 110. valdecoxib.ab,hw,ti,nm. 111. or/67-110 112. Actron.ti,ab. 113. Acular.ti,ab. 114. Advil.ti,ab. 115. Afrolate.ti,ab. 116. Aleve.ti,ab. 117. Algesalona.ti,ab. 118. Amigesic.ti,ab. 119. Anacin.ti,ab. 120. Anaflex 750.ti,ab. 121. Anaprox.ti,ab. 122. Ansaid.ti,ab. 123. Arthitab.ti,ab. 124. Arthropam.ti,ab. 125. Arthrotec.ti,ab. 126. Ascriptin.ti,ab. 127. Bayer.ti,ab. 128. Bayro.ti,ab. 129. Bextra.ti,ab. 130. Bufferin.ti,ab. 131. Cambia.ti,ab. 132. Cataflam.ti,ab. 133. celebrex.ti,ab. 134. Clinoril.ti,ab. 135. Cuprofen.ti,ab. 136. Daypro.ti,ab. 137. Diflamil.ti,ab. 138. Dignodolin.ti,ab. 139. Disalcid.ti,ab. 140. Doan's Pills.ti,ab. 141. Dolinac.ti,ab. 142. Dolobid.ti,ab. 143. Duexis.ti,ab. 144. Ecotrin.ti,ab. 145. Feldene.ti,ab. 146. Fenbid.ti,ab. 147. Fenomel.ti,ab. 148. Fentiazac.ti,ab. 149. Flector.ti,ab. 150. Flexidol.ti,ab. 151. Flexium.ti,ab. 152. Flogoprofen.ti,ab. 153. Flurwood.ti,ab. 154. Froben.ti,ab. 155. Hifenac.ti,ab. 156. Ibuprofen.ti,ab. 157. Indocin.ti,ab. 158. Indomethegan.ti,ab. 159. Ketofen.ti,ab. 160. Lodine.ti,ab. 161. Magan.ti,ab. 162. Marthritic.ti,ab. 163. Meclomen.ti,ab. 164. Mobic.ti,ab. 165. Mobidin.ti,ab. 166. Mobogesic.ti,ab. 167. Mono-Gesic.ti,ab. 168. Motrin.ti,ab. 169. Nalfon.ti,ab. 170. Naprelan.ti,ab. 171. Naprosyn.ti,ab. 172. Niflatol.ti,ab. 173. Niflugel.ti,ab. 174. Nifluril.ti,ab. 175. Nixyn.ti,ab. 176. Nuprin.ti,ab. 177. Oftalar.ti,ab. 178. Orudis.ti,ab. 179. Oruvail.ti,ab. 180. Paraderm.ti,ab. 181. Parfenac.ti,ab. 182. Pennsaid.ti,ab. 183. Ponstel.ti,ab. 184. Pranox.ti,ab. 185. Relafen.ti,ab. 186. Salflex.ti,ab. 187. Salsitab.ti,ab. 188. Sastridex.ti,ab. 189. Solaraze.ti,ab. 190. Solpaflex.ti,ab. 191. Sprix.ti,ab. 192. Suxibuzone.ti,ab. 193. Tiloket.ti,ab. 194. Tolectin.ti,ab. 195. Toradol.ti,ab. 196. Transact Lat.ti,ab. 197. Traumalix.ti,ab. 198. Traumon.ti,ab. 199. Traxam.ti,ab. 200. Trilisate.ti,ab. 201. Triparsean.ti,ab. 202. Triscosal.ti,ab. 203. Vimovo.ti,ab. 204. Vioxx.ti,ab. 205. voltaren*.ti,ab. 206. Voltarol.ti,ab. 207. or/112-206 208. 111 or 207 209. acetylsalicyl*.ti,ab. 210. COX 1.ti,ab. 211. COX 2.ti,ab. 212. COX I.ti,ab. 213. COX II.ti,ab. 214. COX-1.ti,ab. 215. COX-2.ti,ab. 216. COX-I.ti,ab. 217. COX-II.ti,ab. 218. cyclooxygenase.ti,ab. 219. cyclo-oxygenase.ti,ab. 220. non-steroidal anti-inflammatory agent*.ti,ab. 221. nonsteroidal anti-inflammatory agent*.ti,ab. 222. NSAIA*.ti,ab. 223. NSAID*.ti,ab. 224. NSAIM*.ti,ab. 225. salicylate*.ti,ab. 226. or/209-225 227. 208 or 226 228. 66 and 227 229. Meta-Analysis as Topic/ 230. Meta-Analysis.pt. 231. (meta adj analy*).ti,ab. 232. metaanaly*.ti,ab. 233. (systematic adj3 (review* or overview*)).ti,ab. 234. (methodologic* adj3 (review* or overview*)).ti,ab. 235. (integrative adj3 (review* or overview*)).ti,ab. 236. (collaborative adj3 (review* or overview*)).ti,ab. 237. exp Review Literature as Topic/ 238. medline.ab. 239. pubmed.ab. 240. cochrane.ab. 241. embase.ab. 242. (psychlit or psyclit).ab. 243. (psychinfo or psycinfo).ab. 244. (cinahl or cinhal).ab. 245. science citation index.ab. 246. (reference adj3 list*).ab. 247. bibliograph*.ab. 248. (hand-search* or handsearch).ab. 249. manual search*.ab. 250. or/229-249 251. Review/ 252. (selection adj3 criteria).ab. 253. (data adj3 (extraction or synthes*)).ab. 254. 251 and (252 or 253) 255. 250 or 254 256. 228 and 255 257. limit 256 to (english language and humans and yr="2000 -Current") Medication: Muscle Relaxants Search run June 8, 2014 in Ovid MEDLINE(R) 1946 to May Week 4 2014; 65 results; Update run May 29, 2015 in Ovid MEDLINE(R) 1946 to May Week 4 2015; 4 results 1. exp Whiplash Injuries/ 2. exp Neck Injuries/ 3. exp Neck Pain/ 4. Neck Muscles/in [Injuries] 5. exp Cervical Vertebrae/in [Injuries] 6. exp Radiculopathy/ 7. exp Brachial Plexus Neuropathies/ 8. exp Torticollis/ 9. whiplash.ab,ti. 10. "neck injur*".ab,ti. 11. "neck pain*".ab,ti. 12. "cervical pain*".ab,ti. 13. "neck ache*".ab,ti. 14. "neckache*".ab,ti. 15. "cervicalgia*".ab,ti. 16. "cervicodynia*".ab,ti. 17. "radiculopath*".ab,ti. 18. "brachial plexus neuropath*".ab,ti. 19. torticollis.ab,ti. 20. WAD.ab,ti. 21. NAD.ab,ti. 22. or/1-21 23. exp Back/ 24. exp Back Injuries/ 25. exp Back Pain/ 26. Coccyx/in [Injuries] 27. Intervertebral Disc Degeneration/ 28. intervertebral disk hernia/ 29. Lumbar Vertebrae/in [Injuries] 30. exp Lumbosacral Plexus/ 31. Lumbosacral Region/in [Injuries] 32. Osteoarthritis, Spine/ 33. Piriformis Muscle Syndrome/ 34. Polyradiculopathy/ 35. Sacroiliac Joint/ 36. Sacrococcygeal Region/ 37. Sacrum/ 38. Spinal Diseases/ 39. Spinal Stenosis/ 40. Sciatica/ 41. (avulsed lumbar adj3 (disc* or disk*)).ab,ti. 42. (back adj3 (ache* or injur* or pain*)).ab,ti. 43. (backache* adj3 (injur* or pain*)).ab,ti. 44. (back pain or back-pain).ab,ti. 45. coccydynia.ab,ti. 46. coccyx.ab,ti. 47. dorsalgia.ab,ti. 48. (lumbar disc* adj3 (extruded or degenerat* or herniat* or prolapse* or sequestered or slipped)).ab,ti. 49. (lumbar disk* adj3 (extruded or degenerat* or herniat* or prolapse* or sequestered or slipped)).ab,ti. 50. "low* back pain".ab,ti. 51. "low*-back-pain*".ab,ti. 52. (lumbar adj3 (pain or facet or nerve root* or osteoarthritis or radicul* or spinal stenosis or spondylo* or zygapophys*)).ab,ti. 53. "lumbarsacr*".ab,ti. 54. lumboischialgia.ab,ti. 55. "lumbosacr*".ab,ti. 56. "Piriformis syndrome*".ab,ti. 57. radiculalgia.ab,ti. 58. (sacral adj2 pain*).ab,ti. 59. (sacrococcygeal adj2 pain*).ab,ti. 60. (sacroiliac or sacro-iliac).ab,ti. 61. "sciatic*".ab,ti. 62. (SI adj joint).ab,ti. 63. (spinal adj2 stenos?s).ab,ti. 64. spondylosis.ab,ti. 65. "tailbone adj3 pain*".ab,ti. 66. "vertebrogenic adj3 pain*".ab,ti. 67. or/23-62 68. 22 or 67 69. Meta-Analysis as Topic/ 70. Meta-Analysis.pt. 71. exp Review Literature as Topic/ 72. (meta adj analy*).ti,ab. 73. metaanaly*.ti,ab. 74. (systematic adj3 (review* or overview*)).ti,ab. 75. (methodologic* adj3 (review* or overview*)).ti,ab. 76. (integrative adj3 (review* or overview*)).ti,ab. 77. (collaborative adj3 (review* or overview*)).ti,ab. 78. medline.ab. 79. pubmed.ab. 80. cochrane.ab. 81. embase.ab. 82. (cinahl or cinhal).ab. 83. science citation index.ab. 84. (reference adj list*).ab. 85. bibliograph*.ab. 86. (hand-search* or handsearch).ab. 87. manual search*.ab. 88. (selection adj3 criteria).ab. 89. or/69-88 90. Muscle Relaxants, Central/ 91. exp Neuromuscular Agents/ 92. Neuromuscular Nondepolarizing Agents/ 93. Neuromuscular Blocking Agents/ 94. Neuromuscular Depolarizing Agents/ 95. exp Benzodiazepines/ 96. "muscle relaxant*".ti,ab. 97. "benzodiazepine*".ti,ab. 98. "neuromuscular blocking agent*".ti,ab. 99. "neuromuscular depolarizing agent*".ti,ab. 100. "neuromuscular nondepolarizing agent*".ti,ab. 101. (Alprazolam or Xanax or Xanor or Tafil or Alprox or Frontal).ti,ab. 102. (Bromazepam or Lexotanil or Lexotan or Lexomil or Somalium or Bromam).ti,ab. 103. (Chlordiazepoxide or Librium or Tropium or Risolid or Klopoxid).ti,ab. 104. (Cinolazepam or Gerodorm).ti,ab. 105. (Clonazepam or Klonopin or Rivotril or Iktorivil).ti,ab. 106. (Cloxazolam or Olcadil).ti,ab. 107. (Clorazepate or Tranxene).ti,ab. 108. (Diazepam or Valium or Pax or Apzepam or Stesolid).ti,ab. 109. (Estazolam or ProSom).ti,ab. 110. (Flunitrazepam or Rohypnol or Fluscand or Flunipam or Rona or Rohydorm).ti,ab. 111. (Flurazepam or Dalmadorm or Dalmane).ti,ab. 112. (Flutoprazepam or Restas).ti,ab. 113. (Halazepam or Paxipam or Ketazolam or Anxon or Loprazolam or Dormonoct or lorazepam or Ativan or Temesta or Tavor or Lorabenz or Lormetazepam or Loramet or Noctamid or Pronoctan or Medazepam or Nobrium or Midazolam or Dormicum or Versed or Hypnovel or Dormonid or Nimetazepam or Erimin or Nitrazepam or Mogadon or Alodorm or Pacisyn).ti,ab. 114. (Dumolid or Nordazepam or Madar or Stilny or Oxazepam or Seresta or Serax or Serenid or Serepax or Sobril or Pinazepam or Domar or Prazepam or Lysanxia or Centrax or Quazepam or Doral or Temazepam or Restoril or Normison or Euhypnos or Tenox or Tetrazepam or Mylostan or Triazolam or Halcion or Rilamir).ti,ab. 115. (Orphenadrine or Norgesic or Norflex or Disipal or Banflex or Flexon or Tizanidine or Zanaflex or Sirdalud or Flupirtine or Dantrolene or Dantrium or Dantrolen or Baclofen or Kemstro or Lioresal or Nurasic or Norphen or Nabesac or Muscol or Biorphen or Brocasipal or Dolan or OrfenAce or Gablofen or Kemstro or Liofen or Lyflex or Beklo or Baclosan).ti,ab. 116. (Methocarbamol or Robaxin or Robaxisal).ti,ab. 117. (Cyclobenzaprine or Flexeril or Amrix or Flexmid).ti,ab. 118. (Carisoprodol or Soma or Sanoma or Carisoma).ti,ab. 119. Equagesic.ti,ab. 120. (Meprobamate or Miltown or Equanil or Meprospan).ti,ab. 121. (Metaxalone or Skelaxin).ti,ab. 122. (Carbamazepine or Tegretol or Mazetol or Hermolepsin or Carbatrol or Equetro).ti,ab. 123. or/90-122 124. 68 and 89 and 123 125. limit 124 to (english language and humans and yr="2000 -Current") Multimodal Therapies Search run May 16, 2013 in Ovid MEDLINE(R) 1946 to May Week 2 2013; 777 results RCT update run May 28, 2015 in Ovid MEDLINE(R) 1946 to May Week 4 2015; 24 results [other study designs removed] 1. Combined Modality Therapy/ 2. (pragmatic and (randomized clinical trial or RCT or approach*)).ab,ti. 3. "physical modalit*".ab,ti. 4. (team* and (care or health or healthcare or medical)).ab,ti. 5. (grouped and (care or approach)).ab,ti. 6. (care and (package or packages)).ab,ti. 7. (collaborat* and (treatment* or therap* or care or procedure* or approach or rehabilitat*)).ab,ti. 8. (combined and (treatment* or therap* or care or procedure* or approach or rehabilitat*)).ab,ti. 9. (comprehensive and (treatment* or therap* or care or procedure* or approach or rehabilitat*)).ab,ti. 10. (integrated and (treatment* or therap* or care or procedure* or approach or rehabilitat*)).ab,ti. 11. (disciplin* and (approach or care)).ab,ti. 12. (pragmatic and (approach or care)).ab,ti. 13. ((multicentre* or multi-centre* or multicenter* or multi-center*) and (treatment* or therap* or care or procedure* or approach* or rehabilitat*)).ab,ti. 14. Multicenter Study.pt. 15. or/1-14 16. (treatment* or therap* or care or procedure* or approach or rehabilitat*).ab,ti. 17. (co-ordinat* or coordinat*).ab,ti. 18. (multimodal* or multi-modal* or multi modal*).ab,ti. 19. (interdisciplin* or inter-disciplin* or inter disciplin*).ab,ti. 20. (interprofessional or inter-professional).ab,ti. 21. (multidisciplin* or multi-disciplin* or multi disciplin*).ab,ti. 22. or/17-21 23. 16 and 22 24. 15 or 23 25. Osteopathic Physicians/ 26. (osteopath or osteopaths or osteopathic physicians).ab,ti. 27. Physicians, Family/ 28. exp Physicians, Primary Care/ 29. General Practitioners/ 30. Occupational Health Physicians/ 31. (general practitioner* or family physician* or medical doctor* or primary care physician*).ab,ti. 32. Chiropractic/ 33. (chiropractor* or DC*).ab,ti. 34. "manual therapist*".ab,ti. 35. "massage therapist*".ab,ti. 36. Physical Therapists/ 37. (physical therap* or physiotherap*).ab,ti. 38. Occupational Therapy/ 39. "occupational therap*".ab,ti. 40. Acupuncture/ 41. "acupuncturist*".ab,ti. 42. Kinesiology, Applied/ 43. "kinesiologist*".ab,ti. 44. napropathy.ab,ti. 45. or/25-44 46. 24 and 45 47. Randomized Controlled Trials as Topic/ 48. Controlled Clinical Trials as Topic/ 49. Clinical Trials as Topic/ 50. exp case-control studies/ 51. exp Cohort Studies/ 52. Double-Blind Method/ 53. Single-Blind Method/ 54. Placebos/ 55. randomized controlled trial.pt. 56. controlled clinical trial.pt. 57. comparative study.pt. 58. (meta analys* or meta-analys* or metaanalys*).ab,ti. 59. (cohort and (study or studies or analys*)).ab,ti. 60. (random* and (control* or clinical or allocat* or trial*)).ab,ti. 61. (case adj control*).ab,ti. 62. ((double or single) and blind*).ab,ti. 63. "placebo*".ab,ti. 64. (comparative and (study or studies)).ab,ti. 65. or/47-64 66. 46 and 65 67. Whiplash Injuries/ 68. Neck Injuries/ 69. Neck Pain/ 70. Neck Muscles/in [Injuries] 71. exp Cervical Vertebrae/in [Injuries] 72. Radiculopathy/ 73. exp Brachial Plexus Neuropathies/ 74. Torticollis/ 75. whiplash.ab,ti. 76. "neck injur*".ab,ti. 77. "neck pain*".ab,ti. 78. "cervical pain*".ab,ti. 79. (neck ache* or neckache*).ab,ti. 80. "cervicalgia*".ab,ti. 81. "cervicodynia*".ab,ti. 82. "radiculopath*".ab,ti. 83. "brachial plexus neuropath*".ab,ti. 84. torticollis.ab,ti. 85. (headache* and (whiplash or WAD or neck pain)).ab,ti. 86. or/67-85 87. 24 and 65 and 86 88. limit 87 to (english language and yr="1990 -Current") Passive Modalities Search run April 9, 2013 in Ovid MEDLINE(R) 1946 to March Week 4 2013; 502 results; RCT update run May 29, 2015 in Ovid MEDLINE(R) 1946 to May Week 4 2015; 60 results [other study designs removed] 1. exp Hydrotherapy/ 2. Laser Therapy, Low-Level/ 3. Cryotherapy/ 4. Magnetic Field Therapy/ 5. exp Electric Stimulation Therapy/ 6. exp Orthotic Devices/ 7. exp Diathermy/ 8. Hot Temperature/tu [Therapeutic Use] 9. Casts, Surgical/ 10. Fluid Therapy/ 11. Magnetics/tu [Therapeutic Use] 12. "Bedding and Linens"/ 13. High-Energy Shock Waves/tu [Therapeutic Use] 14. Bed Rest/ 15. Rest/ 16. Self-Help Devices/ 17. Restraint, Physical/ 18. or/1-17 19. (cold and (therap* or pack* or compress or massage or immersion or soak or treatment or therap*)).ab,ti. 20. (ice and (therap* or pack* or compress or massage or immersion or soak or treatment or therap*)).ab,ti. 21. (heat* and (therap* or pack* or compress or massage or lamp or pad or bath or soak or tub or bottle or superficial or therapeutic)).ab,ti. 22. (hot and (therap* or pack* or compress or massage or lamp or pad or bath or soak or tub or bottle or superficial or therapeutic)).ab,ti. 23. ((shockwave* or shock wave* or shock-wave*) and (ultrasonic or therap* or radiation)).ab,ti. 24. "assistive device*".ab,ti. 25. (athletic and (tape or taping)).ab,ti. 26. "back belt*".ab,ti. 27. (braces or brace or bracing).ab,ti. 28. (cast or casts).ab,ti. 29. (collar or collars).ab,ti. 30. (corset or corsets).ab,ti. 31. "cryotherap*".ab,ti. 32. diathermy.ab,ti. 33. (electric* and (stimulation or EMS or heating pad*)).ab,ti. 34. electroanalgesia.ab,ti. 35. (electrogalvanic stimulation or EGS).ab,ti. 36. (electromagnet* and (radiation or therap*)).ab,ti. 37. "electromodalit*".ab,ti. 38. electrotherapy.ab,ti. 39. "fluidotherap*".ab,ti. 40. galvanic stimulation.ab,ti. 41. (guard* and (teeth or night or mouth or wrist or knee)).ab,ti. 42. (high energy shock wave* or high-energy shock wave* or HESW).ab,ti. 43. (H-Wave Device Stimulation or HWDS).ab,ti. 44. "hydrocollar*".ab,ti. 45. "hydrotherap*".ab,ti. 46. infrared.ab,ti. 47. (interferential current* or ICS or IFC).ab,ti. 48. iontophoresis.ab,ti. 49. "kinesiotap*".ab,ti. 50. (laser* and (phototherapy or irradiation or biostimulation or light or therap*)).ab,ti. 51. "low level laser*".ab,ti. 52. "lumbar support*".ab,ti. 53. (magnetic and (necklace* or therap* or bracelet*)).ab,ti. 54. Microcurrent Electrical Neuromuscular Stimulation.ab,ti. 55. "microwave*".ab,ti. 56. "moist air bath*".ab,ti. 57. muscle activation.ab,ti. 58. myofascial release.ab,ti. 59. (Neuromuscular Electrical Stimulation or NMES).ab,ti. 60. "orthotic*".ab,ti. 61. (paraffin and (treatment* or therap*)).ab,ti. 62. "passive modalit*".ab,ti. 63. "Percutaneous Electric* Nerve Stimulation".ab,ti. 64. "pillow*".ab,ti. 65. (pulsed and (electromagnetic or magnetic or radio frequency or energy)).ab,ti. 66. radiant light.ab,ti. 67. Russian stimulation.ab,ti. 68. "seat cushion*".ab,ti. 69. (short wave* or short-wave*).ab,ti. 70. (sling or slings).ab,ti. 71. (splint or splinting or splints).ab,ti. 72. "spray and stretch".ab,ti. 73. (tape or taping).ab,ti. 74. (transcutaneous electrical stimulation or TENS).ab,ti. 75. ultrasound.ab,ti. 76. vapocoolant spray.ab,ti. 77. "vibration therap*".ab,ti. 78. "warm compress*".ab,ti. 79. "wax treatment*".ab,ti. 80. whirlpool.ab,ti. 81. or/19-80 82. 18 or 81 83. Whiplash Injuries/ 84. Neck Injuries/ 85. Neck Pain/ 86. Neck Muscles/in [Injuries] 87. exp Cervical Vertebrae/in [Injuries] 88. Radiculopathy/ 89. exp Brachial Plexus Neuropathies/ 90. Torticollis/ 91. whiplash.ab,ti. 92. "neck injur*".ab,ti. 93. "neck pain*".ab,ti. 94. "cervical pain*".ab,ti. 95. "neck ache*".ab,ti. 96. "neckache*".ab,ti. 97. "cervicalgia*".ab,ti. 98. "cervicodynia*".ab,ti. 99. "radiculopath*".ab,ti. 100. "brachial plexus neuropath*".ab,ti. 101. torticollis.ab,ti. 102. (headache* adj4 (whiplash or WAD or neck pain)).ab,ti. 103. or/83-102 104. Randomized Controlled Trials as Topic/ 105. Controlled Clinical Trials as Topic/ 106. exp case-control studies/ 107. exp cohort studies/ 108. double-blind method/ 109. single-blind method/ 110. Placebos/ 111. randomized controlled trial.pt. 112. controlled clinical trial.pt. 113. meta-analysis.pt. 114. (meta analys* or meta-analys* or metaanalys*).ab,ti. 115. (cohort adj4 (study or studies or analys*)).ab,ti. 116. (cohort adj4 (study or studies or analys*)).ab,ti. 117. (random* adj4 (control* or clinical or allocat* or trial*)).ab,ti. 118. (case adj control*).ab,ti. 119. ((double or single) adj3 blind*).ab,ti. 120. "placebo*".ab,ti. 121. or/104-120 122. 82 and 103 and 121 123. limit 122 to (english language and yr="1990 -Current") Psychological Interventions Note: The original searches included WAD/NAD and psychological injuries. The results provided in this guideline relate only to WAD/NAD. Search run June 27, 2013 in Ovid MEDLINE(R) 1946 to June Week 3 2013; 945 results; Update run January 9, 2015 in Ovid MEDLINE(R) 1946 to November Week 3 2014 and Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations January 08, 2015; 133 results 1. Whiplash Injuries/ 2. Neck Injuries/ 3. Neck Pain/ 4. Neck Muscles/in [Injuries] 5. exp Cervical Vertebrae/in [Injuries] 6. Radiculopathy/ 7. exp Brachial Plexus Neuropathies/ 8. Torticollis/ 9. whiplash.ab,ti. 10. "neck injur*".ab,ti. 11. "neck pain*".ab,ti. 12. "cervical pain*".ab,ti. 13. "neck ache*".ab,ti. 14. "neckache*".ab,ti. 15. "cervicalgia*".ab,ti. 16. "cervicodynia*".ab,ti. 17. "radiculopath*".ab,ti. 18. "brachial plexus neuropath*".ab,ti. 19. torticollis.ab,ti. 20. or/1-19 21. Psychotherapy/ 22. Stress, Psychological/px, th [Psychology, Therapy] 23. Psychological Techniques/ 24. Anxiety/px, th [Psychology, Therapy] 25. Catastrophization/px, th [Psychology, Therapy] 26. Fear/px, th [Psychology, Therapy] 27. Helplessness, Learned/px [Psychology] 28. Psychotic Disorders/px, th [Psychology, Therapy] 29. Stress Disorders, Post-Traumatic/px, th [Psychology, Therapy] 30. Animal Assisted Therapy/ 31. Art Therapy/ 32. Autogenic Training/ 33. exp Behavior Therapy/ 34. Bibliotherapy/ 35. Color Therapy/ 36. Crisis Intervention/ 37. Dance Therapy/ 38. exp Feedback, Psychological/ 39. Feedback, Sensory/ 40. Gestalt Therapy/ 41. Helplessness, Learned/px [Psychology] 42. exp Hypnosis/ 43. "Imagery (Psychotherapy)"/ 44. Music Therapy/ 45. Narrative Therapy/ 46. Nondirective Therapy/ 47. Play Therapy/ 48. exp Psychoanalytic Therapy/ 49. exp Psychotherapeutic Processes/ 50. Psychotherapy, Brief/ 51. Psychotherapy, Multiple/ 52. Psychotherapy, Rational-Emotive/ 53. Reality Therapy/ 54. exp Socioenvironmental Therapy/ 55. Galvanic Skin Response/ 56. Interview, Psychological/ 57. Mind-Body Therapies/ 58. Aromatherapy/ 59. Breathing Exercises/ 60. exp Hypnosis/ 61. Laughter Therapy/ 62. Meditation/ 63. Mental Healing/ 64. Psychodrama/ 65. Psychophysiology/ 66. Relaxation Therapy/ 67. "psychotherap*".ab,ti. 68. "psychodynamic*".ab,ti. 69. "psychoanaly*".ab,ti. 70. (cogniti* behavio* or cogniti*-behavio*).ab,ti. 71. "cogniti* therap*".ab,ti. 72. (psychological or psychologist* or psychology).ab,ti. 73. "interpersonal therap*".ab,ti. 74. "animal therap*".ab,ti. 75. "art therap*".ab,ti. 76. autogenic training.ab,ti. 77. ((behavior or behaviour) and therap*).ab,ti. 78. "aversive therap*".ab,ti. 79. (biofeedback and psycholog*).ab,ti. 80. (desensiti?sation and psycholog*).ab,ti. 81. (relax* and (therap* or train* or technique*)).ab,ti. 82. "bibliotherap*".ab,ti. 83. (catastrophi?ation or catastrophi?ing).ab,ti. 84. ((color* or colour*) and therap*).ab,ti. 85. crisis intervention.ab,ti. 86. "dance therap*".ab,ti. 87. (feedback and psycholog*).ab,ti. 88. sensory feedback.ab,ti. 89. "gestalt therap*".ab,ti. 90. helplessness.ab,ti. 91. (hypnosis or hypnoti*).ab,ti. 92. (psychotherap* and imagery).ab,ti. 93. "music therap*".ab,ti. 94. "narrative therap*".ab,ti. 95. "nondirective therap*".ab,ti. 96. "play therap*".ab,ti. 97. "psychoanaly* therap*".ab,ti. 98. (psychotherap* and (brief or multiple or rational-emotive or group)).ab,ti. 99. "milieu therap*".ab,ti. 100. "residential treatment*".ab,ti. 101. (psycholog* and (treatment* or therap* or technique* or interview*)).ab,ti. 102. galvanic skin response.ab,ti. 103. ((mind-body or mind body) and therap*).ab,ti. 104. "aromatherap*".ab,ti. 105. (psycholog* and biofeedback).ab,ti. 106. "breathing exercise*".ab,ti. 107. "laugh* therap*".ab,ti. 108. (meditate or meditation or meditating).ab,ti. 109. mental healing.ab,ti. 110. psychodrama.ab,ti. 111. psychophysiology.ab,ti. 112. or/21-111 113. exp Motor Vehicles/ 114. (vehicle* or car or cars or bus or buses or auto or automobile* or ambulance* or motorcycle* or truck* or bicycle* or bike* or traffic or pedestrian* or ATV* or all terrain vehicle*).ab,ti. 115. (accident* and injur*).ab,ti. 116. or/113-115 117. exp Accidents, Traffic/ 118. (collision* or crash or crashes or MVC* or MVA* or accident*).ab,ti. 119. "traffic injur*".ab,ti. 120. (accident* and injur*).ab,ti. 121. or/117-120 122. 116 and 121 123. Randomized Controlled Trials as Topic/ 124. Controlled Clinical Trials as Topic/ 125. Clinical Trials as Topic/ 126. exp Case-Control Studies/ 127. exp Cohort Studies/ 128. Double-Blind Method/ 129. Single-Blind Method/ 130. Placebos/ 131. randomized controlled trial.pt. 132. controlled clinical trial.pt. 133. comparative study.pt. 134. (meta analys* or meta-analys* or metaanalys*).ab,ti. 135. (cohort and (study or studies or analys*)).ab,ti. 136. (random* and (control* or clinical or allocat*)).ab,ti. 137. case control*.ab,ti. 138. ((double or single) and blind*).ab,ti. 139. "placebo*".ab,ti. 140. (comparative and (study or studies)).ab,ti. 141. (meta analys* or meta-analys* or metaanalys*).ab,ti. 142. or/123-141 143. (20 or 122) and 112 and 142 144. limit 143 to (english language and humans and yr="1990 2015") 145. limit 144 to (english language and humans and ed=20130627-20150114) Soft Tissue Therapies Note: The original searches included back pain and WAD/NAD. The updates included only WAD/NAD. Search run May 30, 2013; Ovid MEDLINE(R) 1946 to May Week 4 2013; 1378 results; update run Feb. 26, 2014 in Ovid MEDLINE(R) 1946 to February Week 2 2014; 113 results; RCT update run May 29, 2015 in Ovid MEDLINE(R) 1946 to May Week 4 2015; 68 results [other study designs removed] 1. Acupressure/ 2. Complementary Therapies/ 3. Manipulation, Chiropractic/ 4. Manipulation, Orthopedic/ 5. Manipulation, Osteopathic/ 6. Massage/ 7. Muscle Stretching Exercises/ 8. Musculoskeletal Manipulations/ 9. Physical Therapy Modalities/ 10. Reflexotherapy/ 11. Therapeutic Touch/ 12. exp Medicine, Chinese Traditional/ 13. Vibration/tu [Therapeutic Use] 14. active release.ab,ti. 15. acupressure.ab,ti. 16. "Alexander technique*".ab,ti. 17. "Anma massage*".ab,ti. 18. Aston patterning.ab,ti. 19. "Ayurvedic massage*".ab,ti. 20. bodywork.ab,ti. 21. Chih Ya.ab,ti. 22. cranial release.ab,ti. 23. (cranio-sacral and (massage or therap*)).ab,ti. 24. (craniosacral and (massage or therap*)).ab,ti. 25. Cyriax friction.ab,ti. 26. "deep tissue therap*".ab,ti. 27. Feldenkrais method.ab,ti. 28. "friction massage*".ab,ti. 29. Graston.ab,ti. 30. Gua Sha.ab,ti. 31. Guasha.ab,ti. 32. Hakomi method.ab,ti. 33. "Hot stone massage*".ab,ti. 34. (instrument assisted and (massage* or soft tissue or soft-tissue)).ab,ti. 35. (instrument-assisted and (massage* or soft tissue or soft-tissue)).ab,ti. 36. Jin Shin.ab,ti. 37. "manual therap*".ab,ti. 38. "massage*".ab,ti. 39. "muscle energy technique*".ab,ti. 40. myofascial release.ab,ti. 41. "neuromuscular therap*".ab,ti. 42. Nimmo.ab,ti. 43. "Pfrimmer therap*".ab,ti. 44. "polarity therap*".ab,ti. 45. ((post isometric or post-isometric) and relaxation).ab,ti. 46. "pressure point* therap*".ab,ti. 47. proprioceptive neuromuscular facilitation.ab,ti. 48. reflexology.ab,ti. 49. "reflexotherap*".ab,ti. 50. Reiki.ab,ti. 51. Rolfing.ab,ti. 52. Shiat?u.ab,ti. 53. (soft tissue and (mobili?ation or therap*)).ab,ti. 54. (soft-tissue and (mobili?ation or therap*)).ab,ti. 55. "sports massage*".ab,ti. 56. "Swedish massage*".ab,ti. 57. TCM.ab,ti. 58. "Thai massage*".ab,ti. 59. "therapeutic touch*".ab,ti. 60. Thumper.ab,ti. 61. traditional Chinese medicine.ab,ti. 62. Trager psychophysical.ab,ti. 63. "trigger point* therap*".ab,ti. 64. Tui Na.ab,ti. 65. Tuina.ab,ti. 66. "vibration therap*".ab,ti. 67. Vibromax.ab,ti. 68. VMTX.ab,ti. 69. Zhi Ya.ab,ti. 70. "Zone therap*".ab,ti. 71. or/1-70 72. exp Back/ 73. exp Back Injuries/ 74. Back Pain/ 75. Low Back Pain/ 76. Coccyx/in [Injuries] 77. Intervertebral Disc Degeneration/ 78. Intervertebral Disc Displacement/ 79. Lumbar Vertebrae/in [Injuries] 80. exp Lumbosacral Plexus/ 81. Lumbosacral Region/in [Injuries] 82. Osteoarthritis, Spine/ 83. Piriformis Muscle Syndrome/ 84. Polyradiculopathy/ 85. Radiculopathy/ 86. Sacrococcygeal Region/ 87. Sacroiliac Joint/ 88. Sacrum/ 89. Sciatica/ 90. Spinal Diseases/ 91. Spinal Stenosis/ 92. (avulsed lumbar and (disc* or disk*)).ab,ti. 93. (back and (ache* or injur* or pain*)).ab,ti. 94. (backache* and (injur* or pain*)).ab,ti. 95. (back pain or back-pain).ab,ti. 96. coccydynia.ab,ti. 97. coccyx.ab,ti. 98. dorsalgia.ab,ti. 99. (lumbar disc* and (extruded or degenerat* or herniat* or prolapse* or sequestered or slipped)).ab,ti. 100. (lumbar disk* and (extruded or degenerat* or herniat* or prolapse* or sequestered or slipped)).ab,ti. 101. "low* back pain".ab,ti. 102. "low*-back-pain*".ab,ti. 103. (lumbar and (pain or facet or nerve root* or osteoarthritis or radicul* or spinal stenosis or spondylo* or zygapophys*)).ab,ti. 104. "lumbarsacr*".ab,ti. 105. lumboischialgia.ab,ti. 106. "lumbosacr*".ab,ti. 107. "Piriformis syndrome*".ab,ti. 108. radiculalgia.ab,ti. 109. sacral pain*.ab,ti. 110. sacrococcygeal pain*.ab,ti. 111. (sacroiliac or sacro-iliac).ab,ti. 112. "sciatic*".ab,ti. 113. SI joint.ab,ti. 114. spinal stenos?s.ab,ti. 115. spondylosis.ab,ti. 116. "tailbone pain*".ab,ti. 117. "vertebrogenic pain*".ab,ti. 118. or/72-117 119. Whiplash Injuries/ 120. Neck Injuries/ 121. Neck Pain/ 122. Neck Muscles/in [Injuries] 123. exp Cervical Vertebrae/in [Injuries] 124. Radiculopathy/ 125. exp Brachial Plexus Neuropathies/ 126. Torticollis/ 127. whiplash.ab,ti. 128. "neck injur*".ab,ti. 129. "neck pain*".ab,ti. 130. "cervical pain*".ab,ti. 131. "neck ache*".ab,ti. 132. "neckache*".ab,ti. 133. "cervicalgia*".ab,ti. 134. "cervicodynia*".ab,ti. 135. "radiculopath*".ab,ti. 136. "brachial plexus neuropath*".ab,ti. 137. torticollis.ab,ti. 138. "headache* and (whiplash or WAD or neck pain*)".ab,ti. 139. or/119-138 140. 118 or 139 141. Randomized Controlled Trials as Topic/ 142. Controlled Clinical Trials as Topic/ 143. Clinical Trials as Topic/ 144. exp Case-Control Studies/ 145. exp Cohort Studies/ 146. Double-Blind Method/ 147. Single-Blind Method/ 148. Placebos/ 149. randomized controlled trial.pt. 150. controlled clinical trial.pt. 151. comparative study.pt. 152. (meta analys* or meta-analys* or metaanalys*).ab,ti. 153. (cohort and (study or studies or analys*)).ab,ti. 154. (random* and (control* or clinical or allocat* or trial*)).ab,ti. 155. (case adj control*).ab,ti. 156. ((double or single) and blind*).ab,ti. 157. "placebo*".ab,ti. 158. (comparative and (study or studies)).ab,ti. 159. (case adj control*).ab,ti. 160. (meta analys* or meta-analys* or metaanalys*).ab,ti. 161. or/141-160 162. 71 and 140 and 161 163. limit 162 to (english language and humans and yr="1990-2015") Appendix III. Interventions with Inconclusive Evidence Inconclusive Evidence for Persistent Neck Pain and Associated Disorders (NAD) I-IIAcupuncture  ADDIN EN.CITE Wong2015102[21]10210217Wong, J. J.;Shearer, H.M.;Mior, S.;Jacobs, C.;Ct, P.;Randhawa, K.;Yu, H.;et al.Are manual therapies, passive physical modalities, or acupuncture effective for the management of patients with whiplash-associated disorders or neck pain and associated disorders? An update of the Bone and Joint Decade Task Force on Neck Pain and its Associated Disorders by the OPTIMa Collaboration (Accepted for the publication in The Spine Journal)2015[21]Needle and multimodal (body needle acupuncture and ear acupressure) acupuncturePsychological Interventions  ADDIN EN.CITE Shearer2015110[19]11011017Shearer, H.M.;</author><author>Carroll, L.J.;</author><author>Wong, J.J.;</author><author>Ct, P.;</author><author>Varatharajan, S.;</author><author>Southerst D, Sutton D, Randhawa K, Yu H, Mior S, van der Velde G, Nordin M, Stupar M, Taylor Vaisey A.</author>Are psychological interventions effective for the management of neck pain and whiplash associated disorders? A systematic review by the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration (Accepted for publication in The Spine Journal)2015[19]Cognitive behavioural therapy (CBT)Psychological Interventions  ADDIN EN.CITE Shearer2015110[19]11011017Shearer, H.M.;Carroll, L.J.;Wong, J.J.;Ct, P.;Varatharajan, S.;Southerst D, Sutton D, Randhawa K, Yu H, Mior S, van der Velde G, Nordin M, Stupar M, Taylor Vaisey A.</author></authors></contributors><titles><title>Are psychological interventions effective for the management of neck pain and whiplash associated disorders? A systematic review by the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration (Accepted for publication in The Spine Journal)2015[19]Biofeedback Appendix IV. Canadian C-spine Rule  ADDIN EN.CITE  ADDIN EN.CITE.DATA [35]a aAdopted with permission from Stiell et al. The Canadian C-Spine Rule for Radiography in Alert and Stable Trauma Patients. JAMA 2001; 286(15):1841-1848. doi:10.1001/jama.286.15.1841 Appendix V. Examples of Questions or Tools to Assess Prognostic Factors for Delayed Recovery These are examples of measures that may be helpful. This is not meant to represent a comprehensive list of measures. A.1 Poor expectation of recovery Do you think that your injury willa) get better soon; b) get better slowly; c) never get better; d) dont know A.2 Depressed mood, feelings of depression about the pain Patient Health Questionnaire-9 (PHQ-9) Center for Epidemiologic Studies Depression Scale Revised (CESD-R) Depression scale of the Hospital Anxiety and Depression Scale (HADS) Beck Depression Inventory-II A.3 Anxiety or fear about the pain, kinesiophobia or avoidance of activities due to fear of pain Tampa Scale of Kinesiophobia Fear Avoidance of Pain Scale A.4 Symptoms of Acute Stress Disorder (symptoms exhibited within 4 weeks of the injury)/Post-Traumatic Stress Disorder (symptoms lasting at least one month) Impact of Events Scale Revised Trauma Screening Questionnaire A.5 High levels of frustration or anger about the pain Stand-alone question such as: How frustrated (angry) do you feel about your pain (0 means no frustration/anger - 10 means as frustrated/angry as you can imagine) A.6 Passive coping Passive coping scale of the Pain Management Inventory Pain Catastrophizing Scale Appendix VI. Glossary of Interventions Type of Intervention DefinitionClinical MassageClinical massage is a form of soft tissue therapy that aims to accomplish specific goals such as releasing muscle spasms. An example of clinical massage is myofascial trigger point therapy [85].High-dose Strengthening ExercisesStrengthening exercises with emphasis on high number of repetitions and progressively increased loads [84].Iyengar YogaIyengar yoga involves a range of classical yoga poses adapted to patients with neck pain with the use of supportive props [82]. Emphasis is placed on muscle strengthening, stretching, joint mobility, and proper posture [82].QigongQigong is a gentle focused exercise for the mind and body that aims to increase and restore the flow of qi energy and encourage healing [80,81].Relaxation MassageRelaxation massage is a form of soft tissue therapy that aims to relax muscles, move body fluids, and promote wellness . An example of relaxation massage is Swedish massage [85].Strain-counterstrain TherapyStrain-counterstrain therapy involves passive body positioning aimed to reduce tenderness in muscles [67]. Appendix VII. Graded Neck Strengthening Exercises for Recent Neck Pain and Associated Disorders (NAD) Grade III based on the Kuijper et al. Study [100] Graded neck strengthening exercises were prescribed as follows: Supervised hands-off exercise therapy: Exercise 1: Chest press, sitting position Purpose: warming-up 2 x 10 repetitions with 5 kg. Exercise 2: Lateral pull-down, sitting position Purpose: warming-up 2 x 10 repetitions with 20 kg Exercise 3: Low-back flies Purpose: warming-up Dumbbells in both hands and make flying movements, bent forward standing position or in roman chair 2 x 10 repetitions with 1 kg Exercise 4: Neck-press Purpose: stability Push dumbbells from the shoulder above the head, standing position 2 x 10 repetitions with 1 kg Exercise 5: Front-raises Purpose: stability Elevate dumbbells forward to shoulder height, standing position 2 x 10 repetitions with 1 kg Exercise 6: Upright row Purpose: strength Rowing up bar with weights; elbows finish above shoulder height and wrists finish at shoulder height, standing position 2 x 10 repetitions with 7.5 kg Exercise 7: Weight rotation Purpose: strength and stability In standing position, keep bar with weights on top in vertical position, bottom part stays on the ground, with stretched arms and rotate to left and right 3 repetitions: 5 x to left, 5 x to right with 7.5 kg Home exercises prescribed in addition to supervised exercises: Once a day 2x10 repetitions. Exercise 1. Purpose: mobility Standing position. In neutral position: withdraw chin. Exercise 2. Purpose: mobility Lying on the back. Withdraw chin while keeping head on the ground. Exercise 3. Purpose: mobility Standing position. Withdraw chin and turn head to one side as far as possible. Repeat in the opposite direction. Exercise 4. Purpose: stability and muscle strength Standing position. Withdraw chin, place the palm of the hand against the head (left or right side of the forehead), and give resistance against the hand with the head (do not allow any movements of the head). Exercise 5. Purpose: stability and muscle strength Standing position. Place right hand against the head behind the right ear, left hand on the left side of the forehead. Rotate the head to the right against the resistance of the hands. Reverse hand positions and repeat to the left. No movements of the head. Exercise 6. Purpose: stability and muscle strength Standing position. Withdraw chin, place both hands on the back of the head, and push the head against the hands. No movement of the head allowed. Exercise 7. Purpose: stability and muscle strength Standing position. Withdraw chin, place the right hand on the right side of the head and move the head to the right against resistance. Repeat to the left. Exercise 8. Purpose: stability and muscle strength Lying on the back. Lift the head a little from the ground and move the chin just a little bit towards the chest. Exercise 9. Purpose: stability and muscle strength Lying on the back, lift the head a little from the ground and turn the head to the right. Repeat to the left. Exercise 10. Purpose: relaxation. Sitting on a chair. Keep both arms down. Pull back the shoulders and relax again. Appendix VII: Research Questions Covered by the Guideline What is the effectiveness of structured patient education interventions compared to other interventions, placebo/sham interventions, or no intervention in improving self-rated recovery, functional recovery (e.g., return to activities, work or school), clinical outcomes (e.g., pain, health-related quality of life, depression), administrative outcomes (e.g., time to claim closure), or adverse events in patients with grade I-III whiplash-associated disorders (WAD) or neck pain and associated disorders (NAD)? What is the effectiveness of exercise compared to other interventions, placebo/sham interventions, or no intervention in improving self-rated recovery, functional recovery (e.g., return to activities, work or school), clinical outcomes (e.g., pain, health-related quality of life, depression), administrative outcomes (e.g., time to claim closure), or adverse events in patients with grade I-III whiplash-associated disorders (WAD) or neck pain and associated disorders (NAD)? What is the effectiveness of manual therapy (i.e., manipulation, mobilization, or traction) compared to other interventions, placebo/sham interventions, or no intervention in improving self-rated recovery, functional recovery (e.g., return to activities, work or school), clinical outcomes (e.g., pain, health-related quality of life, depression), administrative outcomes (e.g., time to claim closure), or adverse events in patients with grade I-III whiplash-associated disorders (WAD) or neck pain and associated disorders (NAD)? What is the effectiveness of soft tissue therapy compared to other interventions, placebo/sham interventions, or no intervention in improving self-rated recovery, functional recovery (e.g., return to activities, work or school), clinical outcomes (e.g., pain, health-related quality of life, depression), administrative outcomes (e.g., time to claim closure), or adverse events in patients with grade I-III whiplash-associated disorders (WAD) or neck pain and associated disorders (NAD)? What is the effectiveness of acupuncture compared to other interventions, placebo/sham interventions, or no intervention in improving self-rated recovery, functional recovery (e.g., return to activities, work or school), clinical outcomes (e.g., pain, health-related quality of life, depression), administrative outcomes (e.g., time to claim closure), or adverse events in patients with grade I-III whiplash-associated disorders (WAD) or neck pain and associated disorders (NAD)? What is the effectiveness of passive physical modalities compared to other interventions, placebo/sham interventions, or no intervention in improving self-rated recovery, functional recovery (e.g., return to activities, work or school), clinical outcomes (e.g., pain, health-related quality of life, depression), administrative outcomes (e.g., time to claim closure), or adverse events in patients with grade I-III whiplash-associated disorders (WAD) or neck pain and associated disorders (NAD)? What is the effectiveness of multimodal care (i.e., two or more modalities provided by one or more health care professionals) compared to other interventions, placebo/sham interventions, or no intervention in improving self-rated recovery, functional recovery (e.g., return to activities, work or school), clinical outcomes (e.g., pain, health-related quality of life, depression), administrative outcomes (e.g., time to claim closure), or adverse events in patients with grade I-III whiplash-associated disorders (WAD) or neck pain and associated disorders (NAD)? What is the effectiveness of non-steroidal anti-inflammatory drugs (NSAIDs) compared to other interventions, placebo/sham interventions, or no intervention in improving self-rated recovery, functional recovery (e.g., return to activities, work or school), clinical outcomes (e.g., pain, health-related quality of life, depression), administrative outcomes (e.g., time to claim closure), or adverse events in patients with grade I-III whiplash-associated disorders (WAD) or neck pain and associated disorders (NAD)? What is the effectiveness of non-opioid analgesics compared to other interventions, placebo/sham interventions, or no intervention in improving self-rated recovery, functional recovery (e.g., return to activities, work or school), clinical outcomes (e.g., pain, health-related quality of life, depression), administrative outcomes (e.g., time to claim closure), or adverse events in patients with grade I-III whiplash-associated disorders (WAD) or neck pain and associated disorders (NAD)? What is the effectiveness of muscle relaxants compared to other interventions, placebo/sham interventions, or no intervention in improving self-rated recovery, functional recovery (e.g., return to activities, work or school), clinical outcomes (e.g., pain, health-related quality of life, depression), administrative outcomes (e.g., time to claim closure), or adverse events in patients with grade I-III whiplash-associated disorders (WAD) or neck pain and associated disorders (NAD)? What is the effectiveness of psychological interventions compared to other interventions, placebo/sham interventions, or no intervention in improving self-rated recovery, functional recovery (e.g., return to activities, work or school), clinical outcomes (e.g., pain, health-related quality of life, depression), administrative outcomes (e.g., time to claim closure), or adverse events$%45>?KTt u _ ` j l  + ; < > S ²}n_TDhgGhgG5CJOJQJaJh h7^LOJQJhgGhJKCJOJQJaJhgGh9eCJOJQJaJhgGh(CJOJQJaJhgGh7^LCJOJQJaJ h h7^LhgGh7^L5CJOJQJaJhgGhpP5CJOJQJaJhgGh5CJOJQJaJh\#kh7^LCJOJQJh\#kh5CJOJQJaJh\#kh7^L5CJOJQJaJ?UgrHkd$$Ifl\ # 4    t0y4644 layt#7d$Ifgd#7dgd3d ' 4 N b t u v Pkd$$Ifl\ # 4    t0y4644 layt#7d$Ifgd#7  & - : _ ` a j Pkd$$Ifl\ # 4    t0y4644 layt#7d$Ifgd#7 j    : ; < > T PKgd3dkd$$Ifl\ # 4    t0y4644 layt#7d$Ifgd#7S T e f p q d e # $ 457LM^_ijQo01Ĺ˓˓˓˓˄˄˄˄hgGhJKCJOJQJaJ$hgGh7^LCJOJQJaJnH tH $h hgGCJOJQJaJnH tH h h7^LOJQJ h h7^LhgGh7^LCJOJQJaJ h hgGhgGhgG5CJOJQJaJh hgGCJOJQJaJ1T f q 8 N Mkd $$Ifl\ # 4    t0y4644 layt#7d$Ifgd#7N d e f s # Lkd$$Ifl4\ # 4`    t0y4644 layt#7d$Ifgd#7# $ % . ZLLLLLd$Ifgd#7kd$$$Ifl4\ # 4     t0y4644 layt#7 #4ZLLLLLLd$Ifgd#7kd$$Ifl4\ # 4     t0y4644 layt#7457M_j[VHHHHd$Ifgd#7gd3dkdD$$Ifl\ # 4    t0y4644 layt#7R|[MMMMMMMd$Ifgd#7kd$$Ifl\ # 4    t0y4644 layt#7pxLkdT$$Ifl4\ # 4`    t0y4644 layt#7d$Ifgd#7")Lkd$$Ifl4\ # 4     t0y4644 layt#7d$Ifgd#7)012NL@@ d$Ifgd#7kdt$$Ifl4\ # 4     t0y4644 layt#7d$Ifgd#7'C555d$Ifgd#7kd$$Ifl\ # 4    t0y4644 layt#7 d$IfgdgG d$Ifgd#7'/X̹̪۟mYm=6hLh{B*CJOJQJaJfHph q 'hLh{5CJOJQJaJmH sH $hLh{CJOJQJaJmH sH h{h0#05CJOJQJaJh h7^LCJOJQJaJh h7^LOJQJhgGh(CJOJQJaJ$hgGh7^LCJOJQJaJnH tH hgGh7^LCJOJQJaJh h7^LCJOJQJaJ h h7^LhgGhgGCJOJQJaJMEEdgd3dkd$$Ifl\ # 4    t0y4644 layt#7d$Ifgd#7/B]E !"$$-%&&0&B&d-D9DM gd0#0gd0#0dgd0#0d-D9DM gd{gd{dgdLXYABJ89 ]sVWƳƳƳƳƳƳ|lƳƳhbj CJOJQJaJmH sH 'hLh{6CJOJQJaJmH sH hLh{CJOJQJaJ'hLh{5CJOJQJaJmH sH $hLh{CJOJQJaJmH sH 6hLh{B*CJOJQJaJfHph q :hLh{0J8B*CJOJQJaJfHph q *NXY9EY? !O!!!!""" # ##$[$$$$$غ؞غ؞؞뇞؞s؞؞fh0#05CJOJQJaJ'hLh{6CJOJQJaJmH sH -hLh{B*CJOJQJaJnH ph tH 6hLh{B*CJOJQJaJfHph q :hLh{0J8B*CJOJQJaJfHph q $hLh{CJOJQJaJmH sH 'hLh{5CJOJQJaJmH sH $$%8%9%V%%%&.....ǸmWA(1h0#0h{B*CJOJPJQJaJnH ph tH +h{B*CJOJPJQJaJnH ph tH +h0#0B*CJOJPJQJaJnH ph tH 1h0#0h0#0B*CJOJPJQJaJnH ph tH 2h0#0h0#00J8B*OJQJfHph q .h0#0h0#0B*OJQJfHph q h0#0h0#0OJQJmH sH 'h0#0h0#05CJOJQJaJmH sH 'h{h0#05CJOJQJaJmH sH h{h0#05CJOJQJaJ B&`&&&&&&&')'E']'t'''''((&(8(Z(s((((!)7)d-D9DM gd0#07)U)m))))))* *I*i***+.+M+y++++++,,-,F,`,d-D9DM gd0#0`,,,,--<-i----- .1.>.S...........s/gd0#0d-D9DM gd0#0.. /'/\/s/$6-6.66@AAcAANN'N(NBNUNNXXXXƻբlբXբEXբEX$h0#0h0#0CJOJQJaJmH sH 'h{h0#05CJOJQJaJmH sH 4h0#0h0#05B*CJOJPJQJaJnH ph tH 4h{h0#05B*CJOJPJQJaJnH ph tH 1h0#0h0#0B*CJOJPJQJaJnH ph tH h0#0h0#0OJQJh0#0h0#0OJQJmH sH .h0#0h0#0B*OJQJfHph q $h0#0h0#0CJOJQJaJmH sH s/////030i0001X111`222333334(4?4e4z44d-D9DM gd0#044445,5C5]5x555555#6$667)7;7L7c7y77777gd0#0d-D9DM gd0#0778 888O8i8888889)9M9i999999 : :2:M:: ;d;d-D9DM gd0#0d;;;{<<<==*===_=x===>&>9>W>o>>>>>>?"?K?k?d-D9DM gd0#0k???@0@O@{@@@@@@AAA B*BRBhBBBBBBCC0Cgd0#0d-D9DM gd0#00CJCeCCCCCD3D`DvDDDDDDE2EkEEEE*F@FMFgFyFFd-D9DM gd0#0FFF G|d-D9DM gd0#0>|d||||||}>}]}y}}}}}~~2~E~W~l~~~~~~~~~d-D9DM gd0#0~'=Sew.EZs€ր'd-D9DM gd0#0'<Ph}΁ 7L^rłڂ.@Sd-D9DM gd0#0Sgz̓1G\rĄ؄.D[qd-D9DM gd0#0х 2EWi{ņ*=Pc{ȇ߇d-D9DM gd0#0߇I%5GWvӉ /GWdϊߊ7d-D9DM gd0#078 #5S{ʌ݌*BYsэ 7d-D9DM gd0#0gd0#07Jc̎ (H_uƏԏ8fǐ2֑d-D9DM gd0#0֑[tɒ'Nd~ؓ 4JnՔ Axd-D9DM gd0#0ҕ$I`̖@Yw!j.ld-D9DM gd0#0lkšXž4m?Ne Igd0#0d-D9DM gd0#0IthУ6e0JVҥ PʦצMeƧ,d-D9DM gd0#0,>`#4Pj )G_xê8d-D9DM gd0#08nӫDQ_v*>Woʭ(?yd-D9DM gd0#0yծ֮ï 0I[Ͱ&0G`lٱEԲgd0#0d-D9DM gd0#0DEaeīp]M]M>*'h gh5CJOJQJaJmH sH hg3hg3CJOJQJaJhCJOJQJaJmH sH $h ghCJOJQJaJmH sH 'h gh6CJOJQJaJmH sH 'h{h5CJOJQJaJmH sH $h0#0h0#0CJOJQJaJmH sH 1h0#0h0#0B*CJOJPJQJaJnH ph tH .h0#0h0#0B*OJQJfHph q h0#0h0#0OJQJmH sH 'h0#0h0#05CJOJQJaJmH sH  Բa³ $LgӴ/_͵K¶ܶ =Vd-D9DM gd0#0Vo˷DӸ+Btȹݹ0IhȺ/jd-D9DM gd0#0ػ #:M\{ݼ3Og~νKd-D9DM gd0#0KZϾ+PsĿ4|DEagdgd0#0d-D9DM gd0#0 6^p4Ni7`gdkZw -DY *Oigdk7Ibt$>r "@q9kgdk0Hj)y .a|2JgvgdkvRu ,<My.=bNhgdk&Gbr6Vj9Uud-D9DM gd0#0gd0#0gdk~Dby{|ȴjjQB-)h:Yh0#0B*CJPJaJnH ph tH h:Yh0#0CJaJmH sH 1h0#0h0#0B*CJOJPJQJaJnH ph tH .h0#0h0#0B*OJQJfHph q h0#0h0#0OJQJmH sH h0#0h0#06OJQJmH sH $h0#0h0#0CJOJQJaJmH sH 'h{h0#05CJOJQJaJmH sH !h5CJOJQJaJmH sH h<CJOJQJaJhCJOJQJaJh ghCJOJQJaJ9ZxV.Qb7d-D9DM gd0#07Nj{,JYt&7Vjzd-D9DM gd0#08^'BXdr+Oewa~d-D9DM gd0#0~!;Wp%:VnBV}d-D9DM gd0#0 %@\xAk*Mh @d-D9DM gd0#0@l6yz{|}~ ,$$$xx$@&Ifa$gddgd'bdgdLgd0#0d-D9DM gd0#0|} +,01ȸȸ|lalPl|| h-xh&*"B*mHnHphuh-xh&*"B*phjh-xh^B*Uphh-xhV)B*ph h hV)h-xh5B*phh-xhV)5B*phhTShc 5CJOJQJaJhTSh'b5CJOJQJaJhTShNs5CJOJQJaJhTSh5CJOJQJaJh0#05CJOJQJaJhth0#0CJaJ 2{i,$$xx$@&Ifgd{,$$$xx$@&Ifa$gd&*"nkd$$Iflp## t0644 lap ytV)xcQ,$$xx$@&Ifgd{,$$$xx$@&Ifa$gd_1kd$$Ifl0 p#  t0644 lapytV)FH𸱸𸱢xhXxHhTSh5CJOJQJaJhTSh'b5CJOJQJaJhTShNs5CJOJQJaJhTSh7^L5CJOJQJaJh*5CJOJQJaJh'b5CJOJQJaJh h'bCJOJQJaJ h hV)h-xhV)B*ph h-xh&*"B*mHnHphu!h-xh_1B*OJQJ^Jphh-xh_1B*phjh-xh YB*UphxcQ,$$xx$@&Ifgd{,$$$xx$@&Ifa$gd_1kd< $$Ifl0 p#  t0644 lapytV) xskkkkkck[dgd Sdgd0{wdgdLgd'bkd $$Ifl0 p#  t0644 lapytV)  !)ϥdWH<0<h;CJOJQJaJh0{wCJOJQJaJh0{wh0{wCJOJQJaJh0{w5CJOJQJaJ7j81h-xh-x5CJOJQJUaJmHnHsH u"h,h,5CJH*OJQJaJ$h&*"5CJOJQJaJmHnHu(jh5CJOJQJUaJ(j| h&*"5CJOJQJUaJ"jh&*"5CJOJQJUaJh&*"5CJOJQJaJ"jh5CJOJQJUaJ 6,4EFgh²⚎o_Oo?;h\|h-xh\|5CJOJQJaJhTShQ5CJOJQJaJhTShNl5CJOJQJaJhTShYnw5CJOJQJaJh hTSCJOJQJaJh3JCJOJQJaJh h7^LOJQJhTS5CJOJQJaJhTSh7^L5CJOJQJaJhTSh0#05CJOJQJaJhTSh'b5CJOJQJaJh h7^LCJOJQJaJh0{wh0{wCJOJQJaJ6?@z/NOVgd7$8$H$gd Sdgd SF\g $IfgdJsdgdLdgd Sghy<vmd $IfgdXj $IfgdJskdg$$Ifl0 $ [ t0644 lapyt-xh5:<=SWIQRST8񭞭񭏀qbqh-xh+UCJOJQJaJh-xhzCJOJQJaJh-xhVSfCJOJQJaJh-xh?NCJOJQJaJh-xh7CJOJQJaJh-xhJsCJOJQJaJhU th-xhU tCJOJQJaJh\|h-xhwhCJOJQJaJh-xhJCJOJQJaJh-xh\|CJOJQJaJ!<=_vmd $IfgdiS $IfgdJskdeh$$Ifl0 $ [ t0644 lapyt-xvmd $Ifgd7 $IfgdJskdi$$Ifl0 $ [ t0644 lapyt-xSvmd $Ifgd?N $IfgdJskdi$$Ifl0 $ [ t0644 lapyt-xSTgvmd $IfgdXj $IfgdJskdBj$$Ifl0 $ [ t0644 lapyt-x8vmd $Ifgd+U $IfgdJskdj$$Ifl0 $ [ t0644 lapyt-xDvnnnnnnnnn`d7$8$H$gd Sdgd Skdk$$Ifl0 $ [ t0644 lapyt-x =>CDʺʚ}}m]P@hh7^L5CJOJQJaJh 5CJOJQJaJhTSh 5CJOJQJaJhTSht`W5CJOJQJaJhTS5CJOJQJaJhTSha5CJOJQJaJhTSh[>5CJOJQJaJhTShYnw5CJOJQJaJhTSh'b5CJOJQJaJhTSh7^L5CJOJQJaJhTS5CJOJQJaJhYnw5CJOJQJaJh\|CJOJQJaJD+ , - . m uvw45.ABDS񾯝tdtUFUF:UFUhW`CJOJQJaJhF-hkCJOJQJaJhF-hyCJOJQJaJhTSh5CJOJQJaJhTSh15CJOJQJaJhTS5CJOJQJaJh7^LCJOJQJaJ"h hTS5CJOJQJ\aJhTS5CJOJQJ\aJhU5CJOJQJ\aJ"hTSh7^L5CJOJQJ\aJ"h h7^L5CJOJQJ\aJh h7^LCJOJQJaJ >Ttu-.EZ/ N O g { d7$8$H$gd S{    5 W  + , - . m n       G H f      dgd Sd7$8$H$gd SLYZ tuvwh  & FdgdF-dgd Sd7$8$H$gd SS_~   0<1CO+7 X  0 <  "!"3"?"# $$)$%%&&_&ĵ񵩵񵩵񵩵񵩵񵋩񋵩񵩵񵩵hF-hCJOJQJaJhW`hW`CJOJQJaJhW`CJOJQJaJhF-hkCJOJQJaJhF-h1CJOJQJaJhF-hyCJOJQJaJhF-h$g#CJOJQJaJhF-h1CJOJQJaJ2hX "z$_&oabcdefghijklmnpqs dgd&3dgd(  & Fdgd"  & FdgdF-_&|&&''''oamnoqrtuwxz{񹭡~z~z~z~zrnreWnzjhgGUmHnHuh\#kmHnHuhgGjhgGUhnjhnUhF-h( CJOJQJaJh( CJOJQJaJhRCHCJOJQJaJhACJOJQJaJhF-hCJOJQJaJUhW`hW`CJOJQJaJhW`CJOJQJaJh"CJOJQJaJh U<h"CJOJQJaJ in patients with grade I-III whiplash-associated disorders (WAD) or neck pain and associated disorders (NAD)? What is the cost-effectiveness of non-invasive intervention for the management of grade I-III whiplash-associated disorders (WAD) or neck pain and associated disorders (NAD)? What are the experiences of people injured in a traffic collision?      PAGE \* MERGEFORMAT 5 stvwyzdgd( !!$a$ dgd&3 51h0:pgG= /!8"8#$% 21h:p(O/ =!"#$% $$If!vh#v #v:V l t0y465 5yt#7$$If!vh#v #v:V l t0y465 5yt#7$$If!vh#v #v:V l t0y465 5yt#7$$If!vh#v #v:V l t0y465 5yt#7$$If!vh#v #v:V l t0y465 5yt#7$$If!vh#v #v:V l4 t0y46+5 5yt#7$$If!vh#v #v:V l4 t0y46+5 5yt#7$$If!vh#v #v:V l4 t0y46+5 5yt#7$$If!vh#v #v:V l t0y465 5yt#7$$If!vh#v #v:V l t0y465 5yt#7$$If!vh#v #v:V l4 t0y46+5 5yt#7$$If!vh#v #v:V l4 t0y46+5 5yt#7$$If!vh#v #v:V l4 t0y46+5 5yt#7$$If!vh#v #v:V l t0y465 5yt#7$$If!vh#v #v:V l t0y465 5yt#7$$If!vh#v#:V l t06,5#p ytV)$$If!vh#v #v:V l t06,5 5pytV)$$If!vh#v #v:V l t06,5 5pytV)$$If!vh#v #v:V l t06,5 5pytV)^DStiell200117[35]171717Stiell, I. G.Wells, G. A.Vandemheen, K. L.Clement, C. M.Lesiuk, H.De Maio, V. J.Laupacis, A.Schull, M.McKnight, R. D.Verbeek, R.Brison, R.Cass, D.Dreyer, J.Eisenhauer, M. A.Greenberg, G. H.MacPhail, I.Morrison, L.Reardon, M.Worthington, J.Context High levels of variationinefficiency exist in current clinical practice regarding use of cervical spine radiography in, alertstable trauma patients, Objective To derive a clinical decision rule that is highly sensitive for detecting acute C. spine injurywill allow emergency department physicians to be more selective in use of radiography in, alertstable trauma patients. Design: Prospective cohort study conducted from October to April, in which physicians evaluated patients for standardized clinical findings prior to radiography In some cases a second physician performed independent interobserver assessments Setting Ten EDs in large Canadian communityuniversity hospitals. Patients: Convenience sample of adults who presented to the Ed with blunt trauma to the head/neck, stable vital signsa Glasgow Coma Scale score of 15. Main Outcome Measure: Clinically important C-spine injury, evaluated by plain radiography computed tomographya structured follow-up telephone interview. The clinical decision rule was derived using the kappa coefficient, logistic regression analysischi recursive partitioning techniques. Results: Among the study sample, had important C. spine injury The resultant modelfinal Canadian, C. Spine Rule comprises main questions is there any high-risk factor present that mandates radiography is there any low-risk factor present that allows safe assessment of range of motionis the patient able to actively rotate neck 45 degrees to the, leftright? By cross-validation, this rule had sensitivityspecificity for identifying 151 clinically important C-spine injuries. The potential radiography ordering rate would be 58.2%. Conclusion: We have derived the Canadian C-Spine Rule, a highly sensitive decision rule for use of C. spine radiography in alertstable trauma patients. If prospectively validated in other cohorts, this rule has the potential to significantly reduce practice variationinefficiency in, E. D. use of C. spine radiographyClinical Epidemiology Unit, F6, Ottawa Health Research Institute, 1053 Carling Ave, Ottawa, Ontario, Canada K1Y 4E9. istiell@ohri.caThe Canadian C-spine rule for radiography in alert and stable trauma patientsJamaJamaJamaJamaJamaJama1841-8286152001/10/26AdultAgedCanadaCervical Vertebrae/radiographyCraniocerebral Trauma/*radiography*Decision Support TechniquesEmergency Medical Services/*standardsFemaleHumansMaleMiddle AgedNeck Injuries/*radiographyOutcome and Process Assessment (Health Care)Prospective StudiesRadiography/standardsRegression AnalysisRisk AssessmentSensitivity and SpecificityTomography, X-Ray ComputedTraumatology/*standardsWounds, Nonpenetrating/*radiography2001Oct 170098-7484 (Print) 0098-748411597285NLMeng^DStiell200117[35]171717Stiell, I. G.Wells, G. A.Vandemheen, K. L.Clement, C. M.Lesiuk, H.De Maio, V. J.Laupacis, A.Schull, M.McKnight, R. D.Verbeek, R.Brison, R.Cass, D.Dreyer, J.Eisenhauer, M. A.Greenberg, G. H.MacPhail, I.Morrison, L.Reardon, M.Worthington, J.Context High levels of variationinefficiency exist in current clinical practice regarding use of cervical spine radiography in, alertstable trauma patients, Objective To derive a clinical decision rule that is highly sensitive for detecting acute C. spine injurywill allow emergency department physicians to be more selective in use of radiography in, alertstable trauma patients. Design: Prospective cohort study conducted from October to April, in which physicians evaluated patients for standardized clinical findings prior to radiography In some cases a second physician performed independent interobserver assessments Setting Ten EDs in large Canadian communityuniversity hospitals. Patients: Convenience sample of adults who presented to the Ed with blunt trauma to the head/neck, stable vital signsa Glasgow Coma Scale score of 15. Main Outcome Measure: Clinically important C-spine injury, evaluated by plain radiography computed tomographya structured follow-up telephone interview. The clinical decision rule was derived using the kappa coefficient, logistic regression analysischi recursive partitioning techniques. Results: Among the study sample, had important C. spine injury The resultant modelfinal Canadian, C. Spine Rule comprises main questions is there any high-risk factor present that mandates radiography is there any low-risk factor present that allows safe assessment of range of motionis the patient able to actively rotate neck 45 degrees to the, leftright? By cross-validation, this rule had sensitivityspecificity for identifying 151 clinically important C-spine injuries. The potential radiography ordering rate would be 58.2%. Conclusion: We have derived the Canadian C-Spine Rule, a highly sensitive decision rule for use of C. spine radiography in alertstable trauma patients. If prospectively validated in other cohorts, this rule has the potential to significantly reduce practice variationinefficiency in, E. D. use of C. spine radiographyClinical Epidemiology Unit, F6, Ottawa Health Research Institute, 1053 Carling Ave, Ottawa, Ontario, Canada K1Y 4E9. istiell@ohri.caThe Canadian C-spine rule for radiography in alert and stable trauma patientsJamaJamaJamaJamaJamaJama1841-8286152001/10/26AdultAgedCanadaCervical Vertebrae/radiographyCraniocerebral Trauma/*radiography*Decision Support TechniquesEmergency Medical Services/*standardsFemaleHumansMaleMiddle AgedNeck Injuries/*radiographyOutcome and Process Assessment (Health Care)Prospective StudiesRadiography/standardsRegression AnalysisRisk AssessmentSensitivity and SpecificityTomography, X-Ray ComputedTraumatology/*standardsWounds, Nonpenetrating/*radiography2001Oct 170098-7484 (Print) 0098-748411597285NLMeng6Dd g0F|  JH A?Picture 9"R5:ɷ%5|11F5:ɷ%JFIFC      W  o!1 AQ"a28Vqsu#67BRTWbt3U$5X4CSr%c&'(DE9Fdev)?ښ"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""(G:٣a,!MҖYgq).k "ǜлu_ @g/uA=lH'͜?Y 6rX$f^Ăz,cOE9{ g/uA=lH'͜?Y 6rX$f^Ăz,b\<\aSf^Ăz,cOE9{ g/uA=lH'͜?Y 6rX$f^Ăz,cOE9{ g/uA=lH'͜?Y 6rX$f^Ăz,cOE9{ g/uA=lH'͜?Y 6rX$f^Ăz,cOE9{ g/uA=lH'͜?Y 6rX$f^Ăz,cOE9{ g/uA=lH'͜?Y 6rX$f^Ăz,cOE9{ g/uA=lH'͜?Y 6rX$f^Ăz,cOE9{ g/uA=lH'͜?Y 6rX$f^Ăz,cOE9{ g/uA=lH'͜?Y 6rX$f^Ăz,cOE9{ g/uA=lH'͜?Y 6rX$f^Ăz,cOE9{ g/uA=lH'͜?Y 6rX$f^Ăz,cOE9{ g/uA=lH'͜?Y 6rX$f^Ăz,cOE9{ g/uA=lH'͜?Y 6rX$f^Ăz,cOE9{ g/uA=lH'͜?Y 6rX$f^Ăz,cOE9{ g/uA=lH'͜?Y 6rX$˜X'N/E{:kljm߅ldϼ.ϸK{*?ǸXۣ{QIRRqw5.V?NN?Q]Uo E"""""""էLn_~aQOgbItrtyګR-:dr R?ԥ`+DDDDDDDDDDDDD\ Uy{EUT4oiMWWE|N:>ϝsqP'w37s{]|HyDqi$y;rB"*8W=|4iZ5/{$R"7S]-tii/nϋkgJdSM)N]W* 5pR}ڮTw+Zz~}Ȉ(a:Ǿc[]nTB&:-u{Fs`{GQC-PâlaaAh:<A2a֒ymYׂ/fZH'x'=kƭsxދ|Zkxi*fLO| En]K$vǿ+cƽ"""髫M<&{΀{%| 8h5ײ:\۝qmtO`{^lM9u\qs}۠_GӴ8('_U%ƞ1%,TElj/UDDDDDDDDDDDDDE֤_XSXZu9:\x 7yir4y* @p$s\]u26*y${֗9ǐZ{_olMpu[NUK#qFT@_{T3n1jW{UՓrCPpڳuZ+0\őf1n\zQ5+ T:(dhSAy*6F5V X ׀:in<;61uNMGk㥯3.8kk =g#ftokZG XB8iktڲO,E-d1J'Nz+U R1g1-g) 7Ñ$rY_c{}1L8.s= K'[+^Kpq H\#^ jhp ZHR5 ]x."V #PsWi¶uA#xАGz?0gTm-f.(bWS#s VFU1{ZKʻ:8*%MÏ>H#wCxUQK`]1U}SVK-5<2Ny4(0~bwFUweRa}6O^;S)TI47x|n! {`]npQ2F5 Kl.-kY&"Xb˅# qv vif6/oSR&u]H6s[Ye{VdxEm|N׽[jc;̬fݭڒ-:Y -`8tsX;3]kdiP(V2Պ=lkt29K/K<{T@4V.w23]o,lp:紱 i{8.|UL./v.[fFƐRCK lwI x򹑗ku%h ;t8O#v20lb^[,n]l2Z-ZBfY()׉jn3PX+c5$ 9k9+S&ް x2D5Դ8ja v͍_|k%4B_&Cm!M.Ϭ3zG8^}7g%p< ('/s欐fUIpS4{H\}#oJ78hK:C_$1?5|tD5OWLCDJw׺H]5|W+_6b [#dK$Q^4 k3*`}< Vh_m^2x ENAUUVks!ߎ2N[?c™mϊ aP ay"#w,vYyyxc,Me5K'`l98f9~6d􍨇vad02Xi˫7#Jt̻Nw@Nɞ{@3aslXxG#](ivAڻ{+tbf)i: 3%Yg۪覩{ktV?{m gDžqUMXA{yܯފYXqtƶYz7{آһMNxdmtMRy/7m,m8&As>^LnuPO&%|-N0ׅC.fUW#0s]ku []gL IqMRFAnP#j}6VabM]%K{5yjt12M-޲% {Fk 9ڊ cO8 Y=@LZlanXcl5iF+,H5a=ڦK0N [bM3acf {UUc66}i.n *׈2ׄ^[cTMRIEP_L;ZFcfh]K89s#c=v m3/5sডm=[1=bkMv-qg58h\Ij^vwg-\to5zd]JZ&_xjKglgsz= l@ Ӏ+j,ayeNC|&'VFt-t~mtܗ~{/vCQP\^e;:x״H9*"""""""""""..%žө:˿jHDDDDDDDZ-*>QIRRqsCjX>#pOc+Nzi牬}|ku_ӟ48+gjа 3v3ڏ)H40*;e웛XAdO$M6{P y=wk[RhzEk]llk@-BHx{k"1-o bk [J. iU=q$5;:C)w)p.1E+ޫ]FƒmAO$ eP~2631T1H6uq2N q*8\7/0K0>(2q5΂[mlQSzG<4Ӿ^g&ڝ?zGJ%|ʜ F+55lLK:wѣjn ?⺁k<"v.6Zrbs|-}ҢĻiAn/JLWn_ac|B!#/7o_ˈ1fv1jegRQnk7L]y^Ծzl£S[Em/t; 5M;!J׵38x:P_:,6u!)hv Ӭݱ VO(2F^;IaCW mP@5$n_hl$ܒؠ>+.׸s_ͫ1thyztJD4:#[(l%FLi#MZɤax4|ǣ{˝nypwᮟ|WyJsT:jJHWW [m.';!ֿU!`yef9a7rW]%c%@8uiXekalsbwcȷ"⼍8U6ڏ YkVz=$/ccy#7Gs=[[3ӼhӻoWc<^JdH4$-onN5_Yc1rIu~)`˓.{T\:q5jj̄o?>Amg+ n&w:Ҿvp4It4׏yҭ}&dz[Yh:G3mOL>8pO? fE1quƾy_M!?["͈kxyI /.t{Ӓtv 5&fS9pN W:=DuOdv@Μ7.ĴrOぐBמ wa? vJl.Zq:n|8V{M4?QsZuaOqcieߵV]PZ"""""""-Zt}(FJV)XQ_Gv^1z= 9i'pVk`Lqw@5ku~)Y5( c-,;@c؟3qU]ҩ]uiOێTt_S2j7\ClŅ9,gXګ {H L@?y{`P[GnY#Ғ^B[l6ėdiltWT Ik?_yeycn I[K# n5͑Bֹ*|Gx[(rEq$8pnH~P֟#bv!4Zƅ3 !J"#b`b]}|Bh((yNk8)(٦ vn-^=.oޅv953?,JEeeh枦Z(eh`tKQet*W#w7\yvgL{k[p3WVgޒ팿M_[9pTWUEN3xm;:ݕXB)j.6ZgҗZZٳ ;gzWt1ǏR/sy-922"GҫӢ6+خ *:9F.v89^88&Ed[p}Pclhˈ;i.$ooI|mCvz;emM+h058^=-*exʾW;!>;{[G-lfq:V[9iÂԿKŢ,w'1QjlM<@k'hs>\K]hMQA%& sKNl-zfP߽ȡfC7kU\ӟ+u_J39gAm;ipoiLJ^Ej}^r%hb8jclU ^p٫anU|5ao=Fߪ(l(KM={ )cY+?ɛ;YrKe!;b)jNXnowH8j2\X-|]-9:kmН_ź嘞x* Q+{Q)kYR{jTVgfnACC#$sa޼.)>a  5*-wv}VaҚgakG u ~tE\ob7 Ym69uoסv ] Eg<ʣiuDz07=K_)K骈 %RZ>N:]%oٮ.m^+)37ߨC˾o{~Dj+߸9FuВu |e6{ G[aFphăBnӶz@Z*0ԾV{\G N'E2QGMmT`p;o:&+`6aczx,olf',sΠ:PƵnޭ卲LͼW]X{ +GܽjkuMBL2ә?0Vʘk ڱOOz c}pdDk-S+iS5gA;Z=ieh %v͓ծgֿ]T%O3&G mr Po1GMkXS;WذƹKWYh(ȡAdOsמ+~kCy4na|*ICSPyC>'K󥚘ŷjSɩmǣ" q<}9;CdA#WqJްѻ:+;e01Ѹ X$q|Q#~u'\npPQ:b5!Bz![k1-Įn 0H\%hlo%nYm 8qE|]O-[]B-nS nV*ύpQ\QAgZ%A1CVdԏ69a_Q`c#(ÁзQϘSavSZ,{] M4ڋCØc #{%hsig |ćhi^MKRƆ8^7\[NutU>×a(-qLԁÎ$muj oEz M%%/㮺ii_f{ e\Cbe61Ԇ>1Db˽/y0FKӗY̯ [}$5uH9Q}耸lqlr4VĴj]ǝrCj1$?#.3SKoj.0fGT;v*s,]oi>jj;xK3]a5 W^7"> <5˱yYUM6]fV8\ \!4Ɯ7|p@Fܶn6=]L55\M̔a,Vdt-ݟ'ѴHLmɗ7ncpǽe<茖Sϋ=5ΦސA+~Kx9ӑeŞvS=Ȣp!i@>}6d۔6x)h;y{? [bl_7vku˽ 88-:>͹.(mbgRXHx'|>`E53/bٱixtYS<ǀ L웳[6k!_ϕM>`/{DӵWnijnv&B5O/%ןz4\5\5=t.1Ş)!p*/fGXfv2|@ˍEڑ-8jӠY{$+d8o $P\HZ֒HY8G[Uꙩ;SۢcIԍOunuޔ88˛XZ ׊hkO/au628J;xީswi޻7@y^ :vЪ[9[Uw]\|=kMGW3A^:<@hև4UV45sZx5ә]n7wP-; MϷEɬxRB_arDDDDDDDDDDDDE֤_XSXZu9:d2\%H[;7cܽJڣ>1,&\]HZ߮醜Ԭڋ+m,765#b ]t+휘"ze㊭w'*O=tL{-R{UnmT*jKE!zݡ ܨnxGYn&tK𯎧hܺLWm8rT4'w{{MFQaQ/Xm-]I 傦5490>^2f1D[Ζos66<@@VM"qn6{163!- ͕ġ͜kï1T5Lc"A'Nct5q6ZֻneThR{c1w}1R2VL0~6˃Oq'M5.窿w1ꮰBHt27M8sPe}[q;kE$UT6FXt}R՝XךYe0\-$!~m4.7YL6VH Ϲv_Ci١h璾&6\]ʣIx.cjkb;ǘ^i 64[b5,ކ%TmN~+\]w-: @3GEP^IMW7 e8o[d=aka' gx`։IBʼ;WhTkM$*b nt X̲c@$@V^_m s\SmWӂ_OKUs!q$q;_Q×m]>+۰m(^_QS\AΧwq;ӻxYrۨ+ZuQf ԁýc*ˈ0fZ=V)RI+ws#!QZ. p~Is{a)A hpv#^`Æs/f06lQl^2 zw4.8#Sؼ2=>8tNt@\F^_g*yv5ΙQѴ p$)^L[Qelصi^c4"C1闱}ln.ܨc2G=tL]w Gbd|pl%@H#i .];5]yu6*'آwzz' Nđ ɪڧ*`sck>4xr᳦%S |O ~n ynyYX+bz]Vu m9>_Ӓۛ >7e:׸Hդ|lX>ZU%5b=W\U5v#0uDteN,Nt.u6uObASpcVI*Itвn`< g|{KoJ2 p#V毋>̖ ۳e񪤉y7i%=p'lobY6#WJޠӟ͌k|&A9ǖR .؂q\b F%FbUۧ 89ڐ@qⴙQa\8jpV\׽⺘\[)3hC}OE<_HiVdg\C^$X7e0J5o4%ǒrdi vVZmt4WB褹5twa;PTR2iF82BR~W\dYeŦ;⥦ss՝珕YT_gCmT1;8:d-pb,cf]$F,f%hHަuc͟2كvxR| t]hwypyv,l,Æ|/EwuMn+3C# i4>_YgeMC[+}-\}ʢm6$u<^#>I/!-uuW\-/-=GA+uPt[]\:X(3x3WSmr_SזNV}ymYJԳIQAq 4[Safv-N5a'o6o)!¢7Ů->bke]ӛ}N\( ik ɧNd,PM{Fe;CzڈymB$7 }*X4p-pf味QEu۩D[ Mz5s!_`.-rGt×[k E45rZ<"2 ^1ʻvC1mҗX&I+@vh9qhUmiw{ (e=ED2 ]hw#G#j+7Z~r2 u5 |K,*0f~l5lTU+h{PD1m`S`!ē^osL3<]v}݂y?4uIc av#PwZyۙηX t'ŗtx>1lLY=k4DjOKgY.Z&%LA/HXu? ΰkVhcH ]. ;< uĻqЬ5H+ ]l9m67G)Z1:$Cݝ,Vu>cA=0/ v2pG^ym(2lXW:R$Ë+<;^BmN+6wbG]|-[u$5-vFt-$}룫z d-8uw%#M3u5yv7O|\`مE Jxg ٖtxwkWh̒?QܭmnL7ch5exvMF{w-̪Z[MeVI#eInhxxXxL7fYHLOIBK!ܷ[=bj᪶9 g\OX0SVKC$X"ѡ'>y]0%\.Xj䁩fpаapu 456uG: *0%Tknvj.WETc"PxwKTrGWqMߴ:GeLM07;5/ЍuaIpN\!n/p]2_3auSv_ ΐ%)S-Fj o+c2xzlӎ)(Z%B"Ρ`a[CAإZhDzG4s(SU14;Oi)8mHvxeùӘذVKl}ַF|V˹]-1l?,Պq K-4R wIuX:OB.0\7F=x 3 qd,<ǬPi0]nc2Nǿ<-DRmi_W0O~4\9Vv2"CmWUZcyp--q宝5\i;W)/:ۅ]%@ˡԺW?t YS$p}QW]:ZzSI8,W8lKU8Y}'>XgpVSF#Ik/|<@v,.ǵfj egM'dsx;dqzƵ]nY*)U},IdHK#VcQb =SeYi4Zʦ6|ù_Oui<36H@Ԃ׃x(q1初dYgPwb,qs{.8ek5n 䨧P$tdp׎Kv!U.O Pb%8НyX<;k߅#5 Q{mdU=Q2{_ij-=Czf [,wLUjlBcF4q%K#tCݻÒMx*;ZrbuUJ#ܳ/>!mU&}#+bK.,WGfmjdO)N|׹*#dҚ_U'xzj[Æee]ĘꬑWZk[,$1" zpWwL#,=5nkM±v\qYGpe|9_Ndswct4 >/25X2<[=T σtef|jysNa #_QՒ}W xq ˬydFAmY=+f ѻÈvvdY/*puSlxr/F59ԓgB;ʵf5üʬֈ 0|.QU [u#.U1%l猩p_I$FC1N76/wK]E ]h8y 7ۣxldL/w3eݗYyELR0Hi#ؠ+Bmճn8itDujW.,x6qleഒOo£xϘV$m;&-KxrJ]nMfumzx{yWs_lyWG[$W;mDm^aYK0{fWFN덩x f;^8/3d,eQ` |48fE $jI,:C9IauM]Fktq#O%6\sgfwذݏI+W1cۃS$/9<)Vk @>H4y:Vj_۶i[@l:1uF E`ɇ.J WM$SD^BW?H ,ꪹnH r~`m'f9!f/a>,%E'8]$/qkiLf c wQ]/5_vnA kYJ|Avޫp]*:آ@nYOڥOE ͑hnSQNk\Y-:u!a^ۤI h^cy+?r™탱6Y϶Om ʚt$̎`+.-;m V[S};:>GB7t'ȯ&넯#WKW0Zap˒v xB*^:qTȏ̸4ܰgRگ9[e%*pBqht[{0\ 8] %Li+ET08:Fӫ}+߸nT]tR[,>WBw` :wd-QUlkɩ&FHt=-qul?ps(IGI>'kSdkUm?H~nVCW$1RDZTh$qXW5."m3*Uw}l uaqmK9#k{y[kƷRߢECx#dl]["!r5+cyƓrWF^51mc96Y+륛bŗ95T39:F6Gy .sM]5f !Q鷷tEX vػRmu% F1lPV091Vۍԏfڑϗb3<ܥ,8rgjWs :Ŋp&mDw칲aLEr6VA!3 ,+qLA6JFoUe4A$Lc|n4*ܣmlXvc4D9ǙН-屵%ph|oh}VӀAiB(lxc[uq]YFAr>Uч ;|4FuэӚt,γRw`;f\3eƗ<[KhM7v&km LncX:4=Qv aZ';U<ͦ/s18hIh׹mfl14O{nuT{q;x3IHXۣQf7$qp]F>( .L>LhiF]n Irp=PFǗzbZG!13M7$406(&Ƣ06M4K~x/h Ŋ㊩/]NcHv o"Ƭ-4၅4 Q}r]΢.rgV4E_3Q<4oiK$ hpU̐]&JFD{wF 6ߊ0U %m4h-pǑ >gHnlѾ$Y\'ӽݤSuF52h(UmQIRR0q_/@jjY[ǿ<֤&ַO5? jO`k~tZ?Zߝ<֤&ַO5? jO`k~tZ?Zߝ<֤&ַO5? jO`k~tZ?Zߝ<֤&ַO5? jO`k~tZ?Zߝ<֤&ַO5? jO`k~tZ?Zߝ<֤&ַO5? jO`k~tZ?Zߝ<֤&ַO5? jO`k~tZ?Zߝ<֤&ַO5? jO`k~tZ?Zߝ<֤&ַO5? jO`k~tZ?Zߝ<֤&ַO5? jO`k~tZ?Zߝ<֤&ַO5? jO`k~tZ?Zߝ<֤&ַO5? jO`k~tZ?Zߝ<֤&ַO5? jO`k~tZ?Zߝ<֤&ַO5? jO`k~tZ?Zߝ<֤&ַO5? jO`k~u׺NF7_kd$ u.HԗK۫ {N'G."jӦK/0E'3JVoJ^>s؅=5:DNЂ9-T쫐j9dͳ]ltyw,lbF*+tbNzъi;ilbF*+tbNzъi;ilbF*+tbNzъi;ilbF*+tbNzъi;ilbF*+tbNzъi;ilbF*+tbNzъi;ilbF*+tbNzъi;ilbF*+tbNzъi;ilbF*+tbNzъi;ilbF*+tbNzъi;ilbF*+tbNzъi;ilbF*+tbNzъi;ilbF*+tbNzъi;ilbF*+tbNzъi;ilbF*+tbNڎglv^֛e&5W}[gڶŁpmW|w:Lm$xysZuaOqcieߵV]PZ"""""""-Zt}(FJV)XLGmO9AnEDDDDDDDDDDDDDDDDDDDDDDDDDDDDDE~r/S=ϧ&usZuaOqcieߵV]PZ"""""""-Zt}(FJV)XĞGlu=k *^/ w`:P ֆoyyJ&5 7ZEG5G]iIQ$rOeSrIPF\%s a22V |5㙯sh]ƽ֍Hj;gEJ٤dn/'ozKz7Zê\QinPD0tV;38H <\m;w{bHn4lw4\%ԓ/ 5Kت#{5 iԝ9-I.Y$ͮv0y@'u.:s<V>8[twu`kHuh*UXs7JإﵠZHnlĘ!A-ZBcK#~I=n<¸q*K#8@Ә+F8@ѼJ%E]UU*\֐w՘򖞺6 X DzʭΪ]xڤD&qkSFɘG{1. ֚oOk琈I4W7F]a06,0gNݮSg ̵pĆz]ͥ|%bLݳ=`WX!Td;'6@5@u>U}X6SVgՃ G=lPYeTE(jSpq&n\˻ev9EehwZw q#ĸs#1:7R_նji#f@ev>ZĵW8"u-mqwnu 6qt_~$-2)wWnn;6jÉ-j9.vuNōqk&7f%;!f:G퍺~[:]!jŷWGֲ(+t+ʽ26ok>$ T!d${Vv%e_l=F) C^_|!ciEaF@>1#\ٯfv#lOn|KSmtĭ-lyKk/EƭG_WLD8]Ѝ(.[|jg%ƪZsq9ůgU2ˎ;V]>.M^%V(I9pVoH!W<.m)o*{싋-qVK-rxFZ\Ό֗ UWki٩{bYCN4&0öSM5º1L# SbnqRqzX/75E+mzFmNck@ѭ>U#5ݣqjWz*(-|7e?y5k*Qlj^v!iןܭ~v85 M[ 6;M˨Q1|,q1}gj uejZzʆ%p#\):sX`ecEN!]Z=~aK6Y3 T]a Ce%[ |7A$K}^QlgvpϼT[RhDӷPe΋)sf{]$V!ᬏf7,ѥO͍X|V&ouOpue'[ @: uZ-_f'88F<5eWJ47 ` pi#U:@6i1NzjW c$y8/'xnxX,BZz=jJy9t+?5;/#Yt ]29wZOxo&Nh쟍K UPRB(Z <>6fϝ8{10jdM2Ŭ0[16Vou4VDt"HF+i/TQ{Żz {`nNyUiT撖vu/K!q?IeS9taY:`VxLenŇ5/;ٮCO> '@M[%Oﭻ^VqUVRh<8HbϦ6NXIUpI_=ri8kA4+[$2g]`w`̣Sdd>gjna0jX}Wt{Y r0vb^<1e῭_nr⩶MdطnQErw_H5 #w<ʸašmj$2mnW>߲؝ iR׍Hxhk_>]wzLG#iVz(e]m.c.`$?ĕ2Vb>xSȾBN `>䚽DDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD\]jKՅ=ŏSu~[uBhi%[ߘT|+Xb/bOsj~I Pwr-$~\﫿YgNV#pړ*C G2bx@ -NcB 4N+S/k XLYAs&|y~ɫ> 7$Vp!^M"6uωW~TԲ"u;xeG=R>ɪɳGR4|IT U.#>%DgUeY6IG$CMPmq#NKG%K1^__'n}S#3A Y$!;Oqm:κo{VDh?>?,Gbdem2Q4Lz*#8kJ۽#u&5ޒc`R͵8l㳷QHm<0&-UII0һِ5/ɋ"2PM;As]f>Bm\<4S#hWIvZa| EzGj}ub@|P\7_Sp贻 ^f$5aErtP߭V<ʺYInO4. i.@jړ'r>wa׊[֖K t`:`ױ{8KțJ{ZfNZbꋵ3,3PRKv 5fb9̼S}M<6ʸ>R{2݄s~%lM!9xk }ܶ߫^F'Z.:m59F[Jɽr-L g}QT @ @CC~M1nJlך- ds(1yvt࣮ӹ#f˚-@~Y3Ggs,Nd]`xHu#>][Nλf6sM]ӽ$]Vw{Tqbhi;N{<ё]Zwy{abv>۸惉hb+)_Kx uwWN8+x6 hҞUc6d˝ց"›;J6iV!C.ig5R}4L:p,b)\Fhjt_^ӚȲ$3'F$P]S-kߦ#G=܋*TavsIDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDE֤_XSXZu9: */jmb5 <4Gڶ( 9Y*ߨj_UoXֻWh8>[5ffITTEHrS[d2&1AUv 5׏09ߖdZXM5ѳ>S?Y-rWx/ǹe45&))捬n:;RUyfۋ6zjᬊIlՖH>6f^pTLK iMJ 5ukr[㧜0Y {{ycv{- HD-5\NطX6oSo41jCm v[MyKqӇfHsgpNlZ`+[Шے;f_. f.MZtvq=d f.KWcIlQAJhp^6fPdWjG۲E+Ga\;gtbZykdY(6F5x>l:ʫOLgTɞ@ ;\Salm ɂI C%0mT"=S:6(<{vVdt~kX%q%ѺR;`ܖCC10HnU5$B1xĀq*$g{,6(ɜƵس`[F=T~s@Q Y8>˂,?nZt4h;t{.M;I>xph:)\w j8qx=użx]U/6y#CT&НtnW+2+ [nC;nq=ejt׉%ŔȫՒNkx]NH yv*ב׎jISOrhN5Co~ENNAӫT:puUĸ;ѯn:PuAUxo uB%<;rz^ܪ :i{f%v8+3cM3C5SRKhG 9z+8:G3o#kh[h`$4Ȑd)a۴~3&'5IET7b#qCl }e[)2I ž_I0'[rutm ѧ=˩+J؅I>,%;]CC͆6\A;mrK'h1 3WMO'tt6x댪b8tQG;uJCnI_Y+&p>aqnkknyK%T, }iܻ~h4-{)'X]4WuC%ts~Yo߮/Zk* 6t֕z@3dFljpS\ mHq!k\}5] CbSHÉ)/H5*kt=u7x5ғnZ\ZI'Q[ X$J浠xǗ|Txp0A<:n5[,2M<4.QndJSb_L+M{i,'M l͵6lgNAu~lƔZE<x~O&+cL Ɨ5IZQ:sq fh1u1wCw3ܫEsdvs _vpu. .:pT?, 6j(}n}+h.m&i>uU⛵6(V!v3ӊx-6 \/Q]CE4 ]`-vTWnԷH(b~ ]y ;bIvÎE, vl2 9 E[XU-Otl ^%hpgu;MT_o;*!MS,Tҵ3i:#5q"yVZ)15,'HN /p wVY'4n2 vT,Δ'Mxxbz[0٬J٨*LGW+$cAMsY'Ĺwvl;O[+cvp5LƗQ5ΊeFuau<Tc2豧kM\f{(cʜm“S=F4׳<ޱ^ ,Zdژdk_&O=Ik#0XC]t W2ε}v붆Oin|ϞwgN.+r/z90!6UeξRW Q5oxw(u ŮqUVP׶F.Qkndػ*""׿LGڏ {Tׁ~WItrtyګR-:dr R?ԥ`+Efb?sj~I tPqwȶNjԖCbólUD% s!kptbiI2T虺SZr0Im,O3b گS.<ۥxU0s\K[gj9;›X{\X$׽]pmG LEQy8穼hxQO³I#éۮ ^]hsxbʿJ8/ 1õM.qU źz4Ӊ++mgpm̀u_Wnjm\ìʼeT }ExԺMt1ڠre,iwW|SMU;kgb]#[ƒCctL׷N/i5ltA+GE;[x]w~:e6ayvttz9I~jb=ֆMl꟯n%XK?*31h%"}}6h q_C | cv7=\o6 8\F\KHűL.H 7fEM:YUkߦ#G=܋*TavsIDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDE֤_XSXZu9:dmZ<Ե5CFYM[wrnB[UrVAl;l]eK{pZ*UXSԸͩ;jl_3-RDCP# qi{Du{R]hMNJ8u$8Nq-ԯVE. [(Nt-Op֛\}ytq^Rdv% \9Xc,dm4xZr$'Fw`$opWFk{ *b8ޱiQbvtuSq#D_n;yy1o+ j IQ4|+mb}SYBh..$rȥ&y)[R 9Us~u5m[p8@w.34}uMZƷ{'I' a{{.9Cˑ SUȩ_6)NL.:ow(*魙ڊY c-;(ױ}ek<5U\0PѬRuelv[U%"x.{dy ;'߳rŀ%T46TvԸ6ڟ4f ┘?Ȉ8j6nsĎ>s+DDDE~r/S=ϧ&usZuaOqcieߵV]PZ"""""""-Zt}(FJV)XLGmO9AnEDDE5_]d0\9i&]XRK= "70)픔`<SvDn5x}-[aUEu2b-ﺊXhse@60] /g.V+RB`:JQHi4oWv/ܾJ%dLf[f풚qHzRtR1 ׷PWm6Kec(,Jziak]7+uuPp+m.7@;k%P8D};}CpYQxTu6[ ou;7Oܺ,V3KOm(Z dv(e, ^qƇ.k] ,RA lqV+}2˅Ͻ7p*%WAEKn@Ƨ 1miK-qbZP6G$hׁwb/^Si+11uކ)j淃G bTXzEme$> Ka04?p 맷xclL tW-i-mHά}D { -EM+4|MC6mA{mOoQi:glzL ;q_F٧#xE,#}8#{]Yc DklT϶VGGG4DD5@:Z荻\85/Hāe acZ+m,T Gyz3(&ϒ<^'}̏t7BxDDDE~r/S=ϧ&usZuaOqcieߵV]PZ"""""""-Zt}(FJV)XĞGlP;q@4\Fv*n`05tV | H /;GwUҵ*6f<oN i3y㊣iмy{]3t'Cڹ5ع"""""""""""""""-{}𧻑|Jx.}?5{ԗK۫ {N'G."jӦK/0E'3JVoJV`b?sj~I Ow-""..]{s ^2ce8*Վ˶e7}895n<2ڛ1e>E]lޑԬCr* mlgTɊ-]/ZJgֱ $  jĸ=5ņ*麩\7<4讜'8R6J#kb?h:cw͸fݖX)UW\`1GMo ՚9Ϝؿc̛Tx=-:G ѭph]Q .h^1j<)_!R^ {OM^"""""""""""""""""""""""""""""""..%žө:˿jHDDDDDDDZ-*>QIRR1'?$z(yQ @~,hNMXs[ɏE(:č\ ҼU,0^nH[W7yޛ҃L޸MW5Oslu2AX,q64#^-O[DZo;8,}#b hq"Z ܡT _&l g;0|m޽!{g|_>h-q.NP;=~KfU}\igwFvG!)34LvkE|h'륀xjsO5Ȥ}nF%ua`Ԑ'V[~7iNQ 5 GȤ0<iˉ1c0SULLBSϤID#c|mnLnof1xSȾBN `>䚽DDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD\]jKՅ=ŏSu~[uBhi%[ߘT|+Xb/0{SNPgnETDDDDDDD]51 [-<{Z/4#>b[v(jZg4^d;,,/Wۜ5-CN+F '[؆۳*YTci ;ϱu@xT8tĕ~G=摝dLXB[W ]x䈈^1j<)_!R^ {OM^"""""""""""""""""""""""""""""""..%žө:˿jHDDDDDDDZ-*>QIRRL ͩ'(5AƏ7}""""nެl!tԵ :98yOP۱ZkOJ2F Fq\ ^f㮚* FF~w:i഻u44jJ[WOS㦣Q\\ \3v6{fMtsNu CCy8v*t;B*9j7I% s^^"6'dj'Ѩ^\g͛4L)vE $]r~w9F5GLU#dͬY[|7kQt@Ѡ½ l(q-U!tx{^\4P9={ivؽb=]0/a %lO3ek"cnAZ[b[G V$x`4EGEm/ <~Rbk#3\\ Ĵqij=kߦ#G=܋*TavsIDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDE֤_XSXZu9:(䭦ٟ,m8rIeK+&XeUÞ{h%vї̶Im44ָz-]3Caڎ^eHfabݜ1v3ͧюi|mз]+fm51ktm[mrWM hP]|8rXѽ {D02iM<%ne2GX_ 2x3K0RUNe*,Ol )N=Ûif%^ud0^n!byxcdžJ)ZfI{VűmdWjoW҇US7^ i qӈP:6<).pu&4QN7փ.$k0H.=mSpG 7F^;̸ o`v<- :IEp6$ds\X~hBvT?7:Vҳ|1 R4g=l9x{,*&ݮ0E)#+{ٽ7+5j)Ɨ2&88p%݊7d>yCIYԴqWz.2BubY;[4l_qUE K4zKCWy,qhg=h-Y[fR^:ҵ2o5Vw2.1%S1sX)4^6x{ }qp,OVފB٩@#qjƻ\ &(0%a5ְNU吻X=] ķQIwZn4)bt @էtvv(OQ ʻ-8g`62ӣ7I'P=bSx-cH`lF pl[.4O )LcgyVآ:Şo[rk7d:xSȾBN `>䚽DDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD\]jKՅ=ŏSu~[uBhi%[ߘT|+Xb+0~1?$'yytt1ekx@>EX{웓6[}*-&M7OݨWSKYIjɇW<ѫےi-[CkOh氖Kal^3QU>iBڙ|丒II_K46cJ̥8d|wڇJ[Ƀ*$83,&yP[xZƀ5zs'.-١V9^sUR#k@oӚܺ٧7?w[1GPntb-"K]ּ#6+wG'3e~VvN<>·JH 42M>o9xFO!!yٜK`ZX;\C+3|6-ӲJڃ+ƒUxU}:Wi\7AqnpÊNٍ6luqu 5 p`%<]5NCҨOdoz?vԜGq0s:9q qTnvy8zÕYo\q,6xV2n3GNY 7j;;s)tz +Q1ћ @ןCD\̬<%gQSbaLچ<`tp9 UFF5,cZٯ>JȢotvc|#iyeCGs$RVT#s{$^ "Ӵ _,3x{g<{Yb-o ㋍U:k-}='X浝cK~eLe͇Y5^41koobYYǹ7"Ipܼ؁#<<ѹ|VxPtDDDDDDDDDDZQOw" :/]jQqw5.V?NN?Q]Uo E"""""""էLn_~aQOgb LImO9Ay\q96V]m]i8.q÷8?W-0_/wc)lmgYKhnї=tWWXklp45-Y C6ĶOyz:GCP>8e0Fxz\OuFWz[ 8o,[˼4XS25htm3W8s qf &6:d94 H׎MgG>\o6,]1-@@0 0$ėIƴRUϬ]wxڽ|7`eUumuK,`-ռ~pD[QAtt3hm>u,v#h˅_[cѱGS@5hMA5  ƺUSvc3Z\xWMѻh+#WGۧqιsCֻ /0 `k Xr>gZ֝GEka.3' cn.{`a{#pp;i10ʻŗo,7kOFf⛫mny>N8cE.ݥ%7h!6W 7^1j<)_!R^ {OM^"""""""""""""""""""""""""""""""..%žө:˿jHDDDDDDDZ-*>QIRRL =ͩ'(3AƏ7}"*""*IuisG!\zb$z;גn<:9WGQ@rC.N qp$rb )>*veĎ09] kWWV[la603 NCcStѤ<ٿ6 AExl-{i_|M*V#^iMfwrkب4iUC{ո-""""""""""""""""""""""""""""kR]/n),-:~DDDDDDDEN/ܾ£)X=+[ ͩ'(7?CwOȶgYۮ5hclfZ<5URRa4v4s^1a ﭯ1w]a;\T|`7jXM-W &&G5Y%=Dn=tBqYh""""""""""""""""""-{}𧻑|Jx.}?5{jKNzXj0Ż{$ 3G%b8T*/8jGIqiL܂7mYuw8*A" AneNpӚ戈ItrtyګR-:dr R?ԥ`+Efb?sj~I tPpwȶ۫Ẍ́ (3c37w/"Y/ulT<ǟt6b[|U[0p[5G#G2w8xOuV0 uӆ ƶa_Y ^Vsøы![E|v $5G½G+\Co ]\4Htcd~{m@xvGjw-F=TKNp⍔HxSȾBN `>䚽D\Ku_ u,ahD#B Zμ{cћRS_#E K|@5պn4 tLmEe.$G!UѼMyw]. F\Qqw5.V?NN?Q]Uo E"""""""էLn_~aQOgb :`LImO9AnETDEk,6,eЙM6:z)e{zڲN.$ك}ķJ[G+"s)piح۟4/؊킱{n6f-4=TW7b lCQՔXFJK9Cˁ 9s]:K6qɋ8}Kysosent7|]m&(u:@ců$nllcUg5浍RRM9 fFA{G3b\ 6U&*״ ^ukOGMw{׃|aҫO]"UU.DU7-{}+kYS V7Ub+FO7!#wt+O$C ɷ@۾3==aF7OL;Շ:Fa m\{Vi&1 Ŭ}͞h خ:[mo6A3wtշ?JFiƒ M%KY==$h գxSd\b-3vM7F m&}iִ̾fiZkq>s[1&qjHC:ٙêsDcׁYPXr[Qff6Hf]W]=흘ى}͜ĶZ-$-lӒeIF4˜O&ð4P[`dmla]]ޯ\+v_XgE[T$ CYE{[9݌qV9x1CZ]:M%X.~ؽJ E!\Z$ ckFC.24fb,xś~׶T))6= ndm' Z3kp5VkJDž684lY06C6ZFpiTwIkN{ 9}6_Zf1ŴHC3ѭWěWNEv"""""""׿LGڏ {Tׁ~WNλ ROKULʊy1Ks Vob5`Np̥,vhVtcZkÈ,j5UDDDDDDDDDDDDDDDDDDDDDDDDDD\]jKՅ=ŏSu~[uBhi%[ߘT|+Xb+0~1?$'yyt= 拈$v/%z+&!xG]qMڤVPpȣr0:⽽\˼KzdMqblH-Ѐ7@'P`ͣ32Z+=9+\:$z(lTxK4o v#As5d|FH3*L[_1SW[1 <)4z4 7[vG\F\1ɶ^k)aU,FuòNpbܠd~5 }yΞφ:iˑƆF /J#k/z=̌qN2s%sgپ'q]=}VK?.!](q-Qϒ^jYXVZ*]Q~ZL8nOKں6hs=ku[u/JXo'},̓SV^k%洇= lkx):*u.>f]UmoR sN!.'E{K%ikۼk[J􀵭5޼˓6lW'OJ7F^:X`Dž`c4w}I Ÿ _N#ʋd oƎ<7SSQWn=~x Ź3XRu:=xkhs;s&Tp1|pqk u_>{SddblIW<v?ܱ 蔲V]&e\~a-E=\ut$ AY[7=d+gWχk4tw:P(k4=ϲ]ثQ]KME}P7P:kH֞:iHžE*u_$"".. t_Kv:fnwV6Lsf}V2Rk\s O!-kG"ΛF=0tl9qa=e,n?Y)xn#GwDDDDDDDDDDDDDDDDDDDDDDDDD\]jKՅ=ŏSu~[uBhi%[ߘT|+Xb+0~1?$'yy3yFZ4n*`[ʆO=@5^kx]Iq,:ih"QTGwuѺiTא{Uڟ<#i#" $5<ӫНJq1G:pӂF aӟbugOLuU #"'WwuN]A禪-A#MǯwJ]"Mzq sq\OnB]Zyxݺh|9hijNUw<`tavM 4v^1j<)_!R^ {OM^"""4Oa|4qV,SF#xxll3(ն,]I;٧iL5 b{[3QhYH5x"":Zo?z\;\Uqw5.V?NN?Q]Uo E"""""""էLn_~aQOgb~p5 koȶ߾ o›~|)߾ o›~|)߾ o›~|)߾ o›~|)߾ o›~|)߾ o›~|)߾ o›~|)߾ o›~|)߾ o›~|)߾ o›~|)߾ o›~|)߾ o›~|)߾ o›~|)߾ o›~|)߾ o›|tø HDN+]>;ԘS80=ʭREG ;k{^q=OV|7!$gΞq=OV|7!$gΞq=OV|7!$gΞq=OV|7!$gΞq=OV|7!$gΞq=OV|7!$gΞq=OV|7!$gΞq=OV|7!$gΞq=OV|7!$gΞq=OV|7!$gΞq=OV|7!$gΞq=OV|7!$gΞq=OV|7!$gΞq=OV|7!$gΞq=OV|7!$gΞq=OV|7!$gΞq=OV|7!$gΞq=OV|7!$gΞq=OV|7!$gΞq=OV|7!$gΞq=OV|7!$gΞq=OV|7!$gΞq=OV|7!$gΞq=OV|7!$gΞq=OV|7!$gΞq=OV|7!$gΞq=OV|7!$gΞq=OV|7!$gΞq=OV|7!$gΞq=OV|јbl祾E 8|&]p}oJJxkƆ>""""*YA3QIRRhɢ4 Mh@&4 Mh@&4 Mh@.2x|5tz_PtUt Mh@&4 Mh@&4 Mh@&4 Mh@&SpkEPy Q|7kU=ކz:YQM; r կi}Ѵ&GMLhj[asGsծh\7*ꡒWGUZ498Nŕ;t=9Z|bԔkikN[}BrL7P;~6F7uzT?40} tPQ=A͡s(n̼]L\=he&3{ҬD[:}k ك-q,huGSq԰R%6 4cTk T*(iܛлhJX/૆re\@]M=xgx~4Fo>S5/ٛUUcmsˮ7?zx䪈ItrtyګR-:dr R?ԥ`+DDDDDDDDDDDDDE^+^?w,+b踿ҕ1Ny;x> wSJjn,Ym?rռwMGÒiΫUxFnǼ3@欬{$DDDDDDDDDDDDDDDDDDDECq_KxOM3KdP-um 8cu6i2>V>a N8@ަNvԷT}gVYEzAxrY^3AQع;MeUntdU2#wծ:A"2oSۼ5ړ"Ȼalqm +n6'ViNC;OEk^<7Hưc^:t'LT5ǔN-#jÜd { #Xk%7S? I(`/]YO;v`˳V\7 -L9#2˺#p+2JԗK۫ {N'G."jӦK/0E'3JVoJDDDDDDDDDDDDD_-ύڟ חD;3}ԗB.]8s_Fَ7AsMNzlY1OF)zOMvJ߯bmُ-[#t_Fmt[2 ψоi:=]#P{'I&Q*p#s[tZA#7wԷu{<K箥eTF7mpllg6SB>%|#^wXEL=E`0Ag=UUrx_O%qpiU4@4Mrh;Dw&*"""""""""""""""""..%žө:˿jHDDDDDDDZ-*>QIRRr۪vN˻tw\?"6th3i=8k{?R:{;^nA,XM{H.9dc\0esZt Q߶Ep9\2xݣy^Zo^8bn.8VCx9aoQr^-RVBʊYZk?Ol_j\3._lEǫ"3ıA{{?yvGiY!JFPH޲Z`5UDDDDDDDDDDDDDDDDDDDDD\]jKՅ=ŏSu~[uBhi%[ߘT|+Xb"""""""""""""/5N"F*FBC+dC:[ ڣ0CwwJͽ&x(886 \ѦF4uutlӺq:Yupk|F4UMʖUH.<?q^&X1׍rQcds5`ofA\SN/ }3c$P[$r09iAȵӟ>b퓳R:=]e1! ԃ`v{Aӵr %i{O%מ!2N5uO9b,wTnOͻCۈlE CigsAD>v"""""""""""""""""""""kR]/n),-:~DDDDDDDEN/ܾ£)X=+L-i㦼5dm7t&m^plkdh$.'7M#gb93ÔdxdOa%o_6Qzj:j(㧍h/w*CBekStw*n44w*9&Ӓn@U A+ ,0QM+w_kqk?쭚SPT3%G]y!l\!k[Vi +^톮4Qeԯ#p:z]eԞNA]ȈItrtyګR-:dr R?ԥ`+DDDDDDDDDDDDD]SHӑT:ٽ_kc\o6jgV~C~9CUŇQN+\ !`X3Q`|1j[#GM@kCuNcwu\PWuAv6M+\"p<`uBb}FpdSZp7yf9{16t3qf,$ y,%i-ӓ*""""""""""""""""""..%žө:˿jHDDDDDDDZ-*>QIRRQUPWzut𲢎,R7P9TEؿbѳ988S<ς&e;$j8qoC}(ઈn6[3Fkqkh [' Yl|5D\asi!L};AH /0[So.h 5%8u+"""""""""""""""""""kR]/n),-:~DDDDDDDEN/ܾ£)X=+pt\''i5>DSMO5>DSMO5>DSMO5>DSMO5>DSMO5>DSMO5>DSMO5>DSMO5>DSMO5>DSMO5>DSMO5>DSMO5>DSMO5>DSMO5>DSMO5>DSMO5>DSMOPAظ9sI㎀uTDDDDEB5!|Ih%iH5kFBFu!IV:04]:ͧhSfݢ$Uo @pô,պ戈ItrtyګR-:dr R?ԥ`+Eߥ|z"%6 ׎m!aj1:ل:;-HCZև4dۿ?E>n3(H}ṃ!SA2Oۿ?E>n3(H}ṃ!SA2Oۿ?E>n3(H}ṃ!SA2Oۿ?E>n3(H}ṃ!SA2Oۿ?E>n3(H}ṃ!SA2Oۿ?E>n3(H}ṃ!SA2Oۿ?E>n3(H}ṃ!SA2Oۿ?E>n3(H}ṃ!SA2Oۿ?E>n3(H}ṃ!SA2Oۿ?E>n3(H}ṃ!SA2Oۿ?E>n3(H}ṃ!SA2Oۿ?E>n3(H}ṃ!SA2Oۿ?E>n3(H}ṃ!SA2Oۿ?E>n3(H}ṃ!SA2Oۿ?E>n3(H}ṃ!SA2Oۿ?E>n3(H}ṃ!SA2Oۿ?E>n3(H}ṃ!SA2^>0h1r\3*eBG.O*^&ͭm7Yr}4ӶJ3kTh!k"""""*|wKm==-\ME'-sd—6n:l\=KkZ}]fI|WS3sAטڏ?t^iJ" Mqa){n򛧼){n򛧼){n򛧼){n򛧼){n򛧼){n򛧼){n򛧼){n򛧼){n򛧼){n򛧼){n򛧼){n򛧼){n򛧼){n򛧼){n򛧼){n򛧼){nѡ#q-`w|,xU骇NQ4_-eUqnN9>xl6Ay*"`.sdu=`ᴎ7XK i=8,8q{*ItrtyګR-:dr R?ԥ`+Eܕk폞zؒ""""""""""""""""""""""""""""""""",ow7` )ԼQPWth&7vHùkhl{i3W$/V4xxppSg0XhN#oQz$-qYmV:qw5.V?NN?Q]Uo E"""""""էLn_~aQOgby?~]c[]o$8h7oAݴzA\R-Xef\䱞}'؆֬1P8k)̕kZFSEy[꨺R6#=d6CβV&ĕԱU1< s[TQե} cdcknms L-[FAA2y{zC-w* =QW[x@L1M53Zoc8*.9rUtkgc˽( ҕ5f:GZO _CDsN$pص/}%y3?alv(.3Ray op_^Xc\gEEeC$[t;7mQw|Ă.lBU2ЇnG ަV U`e}X:b;^ ׂI] džZ>e3+/mbSo `c:Mד?Ӷa#|ks#PHp:p ScxS3qE-ƎrI/vI='lcFex['$3=dxDGkBeeC3#Rx3OBWCjF潇c*GiRC;9'k]kZ˙S xuZ@d,c]tQcݻk6ŷ;=V$-k} T|{,/qӫ|''s ˆyHC/Ѡ$al{^qi8֮aXj 8m+(4nnku=pŧ gGYn`>1妡\Y>);ҢQ2c6 4Q9hr݊c:F>kwB$gE7 LW[KKrupVnךyI-- 6=-<ɛ0Wf0݈: LZ矨I+LQ<{} v4\#KrvKᤇ~@Ye\,bSYMOYr9͌k;p2iiuʼ,}U5POV@78k-KUtؼL6RYKw}wlSM߲#6auz }hzF*dH.gf]-{h{w!LJz˝\]n8 VGnoF=g[ɓZ%Q~Y5 ^W%]`.:GrpΛKaMXv𻫫OMzi^+/M>EڈItrtyګR-:dr R?ԥ`+Eܕk폞zؒیs9bg¹{VcH-Õ7j)]&Q6j͸)p,1~SF"h-2CCȷ{`}M).hq']Hh/@H(#;%x]#%"~/R6Zzzmzǀ8zPbWs던2:RzޣMwHN? 5p/VkCnK+K*pGS]uM[J4uNkK:Y^h+PIS-5|g9ڒw5TVVN'S,V\'Jv:5MFǀj[]fr]h'KP0s/k}.~buML4utM:jD|xvc|[2n5UھYj|A7jHvs^y%9o8ve&\+9V8b6L_Urm8+k敌-W 9]X3vIvŗە)in3Ilj9-0=KZupZ)v!Mnw<@ uE\jDAjә jMi9g*8oci l,Mx;Yoy60բ {$UC%p]1ؽvƦr͈*WQ E$#{N ls''6:a֒aSR#v>mW4&u4 %1[rTG-ŇcXSz0no{A׀=_ahuw<[ 9ÔزGT->Lwi^ g9+qU,'j% (dD4OjT2f.0oO5ӊk"5cZGܹ.%sH^s%6**tnjk>.cu6<67 wgd!&X _媛 ܪ*eI-T%<z)n"G,7?ɪ+ 2nR=Z%x6C1ŧbJk.Swui#JŘfȱ^5zN57׀yP C;u^ec55K$Mi:525(I%[.ӼZ5&f(+wu?/o3>d nSC_>lc]0\NW9p0786[ڶC7u:o2U˄כh^o9ctJIg7lmWZIOU5 l`ؘNJcͨأ,h1hbV<1Rplf4|n7LC1G:v3.v Eَ My%Y3c}|3c!#ݭx(n Y,.OQ375 7tY%Dvh$cU7]8"G}q!`RKU׵|W;]5֖X*eU<ܒ qiVs#1FƸO EG 7zՑQjLWA**eöf۫4Ec,uŎYSm-e7jOUʘljLfϳ7xx6 t9۲]N}MC1lQX<v؃ Xsᛅڲ۵1֘5=X$nrU~G/-rGQ4"_՘p띴_$26]u{|Y| I<-(诖STP' ύL:X-U8䱁w5R_o8 Jml\k=Hw }XKdnKGQW,CN׏먓^ 'tbe2q(gEOY3]:ɝi[$Xj =}lΊH*;p{ٶaLf y]5wLIM>|֢F^.Fi5TΙI@a:i 1t0j_wCtGk𫳥wVɝM$ ;cK"8A^Y?3ihxCõd=cf+Xr:U1 vݾǻMrz cqmt SI,/{zea>QOO+ v$Mۧ>k- Xk+nҬ;3Z$0`૝AF|$)hcq>>t䤮řjmΫM ]4W<1ҖGz˹a]o:@mw c~x9W[]l{5/)4.iCۯw]B:"MhuwzHVݏqAޖ-%#mh t6ʰ8H{;Q3IzTv) h_ FL)*+scHWoF'Sv]e$LyY"!1]kζ25Kcc =!Gg"GlouR8iL0G1|br[%:D\聫t .4Z9uI237wgެᶞ]2gйM<{7:5i4Н8whi"y\>K> N(]Oac~?.>z`Tͤ~'S/R ]Cuӗ,R6Mؼ是NJ]C|MJ5_[<4s*1 mLQ]Q!_`9CaeRe]n]i;#s=#;Mjqm=+oE:wTOɣ|]Q[˛$saT"z;|H`+Q޹""G}q!`RKU4_Βzz=<Ѻ9"p=hAZϜ;cs(antn1q'*^N//(qH⭖0k-Pd~8ρ +ELƙcZNvU0xODDDDDDDDDDDDDDE֤_XSXZu9:-5Xs|GUqAⷷLV.x ]o- 2S1r]m(# 7khs$sH:ꘋ-0.MzöۤT{/BDžlf6Klt1`=~}޲vڐ#]E8PUvB&km}ֻ-8(AcGٺN ak6;NS3x;kԮˮʟ(+Nv@2 ddV mK]-+CG uXo\Um `φ ;  Nן[e p./3fog{MuUaWMaIXo:2߽8r^ x E^X-ͬlpoi|1װ9hAKB 3j^V3zMyt Faeg+wd}4 w]rw_.a;EecZ69(1IKE=( f ʬC|l3ky?/U *- t^>[<͆M t7YDz4_5a AetMNڀu[ﴮA]N 0ڰ]f65 x5;c:+f]afU6vږ&]t]Wx–l@[tR\ .UB 禣$35,X-EXXy4kUaH)e[_L{Mxm~fFvx WtӚy=_A*FEEpO nD SbKMOSscMwA9z6-:[}4TlP01_o nvjfuL yJ]mnym߻P]7yslBQO[ oqqRmMtFڰhFx< f8? jrs\<:l#g]zQ{+KCN)tEZv( [UK`Դ6hXׂy@״n_aduX~QU#4s{#U\l77WRCYL7:rx/ nU.a]-5+PѮT QSycѸWEϩN?N䪈y/Kr:$V5Ѵ.@]5ٿ1T? SySah>ӻ⻐:ka:F.i`d-{+H1snk8lg\ă62w bzi8{\ZG=Y5sZuaOqcieߵV]PZ"""""""-Zt}(FJV)XϿ+7JE<=?*$DEBtVng<.Gm<#{:ZI{l*YIqV.M$X9Kq-L+Mnʺ:4gVwiCɞxC"pϛXUDo=kG QHd=;[eHtoJsxkKU[(饞SL/q= JUjWGPY#}-wRb*\Sb[E]*!-ZjN=NqռA0. ]ǹWUU:qyPH To[mYg)yw(Wҹ4ؐ[ `s_᪗/k*FuP|sUq#q!`RKUQqHZyp¸S 39՗:GG+wh%ڪ)-5NZYwɘXOkٰX"""""""""""""""..%žө:˿jHDDDDDDDZ-*>QIRRrWo'ދ>x{~UbHS< ԷKsW Z̒GJ\DFM7w[1y.VYRVbk™2~.'G4vGJj.Ŷ5W奷n--ȱuW1mY0QaCk%jt#ؼ\5p5 Cee?1TwdsfCKӎ/{eͻ(Wiru,5mf-ѦUaW̛%/8!ŀ⓺pO0qۙx6Ӊo\#2FIs=y[r]/Wz5飄/hTb;}R0 As{|uϋ^ت.}TCޖ|~o&Manuh]7A᪕շ}/v}c\~uT4N &e{`Q&P1EVdYly`yd0TC75"Y[ ;6>f09V{s*<֘쵕ZsuC ]z;\]2fXo77uupѼӱ{msң#,+=>xtZ8ksnatI\a469&[xx#]~Mkk[5Ɔ**6GH]eOuhȏiwؽ+K OC%nNǴx uq4R+g 'gGD1UDCCȋFGPtf}}ξdԧ QIn @'7*QX %qݬnl5ڗh 4qxOKW;5O$siL V.xxf UHMJJT #ՃzXf -*vOX#%sv{7*K5W+`Z0 Oڵ)8.tybPF^֍^hxzzGflَb,_CJ`} Ժ9\Ȍ%׳M ;"^mqmaX_UQ#oC#p5=|8Y5#P -k~dmSR }iVMrgLDž.TQM5LOIּn:li$٫.0|Ԃn7CR=J>/1lðg uRCyvc[l6{5ΆbG8Xj͈%̪(6(F|G$4u#2~eV+%EK]Q5++$=q`m9e>u*Z T]V)wZTDqVlOswIkvT/99 *_IG+He#QxX_4K/aZCMAO=-7 6~jy$mMcdZ 1t#}5XGgԏ lVaQQ6'J]1 /ioI᪓m;rgƔx2CE_boI<2qc~!OIvgjݶRŽ o]ݠэF;)|¹?&~+>lWUԸ=4R@>^͝y e.#sk/*F e@r>;U:""""""""""薞:X"xs5iKfG:0S%ǺO±^P!m,kɘcTn}1TDDDDDDDDDDDDDDE֤_XSXZu9:Cv˭oX}Ÿ)wDZ0ڼ{>aIQlv2t |{pnAѠsYSm1}nhWA]re֚g857w69+˗尩bk}U5\WH-q[^11&̋DvH鮱ҼG+@.trtzRfҙ?`E;|]Tyv]OHF[`-~}OQz2*zX# _V݌s?T[馽QݭIL}]+$f/>lGu_i ɜc[fRbO.4a5u;j6Hv,k~FZj ]}~w]*Vto{BLyApTȸ_=OTVɤ0qTu{NbH=өٴ,yƪ?iO2ch{W5jwG=fLP2ecւ^཮ujSGm$c^CZ@ҚV85p_co6RS;qEY r3uÈ;hW~|5L࡯:\&- <{[tXba}U j& +U%/Zje`޵ٓKf[<϶=r_"(XyA&b৑=Au#no z)^vï;IWHCZlM~;I>Җ!M]B6}U;Sۧn<5rcuk*;q/0\tqV;B]I Z鄗\mm/2j(1n[ y~::F(i'Y`:i*p_;6oN:{AKE6ZnJKQ+k,؟"݄2#Mj\8a>_% UAnEFIkk!gm̾JhY0;@7@Jdf3-lx=B2GG^g#ߧ=%s:MWJ4蚯tcgG@R1# aZ>˰:NX*qZ:SVwKMXD)tEv䎯cQ2e;|mJk짧vXi <ۖXe,0Ua(m83 v hߴv2,sS}OSx9*""""""""""""""""""""""""""kR]/n),-:~DDDDDDDEN/ܾ£)X=+y%)Zc燺^$hqNkS(0|ۡVEU B́8qUY;L8ԶxωVȤfk{4m~!0>5Gu&%}nǮp+w/q]FdkGxՌ=d.Lnhcn6LӹOEl:Aˑ4ܶνQ#1nmO.ׅ>gC[Nd2Zaά }fH#7}H'Qߪ# 3 pO1nja!K&qWH[sO$5 v$1׼M9,ז?8Yk{T9 kt#e]CYi)mr^lTk٠wڿLðZ_a&cZ]ŷ! 'R"t!dzyhedaMvXkB{"t}w$7[ 9}ˣ,o1}\Rr$/Ej\C[Qq_LO|Tk FHƓtE^.aY#8'U 㦜Gz)-Ψ/aܓ[!n S583.qU}WCй:}IΠkmq#AiL8h7CL/ŮЉZfP]K|WqAI=/GMdBScvT?Uqlc{_Ub}ڿ'q{HwpwKכb>y\}.ɅWT>F9ky[`k4gX/ԧcRrUDDDDDDDDDDDDDDDDDDDDDDDDDDE֤_XSXZu9:v-v!1ekŶZG\IՇ-˙x5fh馇XO~f'G|:y |X'=䓮سWlAV-Y#xsw_M ?>f15o ^u i§aU%`gWc[VڇcԞew@wmo>7}W ٮǂ m42 OԽfȱPtl`\ܪa^\CUK]Qs滀7,kܱWD:f4xUK1TK`pwd`wG593RAo{G=3 g, Y/êԍ[޾=py\ rX;qک^v(Ъik_4zMN+tMe5VJkksbssDo<¹|,41Q4Sլc53f]x;51%qݡ&b ,mse..F"Ԕ솢UNZ^Kb-[9v(qpL?h+f#:\Zj':qNB$M6*HE5֢vEPRwkx'*1\8wb*g i$u`בSN8kI~w[KlQI[Atnk\t?tr r7b+mBG7ŻK*m#Vj^Kk T2FSeRYjh15C`@2õenW -Oƒ\;wbfi+2WL*D^ޯOӊvX l9S-MeNQiG!͌pZ}+S]yJ*51҇GƎ&Q> @ʇbԖu}4D\F^M4)O_^2>J\7,-7c7R5ׂX; 6$TbM%ݐ $>6ǿ8Ŗw`cp#e^lxXՄF;U:"""""""""""YYz>%BH0kvqmM[zvϝrX֭OujtX֭OujtX֭OujtX֭OujtX֭OujtX֭OujtX֭OujtX֭Oujuض=5ߩϝvLjs6; '#e`s\kv"""kR]/n),-:~DDDDDDDEN/ܾ£)X=+y%)Zc燺^$""""""""",ow7` )ԼQK{Sy2z.inA \x(c6 KfǮ)ZG4=򷙱VR*3)-4u%oj蝂<ȾM1eK?}#Rû; IW9= ; ''aa_0$?+ÓГ0rzvOBN¿aIW9= ; ''aa_0$?+ÓГ0rzvOBN¿a˃$zj m<;֬ɾS-t׳?xq쉵VMk0eQ^jɣ.v4쫫LGܰfCL٠su,vqhcaô7to̖4iخ]k""kR]/n),-:~DDDDDDDEN/ܾ£)X=+y%)Zc燺^$;'Bt 8pC(ɮ䋉vM=:G"""".%;M=]@M|qPx.Mv8k\ .=`ОZ,3sgQq ĠkMQ6-HQ+6l oLY=Up߇!`!9O|8w,= ,A Fi't JX>)iݢ4ɠMrh;Aܚw&4ɠMrh;Aܚw*n#]=NiVfe&ͬ=5Yhr diip:99n#eEV#]Y`|mI-cF`hx mFaTXU2N&7Zi4t=LnS؈ItrtyګR-:dr R?ԥ`+EܕkGuʽlISxkWMed4<ۼGzt[{dn(e:w.B5_ܮ\Kf_a<Ϡى.4nN=fN$À+hv{S:ekClK;+4_Zfͫk.+1z] 0jFN1̮"V9tqTHxwZS* ׀\L@hV8=0U(mKhxg'Yu: 4_ή:7U<̤鮿-C( V_l1q׬i zkLX{S[h$j5vJI6G%>zf$۷?ꪳY O>M 08<5ѼH»gW䨊iϪZA-O"VUrÝ,9+)A4T2'[5,28c#82ױҒt[q yr]bvʊxhMhɵi>_2 5벳ڸ*j*J *w!Ky UÈDV/c muO)vMFI{{@Tcg.PAռCy}̙C ͛/̍l]OKfD5ӻzZz8>J線ɸodVvLWp]O^>J6G06Vضe۱E4wKs`5s@#*fjǴüsb;EAjvveʮF֙Kk+/pV dWB\xkԒxQk9}qipV]i̚7ӄe| xK-ui*.q(Ѻ4 ;.}Jv?ou/%TDDPP#Zڻv5~J {8˻2m=EK^^!Q\!/yv!`c ~ M\&lM7~)W,xt\V}#;Q5@t`Jq=sC"bf}KL,ʼ7"mdO:h^hGVn. rSz!oJFoUlڻ-*j$l,J3JMbrF>{l3iM4=y2F<޺:Ri9wig\q]n@2]طʶW[r;GȊ-5Z%ا:e f\Q->V?'j1f;ߢEQX*!,.s_0U"34#eJ]+,9g-9<)MɍڰO6Jg!/`e#pЃ$ؤvGE^Bt:TF5>x;/rٗG %O=\7V' _G3eU\o+. 74oN޾+G_b e V;=K*C<\~{> ͬx]te2zyوkw|bc rwX)2|>d9Ʊ 5rX%i7A-,Rou;ÈF#^;G,6l~nk4OW;.}Jv?ou/%TDDX;k]\3 ww6un9M4?z͑)n,kj.$&,hcQ=`[Dc*qU l`ᬥ,g[w%m \3z ,1C]O&Zƴp r4ۖ`;jKNu=`yw!0&lQ%L{t!"|!̪VM^\4ߪ抇ߡ0_-4hd37?Zث$g_MV++5S'I,Էoh=6^8<]gfG@&0h9kJHm$+&km“4 7t t{4Oz?6][ Z']]z)#p=y/[NW;.a]/4R("*J< NC]vfj]~m]궇c| vpo`;b썷`gEv1k;n6(餍1!'RGrS'03:xe,qu{Tվ-hsxy ]]7Z2-U17>9^!}u~R~t^n0:4|@ѫ<l7 Qs>ҕj!mwfj(I*$zC__1M6iÉ=WiͺntU$Y+x(߶_ C9I7[5SkSGqQqw5.V?NN?Q]Uo E"""""""էLn_~aQOgby?~]c[DDDDDDDDDZ,-UH}Z6?6”.yխ×&-,2FZvf}} : Zh?+ehhgX+ԧcRr]S;u ;]0_[kNYOQ$n.p:[h~,)EFYPW(Igj%v]vד孠.Um|\ʿWO,'?2}[w}7w̩kg}gCeg>}YӻO&Nw|apP>;nű23{2e UvTppnO赤{ TlwYC|e,* ~Q,qZ8S8no6ˈa,M51З:;tkሇ7Q*tkg^ڌr2u,7Bѡ!aM6ٿXڜuiUp°z7j,IuO&Yj{(]+#nC%a ð퓶[u2[4a ! O5coE Ļwx驵+,Sf\AqQK Ʈizh-O@`}o@|vQPL?cgdۯIZLm 5ȺhU649eޮT+a4#@KOY b{-8zx_6qdcmi0RsNk;RǢwnoK&Q礒Szڦ,Tt̂:Ff]>-nv `}L x2xYGn#v~@88Uxݣ뽊` %:Yic?CՓڶBCxUwܵ{wtwI ꡓtv)ѝolf ) FFBܨNj5U7;0w t\~ST^H懴Ȯ=[Irw&7Aj*Aܚ,uc| <]L? vn諲y).Wӆxv:)p#XtV|mSSpzV9/d4 n'SUޔʵ툦(Kت$)tAl'P8* ̜E:놮rMջujC>c5%{uUz5㛆)};mQԸ4?{]GVFpи>fZƀ4 A:;{"H0Y=Ke_pke'MRtU$Dr.|5Z\~FA'Ę*/f:7EcNӻhx4W~VlE&ۈmrZj̲ u+!1X ^n臄LuǏWմ.Y{=<󆎸Q5 iw!̫[#7& 71؎OAEx1^ u餫WYlc5M;*U_,LS p8y-cu%9Hxy9a l-SDUo;gC'9g}p)-[p6BKwt$=1V; `<֛<> .su:ī>mm/> 7.:!Kz\%wZknv;3.jy+Xc9 6.x F Ğcb*ZֶfRVQ0BEqmW;XӦtqv_l8nZqSQ3oV 3PU8ܠ|11H_{"V4GxQUG5 B4&ůݜ$nlxΓY-(a*y5c _sKN=`>;ycx+ a{MU[b ]&a˱^0yim Zt s^Zcp28c*^,˚O&On}k!7¶a·e\5pZĎ{;#M3G  akf ޮC0!.f/*F148WhfĖ:)O3t'vpp䬌#͋&2K--))Lo9L 8so])z6/j3}0$Ư;?s03g%/*t9YAZ1sHVL]8{q+|*7Zbe(xvkf dNf/a=:jzZzvyss >۵\*yhEIkgu,%V}yݎT/a¶v7MQ,t0!.>™y$cĘxMG3w\4s`|Ynx.b*h'ū׷ZoLG0]mCM36CJ8gb[[b}1=R6l25xyc $NJ4pqF +g`<}k5NKz{׆xٛgNza޼ݮj)O-m# 5v!';S;W]/ym[u*|.h;.}Jv?ou/%TDDDDDDDDEV:/;~8U[3'HG-xa]ϋVM<՟0ux- p;i)-qVG4Q d9ir|7k5jژ)anJֵjb\CxNhi{ THjRԸxԸLn#5Eem5L (ۣ."kR]/n),-:~DDDDDDDEN/ܾ£)X=+y%)Zc燺^$xg»[g>e-N*mC* {ۭs ֱմ>\\bWæU:)\XI`sG 4ӂ'(q5[T>iqGhL [[GlBOW)Ty ɉ7 ӫV^g܋?TՎŻP:b kD`Շ+q]$zG a1s:n[ٔk8ʓ[I&IYJ6G|÷ISͫy.:s=vvf3ldsai 9,;so"q[*S6gtlW-hNWf|f>t>+tvRQ-14<\G {jfs#u\t[c axefqѤW2KAZcac^ kz|owl?,(?ت۪H0g:c b8o<>{|çiY'o4ոC>!ϊ-ZۊEF%D,_ټ{6AfͣMHgȌ9Go1̑؂戈hgX+ԧcRrUDDDDDDDDDEM5Xki]pј&w\ 7tZG HÂafalK|g=$<"#X54"q@D緵a'=/Sܰ݅+XaѲ2)9F{Ԛ˾, rg`:/Mɪ.ѽŚ t2â `ol}Ǫ#;UqE8s;x3hxb\]xwv/{waS2e?[{"d{ܜͩ.K漼۳ӫKQdaeLVOa}y[ѻ_<'}/@4Ă5eE{b["  .'G wj_0H|8[É鲎lǖ(n%dby^8nojiڛ֏1&dl,Τ\Q%tԔ1ъR~]tחrl6wkU-.XޯB?)z{_lOUCSzGHtu`y.V3&YSLFDfa\AL7I:[;ls7NLUS!Op8pYOurDDDDDDDDDDDDDDDDDXhn3,sS}OSx9*"""""""""._U^m8Cm]zD i7@U7rٓض~ƾݠrZ=Ι]G/SWLZO?M<~Sq^:{NwS w˼78^Eb4e=AryÙԫ4TDE֤_XSXZu9:3'^h`୒7K!dcH $+!p*<]B54$H>tp*'U-[ Ǹ:88cFU7;0w t\~ST^JAjZ-\Nc^ AP \x\6Oͧ*3iJ>d Ҩ~.ϙ?6Oͧ*3iJ>d Ҩ~.ϙ?6Oͧ*3iJ>d Ҩ~.ϙ?6Oͧ*3iJ>d Ҩ~.ϙ?6C-'4:nϙv(i_,'8`:ipzqh wiӚo.#ETDD\]jKՅ=ŏSu~[uBhi%[ߘT|+Xb/>O+_l|Xđfam{+OkNA?Qd60 {,ThNN5y#t|M:ۣ[o|/B}ٚ"""""""""""""""""""""",ow7` )ԼQqw5.V?NN?Q]Uo E"""""""էLn_~aQOgby?~]c[DDDDDDDDDZثmOs2 ()d1sNvfʬaטu^k6GRRTe/PKu'Byw)љEYkيu ] H.#y ȈhgX+ԧcRrUDDDDDDDDDDDDDDDDDDDDDDDDDDE֤_XSXZu9: En03j[W/^ Ƀۮy~֌/L {t/v_Q cIJ;UL7'HH.kycf”ySZPT ^ƞxկBlI!k"^40wWEo4lwkྯhx@\|5֚K*t0< x}.-x<:NoZ,M"Ԟ<^hq k*ऋ]޲ym׻S째Yf:7{p]\ no4sUL7O*@;SmU,~;Z98?V5u)b.hО<4 ~EFMNwSw]_}r/8؁O+_l|Xđ5yx÷ Kia2-jˆǶ,ЖW:\G3&ZO[ ڣn,KO|c|:W3jZ;{V tfc p/$Yv{ Oh.Jam)K{TF4`^Fm(p5M(0M4T1۾;HdsYѷ1fVkd [et;G]vm/ų_hiTy|vAOHY3 ʼ4EꁲiO4;Z=/j,lc,$2+<=3{_w!Wt=}l[dsKx}(x1zTYhvv'5cx=(1nufXQ37:WZ\:oGdOH06slt4t~Bɘk{CYa1Fes8Ml:MJwN}PGmIFܶQINU3*wc՗tE_31Q۱jd5s;St--:Rs&Yo*jJ US\6nH^XGk_3 f;>1\.t|8iÚ]v6 )p[%\Hi[P׹MڊcOUu i.8y9) 4/sb""""""""""""""",ow7` )ԼQ5tUCEVEF|5)`Qާޘ#i]&7L+.$yȻ_❬3~E$vfe+Z>W9xH<Cv64.hԗK۫ {N'G."jӦK/0E'3JVoJ^}_Vz.W"".HkIX;mLlp6͘Ҿ7n7Ŏ#V.Yi{^ Cq vU۽YR3>1{q;9^54Vd\ Ļ56s. +bw3U _2;Lg\1&u 1g&YYf217^jX͉ 74.u&IK ï.0Q{kT5N; &zZ}Cmu4g]+T\|MV /t{5[ݼKۭ$^?|z폑Ѹ\-6?^Gbͦ1TT7R='Tdjh bm?p:HM7\a=طoal6w(ʼn`gg̬X^)et'dG- V4HCتh+@[Al8컀xo?t=S5Qkxirrk ӇV\=4H:h NMc؃AN.:MWe eFc|*U6ޤU,fg`nt\{T_ୖB=n ,G򨟶Ø:C륁AS.a%6XLؒա勁gˎY 5^6 _g 4 PQI]YYUD1<8)ѕd,ouw%7nViʦn:=7;0w t\~ST^J:NsH^M끱%ŸrG\-ꩠu.!{ ]@RV]R\'X]{mSx\bC37_qÑsZuaOqcieߵV]PZ"""""""-Zt}(FJV)XϿ+7JE<=?*$DE,V@UmCz'U6Y%:ZZmv h2Z;3bcL _Վz3*x &> ẒĞtnCs2]EQFc?}7pWF/cm^Vns9譳|soMd1HI)9n) ŎsGbbjm-T:dAx]Qфf_nnW\m㫌gwN`sWvjus)&[=NIji)L6GIk #z>ob4[#djbC.2;x99RV# hč2oxiәV ~jGU?Њ7oPb=[I=q{7F#ZL6d5kø]w-pAkh@uUkx듘뮡rnq.H;.}Jv?ou/%TDDDDDDEBtT=cKjHrKCdd7Lotim5RZ7}< 66*+3b c vq=R4R5\[O:4*"""""""""""""""kR]/n),-:~DDDDDDDEN/ܾ£)X=+y%)Zc燺^$McͶp>T5w#W)+jE67rgMu$yrIUi0KAEG+˺yW&UDDDDDDDDDDDDDDDDDDDDDEF?B]>;U:""""""" a g_gSqtZWT?BtkGD}NbTglS'XmuV٧l"1-pw5ڈԗK۫ {N'G."jӦK/0E'3JVoJ^}_Vz.W"""""""""-[tڗK-{<03xNMOhXqF(ᘲj7Xia"dy4qOgbOF%,-YYQ :9Xv-UDDDDDDDEZuWxX-p drT 4|+ Yv(khmVj(|Dd$/8R< 11 nzk=54XmYOi\)ﴏe:#cCcstĚqY^ݚRtZU񪩈͈ IA&a\" ޲,!I,b-VE.is'xAӚXK24V׈+|2I:hyDDDDDDDDDEF?B]>;U:"""""".;u|tEosj)pwR[(Y,@ֻp^gEF3sj:Wp𳿼uY̞]V-Vk= 2*xX#67Fhx"""""""""""""""""..%žө:˿jHDDDDDDDZ-*>QIRRrWo'ދ>x{~UbH xzdli׉*ۦά [( _eGhCEl|GTc!PuG.7K=zi) n1/ cK&1YwJKI3dh'\8BZ@ rO.Jxhui,C8w M Wݾm]Cc/SǑMUe4ScujNU4Wq"1WQ[ Uut7j=fҊ/RީiNm`jD4ш twAM%EL Hh֎Ii^ jֳu4͑ W]G$v9jKĕ1݂p^h+i2MP׹t/mD ֝t=JA!;׈_=m֚G-]d̦O#XƎO%y`ݺQ% ']5ӗ"Aฉ :zyC+Z5qyUi1-Vb[uuMnpZw]|:IM/x~O 0rr3[AKjkإ2GY#xŮq %EKE 7MS0x)vc!x5ӂ˩6 c7L1$o𮷬p$tM9b,?OfK5Z0MT®8AV5zFw!ئ/MDZb^lu>I캆F=0PIU.~Tevꬶ*ڹ9vuiSڎk[ߗCS[tՙdEH LDDDDDDDDDEF?B]>;U:""""""/:FI,lqD۩Zlǿm۝ʜWR27]v}j\uj9k)gr/lk2*vi;RI%^;EPԗK۫ {N'G."jӦK/0E'3JVoJ^}_Vz.W""*9FFC#]xW"ي=i=- Rx!-,ʕo\G[>e- Gq4Ҟfڒ~6YՈN[QO(1Sa[##[ˇ2Nhݍo@>sCRf&qifjy'Fy⮔+(-h嬸OMql$Dg݃2{b+ url|3D ԍ8*Ic MkCUL:g^׽7ָ֖Mz}*7hs7w놿XC|raX7@鮣耎1񴻟]7I#/<݈^"|ːѮO^,=Z76a6=r¹gxYy_7iV @tDZWF~,xog=GSr}/SSȷ}hNaفS]1/fdP4B :0M+-N $M ?ZK!,=r2UAc[Ux"C;ETDmI](kYĖ{Jȁo{ q; ݚ.6zsfdDDDDDDDDDDDDDXhn3,sS}OSx9*""""");Uۇix&;tu"x|7:kˇ59e|f0>yZakѠk;Tcwxk戈ItrtyګR-:dr R?ԥ`+Eܕk폞zؒ""{I|{mւ;|W OYzU.mH$zo}4gȳxk7.nU8z mms|V{?u-9.:1VƴxvKcz͔bc|&qwrѵ \f5\nh \{w52C WIXh2B .F.Jdݕw}M+ߚ5Nk0i}jl5 %sgҸH?ԴOޫF`Ea~"Z"'PrŽcy7#7{Ij]j T{B֞NVT͞% m®&d︿gQ nJ<I'yoW۽k}=VCCPy/6yUCTjVSZD$y!*n),swPʨ-r\6M9Ƕ`EslvKi8߳6leUj]tks~[OE͈pcY-xsjxl0u̫uf7Ӹb8&i|͓'ROrœWxakn?݊i+ 9W-:S;y?ti;.}Jv?ou/%TDDDDE1pt|$3h;_ [|#QìA#xpQwbF8:Ho̶J DLѻ#Q{OְhGtj*""""""""""""""""""kR]/n),-:~DDDDDDDEN/ܾ£)X=+y%)Zc燺^$wkq,wאN]FO'5]ú'; xpFxMH.}QiQGx[z;۾@'S=Uz wPx 8/6`2\+ $ 'ʺ5i476fDob5Бq^VNx8r@þNO ⫹5v{L[˱P5*2N^8~zyqrН>SiǚuD u44-OwD:9}Ԯ[PDC4!!:+7;0w t\~ST^JOUݛ.mX;m y@I<. ׮0q{e,@uLsN5;tT Qq`ѭ@~ETDDDDDDDDDDDDDDDDDDE֤_XSXZu9:;U:""""/qVU!I$q1x- j\qw֛9 aYu~F ] Y [Ԟ:uWR""""""""""""""""""""kR]/n),-:~DDDDDDDEN/ܾ£)X=+y%)Zc燺^$GV{2:Ȣ~!\ĿX*1ϼ}O`dN]޶7y+ŝi o u"""""""""""""""""""""",ow7` )ԼQQn{x.6Fݟr~[eC)Uђ:Zu>J vs7`,hV4 uZK""""""""""""""""""""kR]/n),-:~DDDDDDDEN/ܾ£)X=+y%)Zc燺^$;'MW!*st ˜JyYt.4ɺ#pFi&GϔjЀOPZtq%rvt;:^uU.G ݫ^Kj]lwuŎvlD״-|cpFIۼʓB?gR_q_m0 i-6kU+ -F?ڽ'FUǎݍ;KM(vezuX(TJ"kIT KZyt﯊+/&Oqӣ<$>(#]QN{Gz~~Ni#CˇxۼΜHB8iZ4>ʪu:PZe7#5ʾ-X] t,vNkjg=;N\#3xkt]>D3'OxhVAhw@mTN'OKܸP)YHllĞھj5 I W׹tѿ oU jO9{8w*Gi5*P4;^xj1F戈;.}Jv?ou/%TDDEĝ D]vOYce zJHwwI9_b \1(WQGI?{%G@9q\Uqw5.V?NN?Q]Uo E"""""""էLn_~aQOgby?~]c[DDT'@ -ې@3h6aMU;'Rw[)3+0יcueELQPT׸VHtxbF|M ۤ%HoIa[_Z]~͈;^: K+$qGǺH#=ޓ[ Uy5]wXW:*:R2 : U]%}[)ۜu.#M;9Zt %ኲisΚ1J׋8O/Xm%dfF:vzJ,g >Yp%tsw=,vٛ.񛹻GxGn:x%y5`ok|c=-/Ÿ,5‚g UI v#Ѻ+.zB;,V[3]3x$vqP4tem,O~|&;]JCYG@'^ :lCZ$\mFhVjojx`{0#N<=sZuaOqcieߵV]PZ"""""""-Zt}(FJV)XϿ+7JE<=?*$DE!pwcl㍮ x2EG;|KCgQ[,.뺝8)V(f;;gK]x]rG줴aj5]=lVwI4v⾬OُYmؾg\H5~誆 F; v]VfyI/nM_SQU9/4i7Vnffh'Jz t|8:eMW/YNQc@^ڝi༝tW֟UafklY ,` k0h`@<sA a̻+tW^&vk1{C{+3]#}]I\v ?:vjx9j]ԍt*ƿM?:0?s6#V1Bv4 [Up˧_~o\0T)#ĎW9*E/Pཬ֜GuK*C޳8ԟx9lvV;Ѯ=|z֜fUYzCm1\NAUrjzgc|`iy߆%Ź{f).~FԘ&zV8kyFc|;"oR +Xzyx.xhZ=bf6=sEfwiiEglX7ixEc!v`49Ə2^q9IjqVܥ!UZt%?EVEnKvll:Iwp'Xg.'TFuBp<zؘ߱φoPaWn 5os^+pU'EXd[`u74a5.x at|楃5rZv÷G{V:og]@_*hgX+ԧcRrUDDDV^lm(u:Qۨ |9iR5w *[]3귍ZtY'tjaG8w]i+:+4stg-^/fz̩zlX+NŻFB&3”X ],M 'A8pصE.?2`1T3?u'_M[Ȳvap91OIimc(ԼJ^uȬOFv'Ȼv)Βʖ[6`[t֎sl1b+@Ht%R zKHlX_ U3N7Gx/k|a zx:7:Cqwj\Iu¸~Q0lnX$el- hš( Q@ϼ]#lij.6םunYs{V 'geTԱBk`~yv84,z6x[ѹ^ I,$p'F~*vCP#h<2 np#{4ܮ[G%F"1ae% e0<^}IWUqQ$Jyp=c]yؤ[4Z]˹0նJ*j<*~[Àp=훱Mخ֫_m9^FxW}׼Azxg:]|^c{Fu8Wekm}}Ko5w;;:8&eX SN㾸Kbos/rg^'ƶdEi$v7/z2G, c__]-1HZ{FNWt_W[qqvf!(s=X<yz컰 #b:% 嶮 QoK#  ja Ccf3 !~.3Nv6I(AwMxM(2{[w9yp.ۏ)dbCۡxo%= 5ZIx:k5sW^ltm*' Պ1GT$~{:$jxf6jk*DI h4{qDDDDDDEF?B]>;U:""/:rYY3iitQIRRrWo'ދ>x{~UbHh.׷bxq<"k*nrvP$SMݚQ;eҒt*XI_;qJE6`\MqQUg݌)4\3|ŒbGӺs?0ަG&nsb ^bi.ko51qw5.V?NN?Q]Uo E"""""""էLn_~aQOgb@tWMIQIRR\ Z, 4CqV?e4&,=9q$I#yr%yOXG'-=bX>!̞w`2yr%yOXG'-=bX>!̞w`2yr%yOXG'-=bX>!̞w`2yr%yOXG'-=bX>!̞w`2yr%yOXG'-=bX>!̞w`2yr%yOXG'-=bX>!̞w`2yr%yOXG'-=bX>!̞w`2yr%yOXG'-=bX>!̞w`2yr%yOXG'-=bX>!̞w`2yr%yOXG'-=bX>!̞w`2yr%yOXG'-=bX>!̞w`2yr%yOXG'-=bX>!̞w`2yr%yOXG'-=bX>!̞w`2yr%yOXG'-=bX>!̞w`2yr%yOXG'-=bX>!̞w`2yr%yOXG'-=bX>!̞w`2yr%yOXG'-=bX>!̞w`2y2G+a N2cSZhIm=$b6I'` /* 5g\!< lmh$Wh7R۟YO7%*bisLhѪÖ+dY袠R#(z^#^'sDEķWkEkEAԮEAor$*iCׁvڝSCWᦺvjջ{-\y;-4MQIRRSP{UQq{9 I.v8,bsFZ-UDDDDDDDDDDDDDDDDDDDDDE)Ѻ]#C6`z ˹$ǘ'@BCLǸD RǗb;mȜ ºcU+Ktkw.wmsR=FsZuaOqcieߵV]PZ"""""""-Zt}(FJV)X_ów6ݩNG O%ɷv7}AR๶M]5S]9'V\tkxXkm3GVmJZ87 VSfٛ͢p׹Y%$S4158)Zt Eͭ TDDDDDDDDDDDDDDDDDDDDDDDD\]jKՅ=ŏSu~[uBhi%[ߘT|+Xb""""""""""""".V/n50-AUq:Z̼ɜkcotԷ7}[em_byKQ4kW:0%{N<|E7-ڶeb\q}uU]kqMO+-rk}amIqn>SdZ[ \QO*Q]MF<;t<q;%[w:H*᫥oE4H:y}USj4VNm权']~%5PR׆BC[3<r[,&"6άʂ_4Kf1~:ivq[v"""""""""""""""""""""""""kR]/n),-:~DDDDDDDEN/ܾ£)X=+uDOZif0-JuP#+N"ʻ^0/6LJfk+g.ɍIĭj#2/:*NW324_)f PlgƐ^[Qtu%EQ̀ tv3KnjN_EC<6A0o::i[SCg5ͶVT#B]x l{e;ɼ "gӈ 򷔙TrUDDDDDDDDDDDDDDECȯb[vCi-qo}]Jρdо`7<2VjۣJG|ڟ2&S$`DA.іpH<|Ij 6Lkr6QDQδuQ4L+BKIaMe͆'0>:v(A1ITb? CzHb~-n0ѭ'P}C(qhjdbkt-vJJC""""""""""""""᫸uO&p<;Jv{7a<&{ Xw#`y`yAl{ JĻR-Y4\k-3COL^Ԑ?zG̙DگZmv@񫡑^OhROfmE6*o e,u x<5ZM. +d^eQV<wGU18-.8.Sj `moCj,e0}C*BdfڀAlgKyK-.'W%D٣Cx7_}J\Ιr&c+M5;tkaNб;3Z>ofY]Y*n񥀴20 ;|S84J6,ʲ7%Oadlt4x@p_JqdovCJ[ͯ\Dϒ)ݡ-qi**w}ys_^\짢ן;)z*w}ys_^\짢ן;)z*w}ys_^\짢ן;)z*w}ys_^\짢ן;)z*w}ys_^\짢ן;)z*w}ys_^\짢ן;)z*w}ys_^\짢ן;)z*w}ys_^\짢ן;)z*w}ys_^\짢ן;)z*w}ys_^\짢ן;)z*w}ys_^\짢ן;)z*w}ys_^\짢ן;)z*w}ys_^\YÛ^}yaT0πk٤vS'-qY'At>]\tZuaOqcieߵV]PZ"""""""-Zt}(FJV)XhwF4ZW[4Q=аSܣC\Opqr-k{1R_1T3#DZ K4S<-AYj>97O ѧr䈈f`漼EVQrVEoO;Z{V-IxGvlUnĂ5:áL]dY#7c/46z(Եf騧r24>R)T<~O`[PU?yma<O`[XO0-S')V o  Մ?yma<O`[XO0-S')V o  Մ?yma<O`[XO0-S')V o  Մ?yma<O`[XO0-S')V o  Մ?yma<O`[XO0-S')V o  Մ?yma<O`[XO0-S')V o `w }G((Ujr$'_wx6Ohe*!#YlIrtyګR-:dr R?ԥ`+DDDDDDDDDDDDD\HN[aV?NN?Q]Uo E"""""""էLn_~aQOgbH\u,w7| +M_oxW?&7| +M_oxW?&7| +M_oxW?&7| +M_oxW?&7| +M_oxW?&7| +M_oxW?&7| +M_oxW?&7| +M_oxWIi kw.Lзw.Hkce+RO|۪_KYh$ǴQp%BؖgyC`!b/cfO[V^pKekxDpϫ@;ٙ6?V=&2 jIk ln;XAo-֞CY4Bm .ˈ,Xo΀hYa÷͟RUOuF,tżאӚrWkʸ9; ,N> S` ,/CnљEPf!i#a@h43u=i;4ced: E UG5Ť4MVU2 w)[÷ E-JM=8wZxs{ut$6l?T3OyTm;aa|U6͊gԆO\7]p"""sݖ|J"7]tjNՅɌ ǸasVXR&㲶e_2_cv> RSTgTZ\M{ ٻ*2Gf_qV!S[9{`u]H#5 m5\mxZ]Ad {Nop{;,yg-3\D*:ˌW{|Ad4ih#f umVj ˕Ykiɘx{jŦ׹[}cmi(!(jŦ?x?JBӡ xaY=atwmoۣX;Ů.3[I {EnƸxFk}8ӂq rk],|IvrxYSic. `b7F k[|V>e՗yџ,qy4U|;Xo5ځ <gOYs)Y%'E uդd/7=NyJ ԏ7dm]$@Kp˓2g J3!бm!{ޟ{{Rd7>EP (t\ #YijOՅ=ŏSu~[uBhi%[ߘT|+Xb/#0A)bK|77?'ޛszn~OM?7?'ޛszn~OM?7?'ޛszn~OM?7?'ޛszn~OM?7?'ޛszn~OM?7?'ޛszn~OM?7?'ޛszn~OM?7?'ޛszqCז }u!R)eiXWb"".!Z'7gԭ+O4 h+I,4w(eC쫧0yHց<)?ǹqMYIm,;Z@)xGvF ?+Ð[q7tӂoaK:x[\}=4Mc1N|؇c7nb_O-;B|g.acvkȒJ! Iد6tHTuM6CO8hLI@#mP]>nlUayA-Eu#i?z'ٲ [0mvDiy'kx_h,}mŗjp(id c0/F}&g׷R6@LJc^J#;1UYw VH 8qhVn"ʛ!A=ₖd*O(Ylط(i֢$xjb$N>6o2f]tgef]bj[ԼPZh*kwW6voy^BzM4 )68?8k+'iU#O"ǕY]rMi{x(\Nyqxorj5nR|<(F{a,wdV:\ 1Иdhs\6*—lfeM}͛T$B5xx喙Վ]io5ߪv9A;Weۣ-u\쯨m馑-4ǐ_6/*܅ QIRR~ů@߲eoE4 tw>ChSa1P9:a Vј*u b;]EG0?%#55Нu䱬}rkL% <tӟ"v*k""""P3+?99e=N{FԟK۫ {N'G."jӦK/0E'3JVoJ^N.e7z+sݓ[VdnʛMso '|NIvڈ <3Rt-I~C]APʺ9AEG}ڏll[QQyl =tVnPm閹ۘ'ʭpdUߴԘKfgdWGJqO+$ß8bl4n>Ӽ 8/o2ۖX&pP1\{[\.AmFbJ)SnZ;܎׳UX׏ X23e% ~.JCJF+H+k6aXiX~\mU:UQBA0{yq;U>wooFj%4Q׼ Oe6a5jWt g2I-i#tk}lѢȬCA(ho50Q$w;WU;~=™*1} ɵUl[t墙Xpڶi\<2znU2E#Xe]ɺز ;[_יXf{cgؤN Nc]rq&My\41 @=x9hywsu8cac>JSG {|P?zǛfbX3a\EUue>W:1gձ@iq57+[OYG 298RU6ifTbR3SY nvx0s;wwKzg*%m/ERV'91ֻG+NlĸzVM-Qpk\I: Zt{b wg]j1'?z \7Si]ȈQCԯx/O:T!KR}/n),-:~DDDDDDDEN/ܾ£)X=+y8RT %ΏvOl!k,37qv=Y|5L kDs'(;.Gy؊٩E rՆ0N#}ۅgibI;Ϊ";9knKtv5F[]P ?`Cl| I)yZ[RϦE sFI^F%glS:gWZAkakZ7[];5'6j 2H+ xjknx}Tw蓩Y-avZ$ Kc+,me5C]FkH s×ojZ3xf-ˍl j4 u\-Ǘ5 U1}n!=NoaǮi{!G7Ҭ5m|a]gVqMѦ^X7.׽ Ջ SN4Hn18/%38ٵ&۱pVRKxŮkŮRQѠKtbs Zw𤥆7ǦH5̕dfؤ96޻]ct bn)cxֺSͩ^>V˸A!V mg-}}@!hyJ l;w,tǮW st]]gnՖE/7#7'WxdSYMlS*t]$5^Apkz {WWH+|9Iv<=Y{̎o.{WwHt- YMFTT6*w;!݋ `nyqu2q*t k{ҽ(q;W.i3%kԘe0ufGrTJ٥to;]t*AI"fɲo]Fڲ.[L❧0zAf4&D-vq;8:8aic|gr %ڊ;[U<*_Q---K{X4^Cʷ0`K4lStx%#VxciÊt)ٱe^+uro1cd`#x1=y8wsYmۙ]pb*)s] #CFlϸetM*oUk)$~u;9,'X1O-l-2JgV˻)Pױ^;t9v /SDGSO$>3\[ty-}텋qјq5-lf"u;4䧽HfVluX^ؘ!~ذ7J~j壻p4 5cC}6\{>zYKRǷBLJqSQejjWs%7{%ù&͸a&sf39 ƷVZ{p{kBַ +WtfޢeQdcuq^$M6˴mkPywSk+FXzg5 ysOsnm|Dm@ku sڲ$78UFCGSln8 Y]Kjmm#C7`7)/lZ0ݎa^ұ64~!f-.ݬG PGKtYx:_G$w[m:GVxES7?r mSQ 9SWZ"".!Z'7gԭZw 뮚=nw׀sXmL{}Ô^i^YN)Akwj#q4kI;&]|U*JuEl[. 5p6>ͨ}p"ж2_Ҥy%0ُ.gaP6wcO7۶fNc<\+Vގq$lds8x˽cS0&t7{PC*IDN$І.Սrd<9EeajK=N-V(c cy|?侼]nkܯ;GS*[L?Rռ}]6Ý1{Î`~"bp彩{ O9[g4Pܮ֛WG,6s ak_.[lTBHMK^Z(F#gSlˍUS |k:eg6щnvtN[G4V6Ōdjx:onl2˼pt8^CLNhѧv[n[:jl;]E<w2ZǬ]~]<gmn:¶+Os⛬UMtm/:={dɳQq? ń"jS@nkؤG^Q̗ȉ,lc]$fd,si=+ϻpK,U߫cq'Ps^nR쇂V+Ƙsa;̸jݻ =grf_^mV8*`ME1И\ q*|=+r{gF9zmxϒ;Lak0\e`JdA !sS* vOf+^kSţu:Cs< (.7 ߍ:+,sG\;U6f MmSPe^ujX\&k#h7ĕ ˜(\5썰gG sq#w*^6$2BY a" yteseXGx3'kHpS#N#K"^\16ǖlOP@$e.qf [i1^1hF*Vl]BɕwXPk/LkK1k$o%bs[&h[]V7.'KmWH8k+/fɓ;Wa(g$q#r"c|Ø~6<i*a|RG<.IoA}9$XFs&OV#Fs[j Ff=ڈy:LJbYOdS^G'žө:˿jHDDDDDDDZ-*>QIRRo?M@ފ.t{a bJFoE|6lѭc :I|Qv0h %xG$0[Y6Tzcv9b<\ZJۺs/lx-Ct%//l*>:j!_3eQWXV:X[Ѩ絭.8o8 lv;n|s^EӌYthv% >6iVdsQb(w{=CD}F{ףq%n:b''1S6=%x@bg S0-$d5sxo{K6CCwXNN?^98d>=4Ϯ臕X>=:NH(mw QbZ+{t:w^fٶ]MQDN8u1x{*Vt#sWhd&goV< |{#b#̚Xj[>`fsgۧ1umvSǷQ6~mG'.Λj5v}UÃ-ϒ C+fq~_M~zHD@惨,IVNUbS/ 7%rxy ()-vG>!g[SOcEz4]VIg tYcֱ}f/'b \=q[3-Rnr[;GVBox><wp ,,{+t_:0ϺC9rCT'8P sÇ {ʑ.(o04-b"N)2WTi7ip|Ng&GQ^ _D}+3)j[a`5tAF+J #37L3x0b},2M\CܴXeMj%[RL5Yf_=:{܏kVΧq5K4`SY"}@Ix(ˊ2Keᩪ'F\Cu>f6G?y=I ) Cy]X\:ƹV[ext|cQ?}hZu"2!-׻rж}|Ao-79Ás5, Q%<笃{F{BtqG<YoFAVF^mKSNAx"Խ8;;,lxn~ࡍ!<4P#=mozCJ E lq9;Κ{Ί=6ԳyԚN%ōXNg7$gFך v(#ٯW-Y쩳n ҽLkU0I'~G<8@FCVl{=44614hg SжuJYosiL+TސLjVU5S}up#M9X7wxKƚԷ뛛(<5ʱ96vu8^ͮS(7W6vfuQen ՐK[IgCiŒ٣K9_itQW2I#3wUinvǸ j'µoI: ]xY9b!58UiÃ'kh ,SqMr}\tn4 WQ^r8#XnY<\ozsNXƵi²mYyǾw/k|}pu:Z}csR|35v{thc FӎMU56Ϲok,9n֝0]k vXk#Q+,MW$kj"lY@#]2콗5sVUbW=c?غ"S,&XkxYd5eU5 iaitthu'AzCP޲):ֻQTnެoCQmmlmC>cruLUqbphyMyW.Ag;Tn熝ov2i˳^yf [+I߆.b|?m⒲*RUzxwZ٦/Z:;uPD@ )ysٮnHG4,!hN}pm3 ]t]NBÓI_բCߩl 5ZQ1#' ?r7 ;>9Pٜ8~g1xdk\~BOο%-:KW̑(]ǯ?Ѥn36dLhwEWp>Ֆ_OCAEq|UOh-ղPA ˖}%ZӇ,5vz xR 7v-Z@=T03CͣO0ȞrA- g#+[h^ԹQV7# }/x)GL wұF\ڊTde$SvGHV7KFؙmu;j$ : p>Ycjݭ0+P]Sh6E):N|]w.7͟26{`YAO< ΊcvsYc,u%utgy).X(pe|zǯx{a/+Ց8 B68cs-[W0j@g (L[^&X- |GJh)}ٟ%,w8*nzV|x m>ߢI\'kbzi#x p}cLʲ`XVuxϙw瑑JHnhN̗kaJ{.wJ馚CGNT[e%~9 c|^@Ly4WHrSw]+\iWHn*:c64r1[Wa--C4w/H9'.xjVUHcAՒ@OKK]â 2K[ LRjOV0ٓ7yKjOOq(l-$o[~x4gg^͸枮 =VȟMf$| 4ls-mOjeE<ԝ2A+8kW&Kcc=7F#^POup,J<093׳j4d`mvv]mW*1+Mt[3w?5iVqF1`jhdc7OϨ ,lcp4U]wsJ+GXxǵch, cK!.9$m-Ⱥfxbg\1UcMsܪİш**=O巻3ܰFYp:GT2:# 3"(|TZɡG0Ss` ͜=Ms ގ*S!urᎩ6#_1 ܰķӥt4wY;Cq+ַ.s[/1hGqK(9~>WrV)WbLW[U&4υ\yzEHvǦ _]'yw\a\vMm=o0#yψ|u̖ys =PoyK.*;33- Ų M zjJ5pJ=vPՕSKYQ,=dIDI_7In!ὗn/d]u4 1Jy`(Iv፮r2Wp lSo?WA7 O~]NJ"5 h#/;.'U ~i4؆:WG0y[qUx.VkȤ8zƹs1art21OIhw< ]K cp|W-W18 V4DDDDDDDT<Š&~{1,/}£ZZuaOqcieߵV]PZ"""""""-Zt}(FJV)Xſb׏B_Eou{Ev #3DH';woԷ7MWounpަ1&+aLs?S55s< WF&aݗ.Xv_]N']ecXj)dFK9j=Cdcc;u[qj77x7_W[=v!1,ԇn?zϣ;^rǃ33US8˵F Ľ9m{4V[[Ia^'i݋,m_-muvkMeo]#馜Μp/ыqtURVIiZѝÊ4WU? 2GIwRy+f!]^"CSW] @4ڥCbc@i%v mCoTh+i@.`M? r7Řr{n)Fژk#-:;t>7 szc{M"p_J oJt[{ ر m] T㨣j4u^{a]ոzpƲO ,@זK_v*Fz>+nQڰZtQeWk[K0:j$qyسћammVKuھIi-hwus5p<wV&16cQef/l ZL!qq 6Y ΋%m ,֖WYQYG$L4vjlfv v 姣BaH4j >|͜,e7j餤0U}Yta 0)O|8i C&; uh.'ٕGآTS& Dqq]7Ί}ZJ+m][f0F㫛Fygtg` Z,ci<2 V;\[Ll 6U: >5uẩnEUUSi٢Ѷ>X)o 0A40߽7U9pN`3A`ҶEW ԓLibXfd{㧭{8 |(Œ]x"sӌe#՝e} qetVIOk4X#e/26*pKESd-!t ^ Yw\e{s˼2';-J̋  g:JiMTJA.]O. ?gE^']Xb3Dֹ{$ğ_:lqmA}nk]ԞZ sBLo=./2Vu ~LOy-J"$7uvO4ܯb͛A׻yK g_'TI`#wNW׳^̶]pˇk.4յYvvܳ<- ӵĮ SжuJYosiL+TސLjVUh:5cW9q'_Y~j*e?MkNp С;aWOnxVCk* βTyEV64x;z)X]g?1sfJXZ {HڢMߣbĕT^lkˡ5UN1c;6Rn>,T;Pw ʷVYoF6Zcex>Fu{GXx[G^nRaSmu65:VJ:ow-]e>x+C($st!T{lQrP1w[SD>RCy,v/3&_3}zd``teLN ЃG~ǽf d&' OˏWrջPwFC ԓTNwOpױ 7-S{4}BߪT$ N]jA*BH禤 t >Yb%ώ,ms8qndHp#{]xkzt#^zN} Ehc[-.ulcAk^.j 2 \'y5G-S c^0mg%+&fo`1vGޢ>:ۿ|of9{WQC[P a{wM@BZL@Iw ./vxIdFܯV[];X=rҿr^\F:kf-.ջC#wI,G0LƘ:K(`rC1Y \AKV?uW;MyҺ;#8wfԭfH:Ϙ=*Rtɉ^caU<&u2GRcLxfږYVMXa@ h@w|c/hp%l_ie(+)'u>3yQIRR~ů@߲VluwX.k'6LtINe|Qy>7ڮΐNMX]#RBtZMzej2co>k٥=fZ(x}197jY.j8/iLo 2;T4$j]OR9rY߈p%a<~08wG7ɧQ? ;a\'eFYky akjl3fRY=Yť}Xׁ-/$jnXKdœ=z]w))KʜUy SS19|hYyخ-Җ&8Vϊ:z*Dd9d^}ov36B&vI vo5!&6yeI k,] yn48 \xxgX~m6f -F'Ҏj t$ɖ6$}baz{F/MqU eۖ8al9q7 ]nw yޚXۊ+u4t4 iM? =fin-6L$-!׊V5,zKsZ;x]Zx+[-`g&wa;Q7XxxbQ-,e>/Ql}7W4C7COi52-ʖ`!;ۗ:;jq:Y֫v.VV[.it;^kQ`V5Ջ T#}z:KR`z @[-]rSgX\3,#.9Fj. GQx8n]0ky%]:\ #YijOՅ=ŏSu~[uBhi%[ߘT|+Xb/'^?3 }dyy‘QޔʢI,ue1$ ̤suOyb]q=q6؋ܱ m :7dm[#aHn;M U٪jk=Vcۆa}*i&Isk +RIg=ˍmX pZǚzT9ᒐAӟZ8ww\(/KsL'N:hehv:`2ZZx#1cS?q^oo+]qgΧ-%)lߙm]XeA4Ks$zذ;qU&ec* yYL];-,Jcc|no"ffblK b Uy\S]ն9w[$ Ŕyͯŏ&KmANzf}20'~mngڝ|%7htTE+k8'prDDDDDDDDDDDDDDDP? lZTʟ6ºuM D9>VlSUHجKVLe_Dm:Q Aqߑ5#X&UzZVާӊ[Zt\z-wm,+qn Q61,'N +fH~d-XZ|NI#OVK[&'"r+ fGRBfx:Mtϰ&ߙ\ܱ[Y-TY#k#2ź8s3m>'̼04ZfduT>A<ۨhxFn&9]cTkhWC;eccOY;zD2 c3jL9YQ`s9gkn\+KwP[_SK,Hx#WYs{g[>&=EK]+u#F@ISdgj̥aG=H;^4vqY>{;Id8:'U ;@2p4SW$tLup ?=[<)n Ό 6[MEOQX -I@kõamTa }0RO.I)`t-D pa;k~q6 ͋1]: )_k+5d)ك+jilՌc05XCf鬻?2_IM(ޕFhֽH׿) 6,Uls{mVY Pc*#$$iې_`5=L7z8U65g uvvW>ܩ7*m8-^$kܛ^$hU:irӆkƇA@{I>U,ڞ%QuڑGD;{OM7U:Hh5'ye^#Z\ #YijOՅ=ŏSu~[uBhi%[ߘT|+Xb/'^?3 }dyy‘qpդ( sN9u>YL/lFXL9I=|gmEvGk˝XjYEݛ9qØfF[*-ک03x#ȷWߩ5F<[Z9v#Pi:?]i]t$U1{ Q ~\/xr \#Ә&'5IN;xa<0Hc4o #vpn>`kcn O3GzP0efRE+N4 ڤsv2HioyhQ+OB=֦*rgͧ0DD]SzB1Noϕ[.+[ fwhOr@ȟ\ڒ[g"`ʻ-h,Th,kD&6bxied3H,nqZ-ӇfNkHou#mսJw _&ƺ˔ֹY]By0XbݖŶ[%udwzY#׋uimOc d '];]57fe[5Zû1hh7U3&ꞦY $n觇F 6Fãҿk Z9ucǙEuޅuOQL,CsV=\(.[qc* =7N4|x(<90tf=EUp&O TO\X95^a(,O VXKps[4 ?KO_vk a]ZyQJeՆcY74*e.(mVbFhH#QǗ%H PC{x*fI?\3TA.u'uoYSDQLvˇR5y'v]tXrBvxKncaohzֻ|Ի ,?ihΧnÎyPI,DoY]O?Y##I=嚘#םmX24/ѲY[Og܌²s+Uqm !W[m)u~{i*q\j؟P}dy1c_7\:H)y igY1pv5x1D|ݞJ"H5Q%.*m4mxh9y0vpcCW92TS9UFc?G^2ϚX>+ۭ2S66:=f燧+'ۖ]YM,v]u+:%jX>lo]xKjUOmGkCZj&Wl2{^1ukU)pq!r›&<uI,O8h TVmYmTyOr77[Uo!<7B̘ÖAV넓Ώ~gj47j6YmXvkJ? )ֿmk8<&nc{^+6ms_ Tr=nj5%eO "hh`#}1X9"""""""""""""""})h[gBNT𷹴&ֈoHV&?vY+`=Ό&Z]uI\; <H׍5]]+.[ Z ߰XS`lA7j-UP7xqwG߹zu]ĸ~7C_WS9tY`p{'GVXTpDuAGPj(z&]Vbem-MYm|Gl_l%ue`neU#|f5hׇ0KяvԷ +y%2Nֵ']+ĽS1 d9塎si_~d ʒ_s ,/b pE+呎v/wdc`pƸjK'uEs\@Эx'['OK-AtP8{]*;ŷ(*`}gvw5%^u;*ڜذcznvJAGEOR؃8:ݪyYslcYOY]UXb!Mu| 24q]]e)wuq ×-e < uC7Y<~ۄ<-Q*:q?2^|\wh|g|+݅$75U `u4sU;ccC}nts> r}{.sz9xSmn$sqtSg044{ɱ ~,In4ٵv,)~u2zeb<,_OU[5t"FR4rbL n%ʩozXtoa 7/]T rZmdhqWsWvk\8Yr+<9.nqԕe.ugz++%.G.^NSwerWICOVk2,r44+ l3c,.+-wW+**%qu | -p>η:k[:+j/~Bά;rDDDDDDEC(gW~sr{'r*?e>V?NN?Q]Uo E"""""""էLn_~aQOgb[-xo*VWG[ DDDT A M Q444ɠ@9@;tx);h;4 t4CDw*n7]t䫠DTi_J7S?k<-m?Ʌu""sݖ|J"pUNk;Ev(㛍Si:^WE+ 8A#Q_e*_e)I=c̏۱P<_NIm܌En7Y)h-JG5 tYJW຺[i`މhDI8s'I쏶Qw a|ds/yK-6w1]N$qlZȪC-bKJ* )3Q{ƃr,qKM~%jp'T4x$hkG59}6DnaUc3%Nj:EN@ǘکpYh7CUYVpecX'WgnW n;\5{!ϋ/=];o޷MOMyhU퇇rݛ؆( _#u'!b=s_glۍv ;ct18C f+6·|^u]je{ePu a=Y o#.q5=ڏ6^ @Ag^*mMaWXOU;7.Lh5UtitAWApBh4ByStw4ky &4jh5DQP (t\ #YijOՅ=ŏSu~[uBhi%[ߘT|+Xb/'ׂ }1toDӑl u:`N'X u:`N'X u:`N'X u:`N'X u:`N'X u:`N'X u:`N'X u:hP4kH{SirNYamF?+TސLjVO*yN8 Zl};:ָpZIھ-u '^>yj#=PemeES֑"P;'ާR⪧Vao f&[DRa#Aj**]k&x$47@ypN<:Re}Kloiz]5Hl|7q_aK^7L5VʌD\[-;uw(Wo(0ϚJ*&b5 u> x)ѱE{f ѱzfugG7Wt'^ؗl w;LTcwH:vIُa^XZi1Kc%hldˮOܯJtY4!nc^>Ea6nRl@u_oº-m98WhjqmU/J+9]yه5E]ޚi[C!dRI5w$LW*1x[E =}k ah@~d#rd*bl;Gn=՜>QQV`ll;lIrDDDDDDDDDDDDDDT<Š&~{1,/}£ZZuaOqcieߵV]PZ"""""""-Zt}(FJV)X<0 S-Rl{vٟ|+w?{{8q Qz*O i?77駢(ߦS~z*O i?77駢(ߦS~z*O i?77駢(ߦS~z*O i?77駢(ߦS~z*O i?77駢(ߦS~z*O i?77駢(ߦS~z*O i?77駢(ߦS~z*O i?77駢(ߦS~z*O i?77駢(ߦS~z*O i?77駢(ߦS~z*O i?77駢(ߦS~z*O i?77駢(ߦS~z*O i?77駢(ߦS~z*O i?77駢(ߦS~z*O i?77駢(ߦS~z*O ieA7F5W XkPݙ\n<>h)[-R>8[M8[`pڈoHV&Hf?>Vlxku{Ƹ*͘8n(jzY۫_@*ɰ˖xn}k`xipO*A6Z*3 T{sG &̖MvCV9Zi.ջ]:s_&A읆23.+Cͪ{%jU5pp.w=ڮL#^Op}=Xs* 8PF+fl8u:Au8s >R^㯔/ e]J)`Rɡ|Tqߧ5KԊ8nb:tCY2cM?®Oa Z޼y5+F[[WION&M fe3[[ F~۽WC^ۨo4PKc)5qS*;] ً,`5xf,j[*h<4RXbXuVPlL]ԓN #.b+aF.ջIW~Ɍ#QڮW.5T~:}F4cF9w.HQCԯx/O:T!KR}/n),-:~DDDDDDDEN/ܾ£)X=+tU'!j2\j}__d^Ow(eU-DbX A W,-iuNftN0$Ŗ[:uS '58Ø+\%TDDDDDDDDDDDDDDDDDDDDDT<Š&~{1,/}£ZZuaOqcieߵV]PZ"""""""-Zt}(FJV)Xn7]t"""""""""""""""""""""""""""""""UDDD]SzBGY@w АOmO`X{k,}TLCsJnVzUTBڪM8uolNq7^k;M٥xnrnm 5B#ۿk}j^bŪ7v6*9!eu5q ui櫱l^2X/ {TmUXdՅ3vEK]ǰһ"""""""""""""""""""""*aE?R󘿃S?뗾Qk--IrtyګR-:dr R?ԥ`+DDDDDDDDDDDDDEY: ;&0Nx_Vl/QUQ[h$U6hnO?N[UDDDDDDDDDDDDDDDDDDDDD]SzBCj)3~7ז tu+mùwNYS>wg{׳Bŗ2Od_b6`=0"*jX֝nO)VolYj|:G\sLS>uc\wx?>r[b5,YwqEJ[C1qkixMC7yv3pk, ڂWŵ5 ym/>mH+\G0@<4_M]RVϫHOv:fNӨUUrc_SQ3t@Ox]bpo}fo ;GJ5?vvk=C`v>V;^Z W O}: ziX#bW= kGšMXy/˹5"uLjjB$T<Š&~{1,/}£ZZuaOqcieߵV]PZ"""""""-Zt}(FJV)Xm:kEμkF^q% kt-rӂ*j;՟-o 5UF {I=r\ dh#.z^I""""""""""""""".!Z!`+`d CNkxiϴ; .4.4[E?%Wҝn.Ӈ aagn8.H(-c[av+ù]qAc0TawZTϬxtU/By&BlcEum(m,R wH-՞gJ| p\.8f©?>'"EWe^&*-ՇWhk@yiX [.vMT8tsIQ{3UmZo8-[VHTICӱK Bɓd\ޝơa۴/"n1y6V k7\$ v'(Þ$L|u+#讐il5|lq%Mlbiu3digM, Nk;qͶ{—K7Y-\9 nJxqW}"_"1”6zG| XC9s\9C]N[ܱ]lm6*UG浺}Vr<ٵa\r9mLm-sNu\P (t\ #YijOՅ=ŏSu~[uBhi%[ߘT|+Xb""""""""""""".cwѠw8Bѣ@*;ҕ_༌צii-B׵wB8Z6jyێ1 tW)i']7[ eQ6駸oy FsVZW6q ^GY5fW\kskLO.X Ѥ7hv8ڵac&׊4:׍7C[tز-wOu8j8a' aCŦٍ`uc 1YҊ i$$HΡA_\z\xjuM D9>VlxAm Lp5~zdM}}﫻[㦼\ 9ms_[3N&Iocs(o8x[Y$lqWͻw_.Viʽ*imt(<1쁺4.qӎvhl5i{We =M% $m$Aa4Nv˔1Vh捓F+ {F}NF%x h7/(Gjp [.plg,458SV:Hixt<; 1Fscc xxSQk;vW6ϊA18e-qZ,3|_l?ox5 c:;¸\fwWeź++f:I&W {f $ncnͫl[a5khc* ۺZgb)\Jܳ᜘~YIJI4V }ϖ졳d6JgpJd&z>(:.4U`Ć{^+2;#McL<4H`>+Y̞jWٯtѺ3R$kj\' PzL/V|QAGZOOkF^@;FPWgl9[i{A#8f(ix V@oAڽՏZ;Jӧ'_93X'dp;c>ʁl7Yީ /|*?aM&V)*6%4Pd1bv C%y7{\9+*݃샕,O.`ZZGe87st ICEilQ IH:Z/ks'A_7` NɖWl9kYD>Hu EdMG>pSS:W6HȞD27twd ʜڧ%EA. :67C7fC 8E26aȺ=2[kSK$Ǹ]yo;u=˒*aE?R󘿃S?뗾Qk--IrtyګR-:dr R?ԥ`+DDDDDDDDDDDDDEG A [ hN@9U9*+tbxP$װ=-S9~wJ kt-lab/c{kimvtޠ>yKnάz {J c}Y!@ .^ıQG״xiཝmIq#t9,ҍSpotGkV|oNķ-4p;hZ5o3y[L aK$uQI#; VFGGsDDDDDDDDDDDDDDD]SzB1Noϕ[D^&5t `x=|.č@p?Vh]1U,j]i]c wi؏`}4-e ) tq5:v ؾ/4/`Gbk5\80"]ؾK31[Mhtxr&n)w&pEg9v\Ii Mu4m=}.%c l'<b_֑ƇM29,yslRRA DI.];8lg|8.m;lW+z7 qn5av5R]h-n;wt_}m( 9_,1AmH}Ë. _bN6gdpIOLZl1CtҸmcfFXoX,bG+e{ Տy 9;|.nQ^jnRi! t{ ٣aCbEjWLjj\F狠1M#z9i}g ["{u|G&r חx ag~ղŻ% zs{ 6+QECm¸]VK8xn6,{#cָa3jpV) #P WٷI 䓭hn8ae\E)qxNND|f^="=)-L'C͸G1;@ǎ@9b1m91 Mu_NK/dTUd[ҷ|i& &=İeÃmlxsEvtd]]:s6M;‹sm~e0et=K:\ >ldٳvTASUK5/c@Ac=;jqsýiҢ-hZ$H(=@Yqsq$/JݱhvdcJmT0ut%1E Qr*al9_M0];jftGH[^E!rEC(gW~sr{'r*?e>V?NN?Q]Uo E"""""""էLn_~aQOgbZ6&zuQ*.pkIw9s!n94𩥚V yi=T?*h+[k61GF.sr:0-հ±GŕCCһ[x v`8-Hj6avXַ9 t3/Ԯ*Y&Ma xkݭ7|n8Dyi|/n՗9mUcsyhO5؈kce+R 踼wzpk(4H<<@!ʨs]t';.Ĭvb&uʹ۽ϻWZhZ^y@uTpG8UѠ%{N\ H=݁Q/[zi'O'nS@:NCԐ8vw./pW2K]4橨w^ 䍆0籮>ɲ3y^^sӹrv@Cxjph'UW;B5R;Ӯ*9k\ ihB57O7[ x\Uķwyẞ"9j;U77q:Oax.3M8aU;Anpr*#Оk4\k7 U=ҝ[A H<Ƹ &U0I^_)upB5_XSXZu9:YZj*/BFڳ(&6Vo=p8}X=)s&sRCi+ Ee䐽4F׀X4x[PWޫ&d׊fH[_\Y :+.U8QM#csXC/VOF=cjMyd5T*z[ǂͷfxMI[j}W3N!--׎=Us]Y$6J RICLk_]Fe챭mhᯥ #4APYڬs6o c&7wZyLy8Hi1\$5{{<.X%5b[g7zα sSٕy¯w6S6*itta_U}Ilغ T\o6c9s㹯;zxʳ*0 +,9Ғ[<ɮ*\+~!/mK\V>&PZIE6U6):8;M@{JZb|vEc mIkd}=9s׎̻ubܻlyf(1=afg}gOfl5+]s-v^j%ta=bΐ*w,RÊ,t}|vB߫hj/16^g7:}ޞ5px{,jJ:| {Otiӹ4]G4 cT |StwUuM D9>VlG+1j[~ Ƶ)YK&xӑ;zq.[J{,EuΡ~socصzVl5RAsn;j(okFWۻ]EhZ5iz}Vm_.xbZ E"`=\ì C䯏)s >* +6ۊ<3S?WE$j#CV-vzS{kei<ۡǙA몴Z(6jatB6[.q1Քk=vtX"ӆTӇ!yhg DOs\ߺ&yHaw/l4t3l5ڧ1o_Ozq? \v2ZD4`E\mi׳ȰEo+40e\Pb9qfeGQ# CKy.Ulgw'~ CӽjzK[~T͈#>Y>B[k_ eCCdmܵBXC ~klvLMRg~jƮ=DggFֱԍdsZqLr^6;u,1TTaɉѴ:Wx|HXb dA+)+hC M;-qAǻacV ] GA=PZy 3Bebdu!q$:nmUr+6jdóbHmUbF&256W44zYYBUv1]~;D-Ry[ lZ{﯂Rߨ65JB#,dΧ}lL-CM=k eY_7l8^jtmtɸǷC\u* 6>s_s9.Hy:LJbYOdS^G'žө:˿jHDDDDDDDZ-*>QIRRpyH yrZsi9jmDӇ+d/4otӿʡ~[+2^q&+W!k7Ix}[kfge4E{6S4j=S-?"戈oHV&?vY+`bu56j -މ^xwMr~U+49;xwBu+"Û`SX#mqi¡[*혫EGQ#^&e+yW`?* i8(YYwSmAU0I^_)upB5_XSXZu9:#;wO{^(}|uGSGj+!iZt<5ӱZ'mǸvGKzv:FAя0P*vǙySbu6 ]ttaqwќ_FsZ]qj5f ĶJ B؞kM,1N8)XO7uuNvB3)pXYh`5=yd6c=TxVl##g,=vb*)hk]hw ܕd>VIꪭϑX3 cm/0= ȸޣP'֝X MJT32!_c5]؞xpԁùz'5PoS%TtX2Ǘ; ęG9ߴvo(*un$ֵtח|N{y\#. _kpYYɒ儐TՈos=QMy,%AYWH$YnKh֚!Uxla x[7s|4Iz¸j"Դ.T%vCǷBe"+1=>[,\(lz )COCSž;q#CKiMwt\m,R06~d{'keƘz6tǵGX:Ƴ_s*SeNJ]_BIii8ыrmc;]cmߩxUo\[oz L eʫχiҾlΉv J.,0>fwC7üH y\t|X`curnupxA`/i.Yh]lxFOX+"S3YM5~=ܮTrphHǁ 4Y0ک͞``'m[]+ii㧁C@Zu)j3DuI GA溭JgI(PD7zX*9lod -}VVZc-h4ȫp–{Ym4Hz· Zm?Ms̯Q""""""""""P3+?99e=N{FԟK۫ {N'G."jӦK/0E'3JVoJDDDDDDEĻCiptMK y@j_+IXE %ڡ g~5+zJ7W5FMa/'Go}?fS>O\ug)d':ٳOgz' 뎳lE=Y6Bz?OD!=q~͟觢}?fS>O\ug)d':ٳOgz' 뎳lE=Y6Bz?OD!=q~͟觢}?fS>O\ug)d':ٳOg6CZ}tE}4%pY4.??,vʜy!7va$ԗ:Z--DU18j G׷s{VIy"""""""""""".!Z'7gԭ3780Ncb۳-R?q;S4߀+f-Zqk* -|fVr}k]0-t-,L[hhJƕO գYݔ xDZkp ܲ~fcݶuOd ?f4:vw93d;6wƓۣrp\'Ŗxk3q&Xb] G\#<4r85p9y ,US%KJn9\c.kU]1.*xEvu-4&XK:K|oOj,כ;0U&;,F;GS\=ږ8x ˴xRun>6xw+9*|pz{7UAӚc-#q\h4N*SJn""""""""""P3+?99e=N{FԟK۫ {N'G."jӦK/0E'3JVoJDDDDDDT'_KjfCM I!A$c]!5i;N8ӳ{FD.&_}=]CkKy}s2W׸}䅭lXM}BݱNL56RGW9FK/?觜%SQOc)(dXy2_iE</V?r_~+O9FK/?觜%SQOc)(dXy2_iE</V?r_~+O9FK/?觜%SQOc)(d:iӻc+le}15{,q,v-0ܠx8háX:2[YgP\wu;b2kX1* {OgT2i rTYE{Y nbe5e\znG':yv<0oʉ*XiYQfijs#6`|oJ˘)>Q# wsi6s[1c\ٷR텈hES$TZZgq<Ifv\Ub!GIqh:zbz@}9j]߹Y6-g)e2R[()c֍4ܶSs۩.H]Ag橪**jj""""""""""P3+?99e=N{FԟK۫ {N'G."jӦK/0E'3JVoJDDDDDEÚs1,Yiko؂[|vhFitgUWb t@qcKO̕:ggHŒ~B޺Rԗitdhԟ/zDDDDDDDDDDDDDX9}kv*RdUN{Zq(On.xjzڌMuaΛ{{p4s[ qB[ek!AW"""""""""""".!Z'7gԭ.XAఞcbe|ՐmTNn[zi_c6$qID7y%`n:ͫ][*]-M=-.Ѯ׏"|2͐5ZMUV1;u3ŲHѼOf*P :3$cdwx];kChQ>ňvbdzuTS^EL)w=@8 %o\Κq+|إ<MC= v~+̜ķe b:[lBYcp/й.^^H-;ϋ1KKEs I=<=@uԟ ul aku. p#AU7 Wn Ud?{Z\Umdl~Fp.v{* Ixp {vX3Օվre\U\ ׼%T4孒F5ĐOº}?Xbl.`~%Jo;qjNBU)9o^ӧZp3۶`'X륨hGi?w_/%|:IMg^}gzO%&RKIT/ut1^+ 3z˻xHFwQP (t\ #YijOՅ=ŏSu~[uBhi%[ߘT|+Xb""""""II,82(\8Ӛm]. C \’.ui<[@B6]+>\nx- v@5?:դr@N"""""""""""""胝,g-x \WZqQmj#vnqnPu}N"@|f8P{ƺtw~`g>bkm=9j^ SCtĎ\UIEQR?PLӿ]"{VXG# z+ Yycǃk1Uj],Aw3w?[V˽e.m OMU=3ds 9iخl,5j% p\m8 X׉ V02y7bj}.V6U#]g0 puEm:)/uvY8Λ]W)4F8j92;z9̌s-+/TTy Ce8-;9ɋOv|Y_zU8sjꝻvMu 41%3I>"¦ 6ʛ/eC)ɸkb[;ie 0WYi.ua|գ@8pYYIf%O53σOQ:Әxl̋uΦ m1.%0sˎvW9V|Z\UqԎ]Ks׎ӦVrbV(XLQO9^hxiJAa~/Z%L G^!䓬iUwsgWfœkCdgSpR;nS;memR`ÆuͣvTcÙ~혶]8NWed45]˱nOs¶jMG 4w{m$4=ʨy:LJbYOdS^G'žө:˿jHDDDDDDDZ-*>QIRR_"yfq;&0.m;IHaӷu^7GE+mmm9n"?t{}+3J7y*NTUUĻM8>DF<^uԍxRt *oA P<;]8諯]Bk*Fu<|k:&B8pG&, 4ce4ˁ=ܗ59;47nj ѥJV[TސLjVQykeu 5cA _`8ulpF¡3m=V ų9Ҿ9,?jw7(r)-.S:^kkf6OcJ:zcatчF >_JWVA/p=tV1 $C걎[6?x3376vF#5{5xʺ[Gi|[ #@,vzCv}ƻ@ C(_-%UH}Dqn|w7^:X쟙7+Ai[K/ 4rD5{Ԁ0;4r"r]>vOI%`s8vI\vs,a3gmW,BaY3eswH5Ï͍F\+-+[<j|8wwDĹ{&OaHjw;{u7]FR>gŸE,SS=nHvS5fwn()(1 T@uv0x7f|GuLo-X::剒 #|{Ҵ:yxfĹJ15>#xEsFx-{~8ĕ^"Ohx[i CFGWVl˝012mlWREAaЎ;)YӑW1h]jұk~7qqFScg1<6_ylM6=9d8oa)I%,p爚 k uzP*f 2%+8O_E j2iuwY^ScŤά-QbaZ[E"bi{@%xB6Z{c8a_pu:1}(^QY짌[UGCIr{D2%l;բ݁m݁1mK|;Ŏi$hO ŲK [=8׸j?z""""""""*aE?R󘿃S?뗾Qk--IrtyګR-:dr R?ԥ`+DDDDDE@4@.{>td_D+Dr AN%,ܥֆz (mŶ5eaW[pU+Y#:_^Vƻo?*a,44ҽh"B}72ߥ7cذM*QC] avڶFKql.EE62fn4O 4vDzK7\G j9g L-mF[nvL#`'b y{˘Tk^O~E g,ZP^d0HHX'#A&o;Ďttn'K4H* k^h\ɨ÷ܾv G0jid HUH Q*2Vz5Ql6PKxK]\Rз-2i)l=MKaYmuڲQQrԖ2_N Y\k:iՎ]SFE^*>fǑC sZt^Atjh"F@μaҎe?ZTDDDDDDDDDDD]SzB1Noϕ[D\^H8Sx!'Mt.w#O`jg s1 $n\h)a.{04| tvG_%U={wj`3ɲ8RGKM<|"0}-$HG\A.h!|rFc>im9RW @>_Yhy׹uv|]QZ ,׻q_>כq%3װS6LyEe<ʚV=G Zv͈hݝ+o3S)ž2HZt-p#l/Όx1>7}p<,Ed8Y^Uem5dSa=u=P-;Ļ]a)0RN'c 0s8 {mGNه0 Ed/6n NgFIME1oΥ &>ӡcwb[N텋6 ]j,7AR)iKY i.:1;,KlFx@s{VKؒ[~|Υ29ڮ Ƹ<+hq[motQwGZ 67sc?.7b W((a`Ku/sF ڼܼګ:sϘp5 $7\i+nuһ ڧ0Op-v{|uNm'{5>s+g.{H彗 P^Q޲'Ă9ӏ9s(1]}&+-WvHAgr m<տQa+&3tߪs`^F!fv Fq˖a_3J$nиq.²[-fcKt57^ApY'i\y*⻎DRHjywhɲk K4[Tyւ78+#N\E|K њNk.=E93+-2\-SM-B<7 Nm/w.z/6|̹͌/w[ږMy)!玻iVNƛOe8YzJ{}k㎥-A;#Az{ g^mf0ZXqôjY%ޏtG6#wm0Ӱr+h| }$8ԑt+`7Tސ~M o-*}TV329CK^y\,)ޣ÷F5c+5\ xp bfNX`_pm'Y[ `;O+!T]iiblT=\|]ӲA[p:qWnE>YEvQ,2jLq.Þ ,85vbĕ6q1shBN?A._Fu:H:92<[Ԛ ?޼[>ӎ@{u}[دhQծuЃLD<,m<, +ԇHt.RO 猱$p0N2w-j<<}ȷ/פ9ƚ[grDDDDDDDDDDDE7+_]ߧ4͖]^my&n-̹v慤(1Qp?}GmBn5WUL]z5 А8M#S.PgN ًnOLvB\ɽY\nl˙ K_\CXZvuLv8:j&ŖZ筢c:SiX].P4qTbY2imۚ}>0:m|nke{ Z-̓7>G]*L۬?9AFV183S14<)4%mʬ-,F}AaHiIt!x{iի9ƳY=;"ԷC&HS<eERYs}e-mfvP4njsџV&ϊd=ʾśB 68s(?1:a`-1U90tՇ+]x=| nc(qif5iSU:ke-. sa ^gCa ti.Hkmf:9{mJX 0nec &+ ZCdPUp}ahŷ4G-7C5ꆑ$Ip'N N1Y4v:;k4v#XOI1úcg߰F"Ce/Ia^QVuٿ.mC%F-ꭏis [73(uUs `>4 whس[eV;JObLΦn/ )-mh\nƧZHY>-wdZ^㏼=ikTZ-94c}.v<5GhY˛6\)[3pmMJe?,@yWG-b\ΛfyAU3[*IQ72>[>E"wW6xb Ů ;y i 383窩iUU h'ovL[o֋,ՔaՑay9`{ENyQ/\͞PuS|a{=aq&YR˅lLycscxx QQ-=ɔuW<IAԦ㞾}ZTʼn> A'ol-ƮPy:LJbYOdS^G'žө:˿jHDDDDDDDZ-*>QIRR^.: t`74q=:O_(`Lk~YR[#s 32 b,UQRtp:VAV3\3$Gw}8=A{p5 /Me)s )aH4w(^%Be媶!kx)5®Eز(/Vkl5,3 lϖ8"敓[(#R&dCyh_V^ q>c[kt*APCy8_*a;Ahh@~9]mmomWS&߯l™li/и(/- ZN:L! ՗+Ib[$ 44?Ӏ8/"Őy{0E߅h ո:zxuWjɜd[5%`-pp~0NsVu}u<[Se71=֦=9|t`<9[nÔVWua3h{&%7ZCI ݎ}ӔtיwOi 9#AB\9E\m]6zXeCCp;*Yw;j#Z[\u[Nt%x$p>fωpަjp[I`KpvCA6{*$m^4ay0-΁Jc<4e:jȌ13+/7[OXNY'͕]k6Qbө4 k~Lk]Gm[wU4P7uMO¾3OK5NV)c$ tYG:K1[-T9ypnq+c/\!I#em7{~+I$3;Pe_2 ZXw8(w+.KfMt.6XL xu1M{ 䈈oHV&?vY+`ZӻZj>pT3)i~ʙF+rqӃ,nu9:ˁ-un>sm?hnN홇&7>eL 1JlS*I(E dk~o9E/÷l)KY"::79=iz}K/mwK[v Y"eHH]C:gaֱtxX)nPG$ڵ;\~ӆ2[ڿ  F0>{שr cZfA}RaբvjGqeÖɭֻ-% vHfx'yS5-e=Mmn2-$xI+^SKu/ߕw:9,1Y)縟;߹d흶ylN:W8x=dfE֯ O\Τk^ر5Zjp i9h.A[n- P<[hިoj4,VC_7GRd1:/dݳOL̚l?vxCj $eLkt\ùB"""""""""""੾8ܺ@٧¢V;jZ0<y-2cii2G7wA5հɗ 1$cd<9G@IKΫAsETDDDDDDDDDDD]SzB1Noϕ[D\dxǒq*TGJ5p kXJ MUK\L $w놤huSQ$*uo.jU8x%kʣH3 5馼x.>Ӯč;fSYč5=څ^vT/]Fo<|~P!R N7>vC.o 74(:7CxY9Aan uCa?z4RTQ/T&jjjjj v I/TO,^JU]ݱ}q!Vl5뢰9Н8JED͝s%jο [rzڀ!nCFQvzKYCpk Q{u\6oږǴe5 ;mzJm8Z\ ѯw {b\WY$o:wi[S *xB-i-FNn=zc^\mTV\k-ܥM(Ё#u^%a}v<8*l>˜U@,MK$fVc;*J Et=igl2h#3P"ѣc~/TqlxɦyzMe{^}V\ U}.44sۿ9-czNxzGMG0]Xu^? м><Wu Xde(Tk^WVmUm? PX4Ӭӛv/c-Xˌ.Z)MUU ,=݌v(enVU&rȨHn3ȈnA^iN|qJG585=o5eL3lf$fںku^`OaB7 a8|a]ݝ ѸmцpՂm>:M |W׋ N!?]7|ra&{WLNou=^ialk=ztY=jMIixs+mk%qA]͇oϨm!#riv}elY뢠õm}FqlujUQjCUKXhhd1LxOva 0o17`MAdz2*8:-]{H6OmC{?E58W͸IuE^24gLg^h`+M]$2=>OhRu{@5Wj""*aE?R󘿃S?뗾Qk--IrtyګR-:dr R?ԥ`+DDDDDDECq^mC&Q\(OU daA (F^X%cV@tɭnugrl1f[-[w`|/mvy<Φ<jwFRtfe鈦] \X]X<rdѮp{W=3ݱ-SR>E#clܛG7YONK`ݘPKg.r=;aciM hYوi_a`z}=stF7~=g;M[tmۗ4F"Q;4馪(S[jrzQ2) N=ˌYM&E hڅu=2psjYCGEtV.VΛ͖!%c]Wü>{佂|иK$MEIB X խ<)Ұ65.c.!4RJz,O^J:/Mao$)&t㪰((*ONjƴd|Vix q5JM(|ܱ]%5ŀvc\ٜ SUZZ}/Vn]1cq%T@>"p]O̱[ZκRzZ@po0xʢ6dCe)ic`DwWWXبf#U{73_e&:i3ky8 |era9YUt/F[g̕Cj<5NsP\7cv mi!GR #B |}|}$&rTu8pԊ!F̱͈.qhveqvP: dh{ 9* E]jLȂv&TM-t2_Ify`NX]ƺn8Wۢ9o"S,u @j4 v"""P3+?99e=N{FԟK۫ {N'G."jӦK/0E'3JVoJDDDDDDEMBƞcTtmstpyU M$84U UDDDDDDDDDE47];W ϘUdMhѺ5@i(J"""""""""""""sݖ|J**,e ,O^0B?v)P`+KSh5ZI5"-CA>P ߲VUrh%.j" Ѡ.=8+k6bD[--?J8Gw%cX68ʈw@°2~7Z{&p'I*ovV%׌-(7K. ys+ h. tTvZiƭrwWUmMfTvں v 4_68ʘEfnXk+_5.|.-~aScʻmMQWn_6o>+ 4,I).4 A@H妁|-epa:(SɨkÉ YucI6Pb0J- $cXm2z;I:NϺ}?i>*UTK _p$ Y532ÌmLڛ3gWfF(Dov_/:2ױPYq=& :Ѯ^sd<\J/\ax!kFNz/gl週ÞkX!xmh%0fEAaEAtVlQ5=ɩM5@^܊&5=ɩMOrj{Sܚ&5=ɩMOrj{Sܚ&4M4T;U&5=ɩ\NphI>RW-SܚUDDENТI?e=N{FԟK۫ {N'G."jӦK/0E'3JVoJDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD]SzB1Noϕ[DDDDDDDDDDDDDDDDDDDDDDDDDQCԭz?K)lupB5_XSXZu9:{xnR}xXYIO^>,?ۧԯo^RW )?+ׅtO}Jae'>{xnR}xXYIO^>,?ۧԯo^RW )?+ׅtO}Jae'>{xnR}xXYIO^>,?ۧԯo^RW )?+ׅtO}Jae'>{xnR}xXYIO^>,?ۧԯo^RW )?+ׅtO}Jae'>{xnR}xXYIO^>,?ۧԯo^RW )?+ׅtO}Jae'>{xnR}xXYIO^>,?ۧԯo^RW )?+ׅtO}Jae'Ten-<1kY)9|]Z>`^A|^N=}d`,XjțsZf?}̉:;VEM|R}/n),-:~DDDDDDDE>QPix)=*wo |&M7o |&M7o |&M7o |&M7o |&M7o |&M7o |&M7o |&M7o |&M7oA=4OM*oyS{ʛT7M*oyS{ʛT7M*oyS{ʛT7M*oyS{ʛT7M*oyS{ʛT7M*oyS{ʛT7M* Nick5u=R0-:pqyګR-dOV9y(@ٶhe)L]{?_6υEeg{Ll_Si~m y2ͳO=Q|/)?_6υEeg{Ll_Si~m y2ͳO=Q|/)?_6υEeg{Ll_Si~m y2ͳO=Q|/)?_6υEeg{Ll_Si~m y2ͳO=Q|/)?_6υEeg{Ll_Si~m y2ͳO=Q|/)?_6υEeg{Ll_Si~m y2ͳO=Q|/)?_6υEeg{Ll_Si~m y2ͳO=Q|/)?_6υEeg{Ll_Si~m y2ͳO=Q|/)?_6υEeg{Ll_Si~m y2ͳO=Q|/)?_6υEeg{Ll_Si~m y2ͳO=Q|/)?_6υEeg{Ll_Si~m y2ͳO=Q|/)?_6υEeg{Ll_Si~m y2ͳO=Q|/)?_6υEeg{Ll_Si~m y2ͳO=Q|/)?_6υEeg{Ll_Si~m y2ͳO=Q|/)?_6υEeg{Ll_Si~m y2ͳO=Q|/)?_6υEeg{Ll_Si~m y2ͳO=Q|/)?_6υEyGtV>Wly8r ]4tC,׉f%P8tyګR- m-0~ Ek]Sqs 8z&%@:z?OB_9@|K7Xh= |'/yc>d%,̞s}Зo2z?OB_9@|K7Xh= |'/yc>d%,̞s}Зo2z?OB_9@|K7Xh= |'/yc>d%,̞s}Зo2z?OB_9@|K7Xh= |'/yc>d%,̞s}Зo2z?OB_9@|K7Xh= |'/yc>d%,̞s}Зo2z?OB_9@|K7Xh= |'/yc>d%,̞s}Зo2z?OB_9@|K7Xh= |'/yc>d%,̞s}Зo2z?OB_9@|K7Xh= |'/yc>d%,̞s}Зo2z?OB_9@|K7Xh= |'/yc>d%,̞s}Зo2z?OB_9@|K7Xh= |'/yc>d%,̞s}Зo2z?OB_9@|K7Xh= |'/yc>d%,̞s}Зo2z?OB_9@|K7Xh= |'/yc>d%,̞s}Зo2z?OB_9@|K7Xh= |'/yc>d%,̞s}Зo2z?OB_9@|K7Xh= |'/yc>d%,̞s}Зo2z?OB_9@|K7Xh= |'/yc>d%,̞s}Зo2z?OB_9@|K7Xh= |'/yc>d%,̞s}Зo2z?TwDtX?Ή덧v+_}VW޲cg#q^-ll &zY|WeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD_ٝ$$If!vh#v #v[:V l t065 5[pyt-x$$If!vh#v #v[:V l t065 5[pyt-x$$If!vh#v #v[:V l t065 5[pyt-x$$If!vh#v #v[:V l t065 5[pyt-x$$If!vh#v #v[:V l t065 5[pyt-x$$If!vh#v #v[:V l t065 5[pyt-x$$If!vh#v #v[:V l t065 5[pyt-xj:  666666666666666666666666666666666666666666 666666666 666666666666 66666666666666666666666666666666666666666666666666666666666666666q62 0@P`p28 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~ OJPJQJ_HmH nH sH tH J`J 9&Normal dCJ_HaJmH sH tH h@h &N6L Heading 1d:1$@&&5CJOJPJQJ\^JaJmH sH Z@"Z 'N6L Heading 2d1$@&^ `dCJ^JaJmH sH T@2T (N6L Heading 3d1$@&^5\^JmH sH DA`D Default Paragraph FontRi@R 0 Table Normal4 l4a (k ( 0No List PB@P 9& Body Textd1$^dCJaJmH sH ToT 9&Body Text Char CJOJPJQJ^JaJmH sH :U`: L0 Hyperlink>*B*^JphF'`!F s\0Comment Reference CJ^JaJB@2B s\0 Comment TextdCJaJFoAF s\0Comment Text Char CJ^JaJ@j@12@ s\0Comment Subject5\RoaR s\0Comment Subject Char5CJ\^JaJR@rR s\0 Balloon Text dCJOJQJ^JaJNoN s\0Balloon Text CharCJOJQJ^JaJtOtQIEndNote Bibliography Title a$CJOJQJmHnHsH unonQIEndNote Bibliography Title CharCJOJQJmHnHufOfQIEndNote BibliographydCJOJQJmHnHsH ubobQIEndNote Bibliography CharCJOJQJmHnHu@@@ $0List Paragraph ^m$r@r }cp Table Grid7:V0CJaJ>> &30HeaderdH$2o2 &30 Header Char^J> @> "&30Footer!dH$2o!2 !&30 Footer Char^Jo3 3dp Table Grid1N:V#044 la#_HmH sH tH FoAF 0List Paragraph CharmH sH @&`Q@ 0Footnote ReferenceH*RoaR N6LHeading 1 Char5CJOJPJQJ\^JaJ@oq@ N6LHeading 2 Char CJ^JaJ>o> N6LHeading 3 Char 5\^JZ+@Z *N6L0 Endnote Text )dCJOJPJQJaJmH sH NoN )N6L0Endnote Text CharCJOJPJQJaJ>*`> N6L0Endnote ReferenceH*^o^ N6L0Default ,7$8$H$)B*CJOJQJ_HaJmH phsH tH H@H .N6L0 Footnote Text -dCJaJLoL -N6L0Footnote Text CharCJaJmH sH @ N6LMedium Shading 1 - Accent 1-:V/0{{{{{j%@ jj jD{{{{jQ{{{{ O44(/fdfdMOJPJQJ^JmH sH 5\5\5\5B*\phD`DN6L0Revision0CJ$_HaJmH sH tH O N6Lp Table Grid27:V101OJPJQJ^JmH sH `O"` N6LTable Paragraph2d1$OJPJQJ^JmH sH P`2P 4N6L No Spacing3 CJPJ_HaJmH nHsH tHNoAN 3N6LNo Spacing CharOJPJQJ^JnHtHOS N6LLight List - Accent 11:V50OOOOj.@OOOOj.OOOOj.OOOOj O44(5fdfdMOJPJQJ^JmH sH 5\5\5\5B*\ph@c N6LLight List - Accent 1:V60OOOOj.@OOOOj.OOOOj.OOOOj O44(6fdfdMOJPJQJ^JmH sH 5\5\5\5B*\ph`^@r` N6L0 Normal (Web)7ddd[$\$CJOJPJQJaJtH BOB N6Lapple-converted-spaceFV`F N6L0FollowedHyperlink >*B*phPK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭V$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3N)cbJ uV4(Tn 7_?m-ٛ{UBwznʜ"Z xJZp; {/<P;,)''KQk5qpN8KGbe Sd̛\17 pa>SR! 3K4'+rzQ TTIIvt]Kc⫲K#v5+|D~O@%\w_nN[L9KqgVhn R!y+Un;*&/HrT >>\ t=.Tġ S; Z~!P9giCڧ!# B,;X=ۻ,I2UWV9$lk=Aj;{AP79|s*Y;̠[MCۿhf]o{oY=1kyVV5E8Vk+֜\80X4D)!!?*|fv u"xA@T_q64)kڬuV7 t '%;i9s9x,ڎ-45xd8?ǘd/Y|t &LILJ`& -Gt/PK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!0C)theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] z  7 *********-S X$.X|hDS_& j T N # 4)B&7)`,s/47d;k?0CFL=PSY\`Xckegil o:r/u/y>|~'S߇77֑lI,8yԲVKv7~@ g<S{ hs+0zQQQQQ@ $&-!T # @H 0(  0(  B S  ?| }   36cf "'>CV[bjmry   ;!>!Y!\!b"g"s"y"""""""""""# ###'#,#8#;#F#K#r#w#####$$1$4$5$D$Y$^$$$$$$$$$$$$$$$$$$%%%)%:%A%F%R%U%Y%`%b%g%m%v%w%%%%%%%%%%% &&/&d&k&&&''((,(1(N(U(b(g((((((((() )>)D)Q)V)))))))))))**!*(*Y*^*}************************l+u+++++++++++++++++,,/,C,F,i,l,~,,,,,,,,,,--%-*-1-9-<-A-H-S-V-[-b-n-q-v-}---------.....//,///f/i/|///////////0001060=0E0H0M0T0_0b0g0n0z0}00000000000011-101Q1T1m1p1111111$2'26292a2g222222233)33383>3]3b33333333333/474F4M4t4y4444444444555.5155555=6@6[6^6d7i7u7{777777777778 888)8.8:8=8H8M8t8y888888899999:-:0:U:X:k:n:::::::::::::;;;&;);.;5;@;C;H;O;[;^;c;j;v;y;~;;;;;;;7<:<z<}<<<<=B=L=R=W=a=d=i=============#>(>9>>>Q>T>k>n>}>>>>>>>>???!?R?T?V?X?w?z???+@3@g@l@@@@@@@AAgAoAtAxA{AAAABB B'BZB_BBBBBBB!C&C,C=CDCKCgClCCCCCCCCDHDMDTD`D~DDDDDDDDDD EE7E;EBEGERETEgEiEjEnEvExE|EEEEEEEEEEEEF FFF GG!G$GQGTGyG|GGGGGGGGGGGHHH#H6H;HBHJHMHRHYHdHgHlHsHHHHHHHHHHHHIIOIRI|IIIIIIJJJJJJJJJJJJK K.K3K?KBKMKRKyK~KKKL(LLLLLLLM"M)M2M:MDMWMaMuMzMMMMMMMMMMM'N,N3N9NKNTNYNbNfNkNNNNN*O/O6O?OsOxOOOOOOOOOOOOOOOOOP"P0P6P:P?PtP{PPP"R%R\R_RRRRRRRRRRRRS SSSS"S-S0S5ScEcJcSc\cccsczcccccccccccccd ddd,d3dBdId[dbdpdwd}dddddddddeeeeEeJeRe^e}eeeeeeeef&f-f6f=fHfOfXf`fhflfsffffffffffffg"g,ggg hh"h$h?iBiyi|iiiiiiiiij jj!j(j0j3j8j?jJjMjRjYjejhjmjtjjjjjjjjjjjjjkkkkkl&l,l:lllllllmm(m-mLmQmWmgmmmymmmmmmmmmn(n-n4n_ndn{nnnnnno oooo"o)o3o6o;oAoVo]ofoionouoooooooooooopppp&p+pApFpYpapcphpnppppppppppq-q3qFqnqqqqqqqqqqq r r!r'r=rCrWr]rsryrrrrrrrrrrsss's(s8s>sVs\sqswsssssssssstt%t{E{Q{X{e{l{x{{{{{{{{{{{{{{| ||!|/|6|E|L|Z|a|p|w|||||||||||||} }} },}3}B}I}Y}`}o}v}}}}}}}}}}}}}})~0~;~C~r~y~~~~~~~~~~ #(6;IN\aty BGO[z#*3:ELU]eip|Ɂс) #%&)VY~̈́ۄ #(;@GORW^ilqxʅυՅ$';>Іӆ,6L]y$16MR_dň+0V_dkωԉ!9AFPTY`jmrxŠNJ͊ߊ %:?GL]blow|ы֋݋NQx{|Όӌڌ :?qv|ƍ̍9CގDGpu>CGLPVchpz~Ґ%',BJNVZcejr|ȑΑґՑّ*:BFNZbdiq{ȒђՒܒ (/38<DHTX_ckox|Ó˓ϓړޓ ")-7;@DJNVZaejnuyÔǔϔܔ  $,09HOQV^jnvzǕ˕Օٕ #*.59@DJNVZdqy}ȖՖٖ $+-2:FRX\dfkrƗЗԗܗޗ"+/68=xBGmršȚ%+R]afśɛΛ +/4;D^c%).ioȝ˝Н )2=FINUf~ÞȞFKil%*Y^x}Ơ̠Ѡݠ!INo|-0KN $.16]cgḷѣ =B.<HMPUhmåȥϥۥޥ!&,=rwæ36LOnp{ȩΩҩש4:>CU[ͪҪZ_ګ߫ "EJ`e¬Ѭ -4CX]˭ҭޭDIǮҮծڮ6;AT[ehmįɯ&,=BHTnѰ$);@cimrƱֱ۱).<GUf|Ʋ (-chn~ѳֳ ,1HM`eltw|ĵǵ̵ DIԶ׶·#)-2`guz¸Ǹٸ޸"029<sv»ǻʻϻ"*-29DGLS_bgnz}CEGIduvxz|ӽս=?AC˾su.1fi")47<CJLSX_ahkpw~ 0>FNagjo#/27>OSbdi &).4FY`cho{ "'.:rw ,QWZ_gruz#07HOe{~5@KPfkns"%* <CGLaf Zaz|Zh#'27CSZcnsy "()7JPSX^ijvOT ,AGJOU`gopvy~#5;LS`chny %*CHNWmr $*5FLOTZhnx~+9$)HMSciu{#(/Z_w| '149@U]finv #-8FT[l [^ #+69>FRUZbnqvsy +.9>ej| IPik (>D,sFJKZ"/?L)0MNZu{   36cf $'@CX[or  * 6 ;!>!Y!\!!!!" ""$"-"d"g"""""##)#,#H#K#t#w#####1$4$[$^$$$$$$$$%%%%(%d%g%m%v%%%%%%%& &&&W&\&''.(1(d(g((((( ) )S)V)))))[*^*****++++++++,,/,C,F,i,l,~,,,,,,,,--'-*->-A-X-[-s-v---------..//,///f/i/|/////////0003060J0M0d0g0000000000011-101Q1T1m1p1111111$2'262922233_3b33333v4y44444455 5.5155555=6@6[6^66667 77&7/7f7i7777788+8.8J8M8v8y8888899999:-:0:U:X:k:n:::::::::::;;+;.;E;H;`;c;{;~;;;;;;;7<:<z<}<<<<<f=i=======%>(>;>>>Q>T>k>n>}>>>>>>?!?V?X?w?z???B@K@r@y@@@@@}AABB\B_BBB#C&C:C=CiClCCCCCCCJDMDDDDDDDDDEEDEGEEEEEFF GG!G$GQGTGyG|GGGGGGGGGHH H#H8H;HOHRHiHlHHHHHHHHHIIOIRI|IIIIIIcYc\cpcsccccccccccccccddd)d,d?dBdXd[dmdpdddddeeGeJeeeeeeeeef&f-f6f=fHfOfXf`fhffffffffg7g=gmgvggh?iBiyi|iiiiiiij jj!j5j8jOjRjjjmjjjjjjjjjjjjkllll*m-m4m8mWmemmmwmmmmmandn}nnnno"o8o;oAoTokonooooooooooo(p+pCpFp_papnp}pppppppq%q=qFq_qhqnq~qqqqqqqqqq r4r=rNrWrjrsryrrrrrrrrrrss/s8s:sMNZu{333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333>7  &&3h5h1 FFDD+-vwMNZu{-T'dyNT.osް`SO&XR~ q0n*R25ogO4qJ±(`urR%`.XXp-;c׮fjs~Ggx­,U8RJjNh^h`B*CJOJQJo(ph- 8^8`OJQJo(o ^`OJQJo(  ^ `OJQJo(  ^ `OJQJo(o x^x`OJQJo( H^H`OJQJo( ^`OJQJo(o ^`OJQJo(h^h`B*CJOJQJo(ph- 8^8`OJQJo(o ^`OJQJo(  ^ `OJQJo(  ^ `OJQJo(o x^x`OJQJo( H^H`OJQJo( ^`OJQJo(o ^`OJQJo(^`^J.^`^J.pLp^p`L^J.@ @ ^@ `^J.^`^J.L^`L^J.^`^J.^`^J.PLP^P`L^J.h^h`B*CJOJQJo(ph- 8^8`OJQJo(o ^`OJQJo(  ^ `OJQJo(  ^ `OJQJo(o x^x`OJQJo( H^H`OJQJo( ^`OJQJo(o ^`OJQJo( h^h`OJQJo(8^8`OJQJ^Jo(o ^`OJQJo(  ^ `OJQJo( ^ `OJQJ^Jo(o x^x`OJQJo( H^H`OJQJo(^`OJQJ^Jo(o ^`OJQJo( h^h`OJQJo(8^8`OJQJ^Jo(o ^`OJQJo(  ^ `OJQJo( ^ `OJQJ^Jo(o x^x`OJQJo( H^H`OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o p^p`OJQJo( @ ^@ `OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o P^P`OJQJo(h^h`B*CJOJQJo(ph- 8^8`OJQJo(o ^`OJQJo(  ^ `OJQJo(  ^ `OJQJo(o x^x`OJQJo( H^H`OJQJo( ^`OJQJo(o ^`OJQJo(h^h`B*CJOJQJo(ph- 8^8`OJQJo(o ^`OJQJo(  ^ `OJQJo(  ^ `OJQJo(o x^x`OJQJo( H^H`OJQJo( ^`OJQJo(o ^`OJQJo(^`CJOJQJo( ^`OJQJo(o ^`OJQJo( x ^x `OJQJo( H^H`OJQJo(o ^`OJQJo( ^`OJQJo( ^`OJQJo(o ^`OJQJo(^`OJPJQJo(- ^`OJQJo(o p^p`OJQJo( @ ^@ `OJQJo( ^`OJQJo(o ^`OJQJo( ^`OJQJo( ^`OJQJo(o P^P`OJQJo(h^h`B*CJOJQJo(ph- 8^8`OJQJo(o ^`OJQJo(  ^ `OJQJo(  ^ `OJQJo(o x^x`OJQJo( H^H`OJQJo( ^`OJQJo(o ^`OJQJo(^`CJOJPJQJo(- ^`OJQJo(o ^`OJQJo( x ^x `OJQJo( H^H`OJQJo(o ^`OJQJo( ^`OJQJo( ^`OJQJo(o ^`OJQJo(^`CJOJQJo( ^`OJQJo(o ^`OJQJo( x ^x `OJQJo( H^H`OJQJo(o ^`OJQJo( ^`OJQJo( ^`OJQJo(o ^`OJQJo(^`^J.^`^J.pL^p`L^J.@ ^@ `^J.^`^J.L^`L^J.^`^J.^`^J.PL^P`L^J.^`o()^`.pL^p`L.@ ^@ `.^`.L^`L.^`.^`.PL^P`L.h^h`B*CJOJQJo(ph- 8^8`OJQJo(o ^`OJQJo(  ^ `OJQJo(  ^ `OJQJo(o x^x`OJQJo( H^H`OJQJo( ^`OJQJo(o ^`OJQJo(GgxqJ(`p-;cfNT,UsSO&oJj'd-%`*R2gO4~ q0z        z                 z                                   z        z        TFz        J        z        >2[                                   z         c( 6 6 6 6D0(Zc 7(&2G28iSL]fHW[]{c6olr# _/l1:>Qi.]  S<R5s?HU;]ev8L`}( ?K ^ o  c& ) c s vv y p $ k /# }  `3 &S a A f ^A2">D FGn\^Rs}~fk@O^cfwh pInj03=}c]f6}I$Oh _"$%BVAR0$wZph+7&=I6lm^sHJHKm!-JLs\"i&kl0$>1]x{`*-ru8=[#,BIg"-UV\S^(:)Hz" ( |5 : X a bj /2!E!P!E\!"&*"-"4V" #)#.#*K#R#GV#]#`#$g#$b;$l % %:%u%&0&9&=6'":'n'o'q'v'o{'z())yF)UO)V)h)5k)f*|*S+H)+d+_,,$A,J, --'-K[-y- ..o%.?.H.Z.a.O$/nf/#t/0#04t0~0+ 1 111;1DL1BS1\12528@2B2i2&3H3Z34= 4O4W4]4:45@k5666Y6}=6i6i6 777A78*"8.8+V8v8899%$9#/909a0929: :; ;TD;G;L;Nn;|<(<.<Y<Pj<v<[=p=>g)>:>[>?7??m?I@@D&@X@ A$A.CB[BhB}B:CGCSC]C^C"D'D EEE|E%E$F8FFqWFhuFwFGjG'G+9GDGgPGgGH"Hu2HRCH-MH\H[`HQIcIa>I@IdI~IJJ3J}gJqJK.K7K%KJK&L L$LN6L PLTL7^LqLv{L|/MWMeMlhMhyMs,NPkN(O6O_OwOPIPpPqxP|PQ Q"Q%Q7QR.RERfRsR SS(&SLSTSSUQTlTj UU'U_?USUVV{oVWW"Wt`WcW>pW/xW~>XaXrXyX~XIYYYb7Y:WY ZZAhZxZ[L[,U[XZ[s[%\]]]^]x]^^(^M^[^_ _.__V_Ah__`))`9,`mP`W`x`6 aPaya3 bbDb%b'b{/bw@bPbib5wbcclcXdedee9ede%fVSf`fafg#gt;g h$h7Vhwh~hi>iW[i8jij)j-@j@jiGjQj_jpk\#k'k2kFOkp_krkNlrUl>qlm0m9mBmvm|*nRphpq3qKq3r&Gr/vrxrbsJsZMsls tU tyGtXUt2ltsulzuvMv\v4whwYnw0{w-x0x:Ox]xozx~xy-yy$y/GyKy 8:<?Nbm(xc%,\4?ni[ %RZ`!2/N9YfyI|} @Qdpx *O5PS0 V6a=Q{ x|&1FGHNV0mC.mzE GX1:Q~S_vK22,IgNj L`3Y\_bgs0{}/7TPDQo*_#.vB[{^ SXj =DTdBa8isz"_6eeqpqOhr3+Ujkf W%jn~-bush;Hen!Vv{#S,7,9P:RnE&y>qCnNsG [26@q |\n?tz}L Gq|7SVedw/Pa3HJ YpCq M"$){._Zc2@wX|&p1g35FHUlQekQe2+1>~c]oM,ktx&;/o/}yw1xG|]}-AzU@^y F_+7 c;U3789HY?z:GSXeNPEN.InstantFormat EN.Layout EN.Libraries<ENInstantFormat><Enabled>0</Enabled><ScanUnformatted>1</ScanUnformatted><ScanChanges>1</ScanChanges><Suspended>0</Suspended></ENInstantFormat><ENLayout><Style>Eur Spine J</Style><LeftDelim>{</LeftDelim><RightDelim>}</RightDelim><FontName>Times New Roman</FontName><FontSize>12</FontSize><ReflistTitle></ReflistTitle><StartingRefnum>1</StartingRefnum><FirstLineIndent>0</FirstLineIndent><HangingIndent>720</HangingIndent><LineSpacing>2</LineSpacing><SpaceAfter>0</SpaceAfter><HyperlinksEnabled>0</HyperlinksEnabled><HyperlinksVisible>0</HyperlinksVisible><EnableBibliographyCategories>0</EnableBibliographyCategories></ENLayout><<Libraries><item db-id="sf0t0pvv3dxsf3eexw8xe9fl2vwr5t9stp55">NAD Guideline Library<record-ids><item>1</item><item>2</item><item>3</item><item>4</item><item>5</item><item>6</item><item>7</item><item>8</item><item>9</item><item>10</item><item>11</item><item>12</item><item>13</item><item>14</item><item>15</item><item>16</item><item>17</item><item>32</item><item>35</item><item>36</item><item>37</item><item>38</item><item>39</item><item>40</item><item>42</item><item>43</item><item>44</item><item>45</item><item>46</item><item>48</item><item>49</item><item>50</item><item>51</item><item>53</item><item>54</item><item>55</item><item>56</item><item>57</item><item>58</item><item>59</item><item>60</item><item>63</item><item>64</item><item>65</item><item>66</item><item>67</item><item>68</item><item>69</item><item>71</item><item>72</item><item>73</item><item>74</item><item>75</item><item>76</item><item>77</item><item>78</item><item>79</item><item>81</item><item>82</item><item>83</item><item>85</item><item>86</item><item>87</item><item>88</item><item>89</item><item>90</item><item>91</item><item>92</item><item>93</item><item>95</item><item>96</item><item>97</item><item>98</item><item>99</item><item>100</item><item>101</item><item>102</item><item>103</item><item>104</item><item>110</item><item>112</item><item>113</item><item>114</item><item>115</item><item>116</item><item>117</item><item>118</item><item>119</item><item>120</item><item>121</item><item>123</item><item>125</item><item>127</item><item>128</item><item>130</item><item>131</item><item>132</item><item>138</item><item>141</item><item>143</item><item>144</item><item>147</item><item>148</item><item>149</item><item>150</item><item>151</item><item>152</item><item>153</item><item>154</item><item>155</item><item>156</item><item>157</item><item>158</item></record-ids></item></Libraries>@Lz`@``@``@`@Unknown G*Ax Times New Roman5Symbol3. *Cx ArialA$BCambria Math7.@Calibri5. .[`)TahomaG=  jMS Mincho-3 fg?= *Cx Courier New;Wingdings"1hC'C'*m4 *m4 "0OHP $P-2!xx Management of Neck Pain and Associated Disorders: A Clinical Practice Guideline from the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaborationmobilef Frank-manP            Oh+'08DT`p    Management of Neck Pain and Associated Disorders: A Clinical Practice Guideline from the Ontario Protocol for Traffic Injury Management (OPTIMa) CollaborationmobilefNormal Frank-man4Microsoft Office Word@F#@PՃ@h(փ4*m՜.+,0 hp  kUOIT  Management of Neck Pain and Associated Disorders: A Clinical Practice Guideline from the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration Title  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./12345679:;<=>?HILRoot Entry F@1փKData l1TableWordDocument kSummaryInformation(0DocumentSummaryInformation88MsoDataStorez1փQ1փXTRU4RA3FAOG==2z1փQ1փItem  PropertiesUCompObj r   F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q